QUARTERLY REPORT

Q2 2020 — Form 6-K results report

Q2 2020PDF · 120 pages4.0 MB
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
of the Securities Exchange Act of 1934
July 29, 2020
Commission File Number: 001-09246
Barclays PLC
(Name of Registrant)
1 Churchill Place
London E14 5HP
England
(Address of Principal Executive Office)
Interim Results Announcement
Indicate by check mark whether the registrant files or will file annual reports under cover of
Form 20-F or Form 40-F.
Form 20-F X Form 40-F
Indicate by check mark whether the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
____
Indicate by check mark whether the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
____
This report on Form 6-K shall be deemed to be incorporated by reference in the registration statements on Form S-8 (No. 333-153723,
333-167232, 333-173899, 333-183110, 333-195098, 333-216361, 333-225082, 333-236905 and 333-236904) and Form F-3 (333-
223156) of Barclays PLC and to be a part thereof from the date on which this report is furnished, to the extent not superseded by
documents or reports subsequently filed or furnished.

-- 1 of 120 --

1
The Report comprises the following:
Exhibit 99.1 Results of Barclays PLC Group as of, and for the six months ended, 30 June 2020.
Exhibit 99.2 A table setting forth the issued share capital of Barclays PLC and the Barclays PLC Group’s total shareholders’
equity, indebtedness and contingent liabilities as at 30 June 2020, the most recent reported statement of
position, and updated for any significant or material items since that reporting date.
101.INS XBRL Instance Document
101.SCH XBRL Taxonomy Extension Schema
101.CAL XBRL Taxonomy Extension Schema Calculation Linkbase
101.DEF XBRL Taxonomy Extension Schema Definition Linkbase
101.LAB XBRL Taxonomy Extension Schema Label Linkbase
101.PRE XBRL Taxonomy Extension Schema Presentation Linkbase

-- 2 of 120 --

2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its
behalf by the undersigned, thereunto duly authorised.
BARCLAYS PLC
(Registrant)
Date: July 29, 2020 By: /s/ Garth Wright
Name: Garth Wright
Title: Assistant Secretary

-- 3 of 120 --

1
Exhibit 99.1
Barclays PLC
This exhibit includes portions from the previously published Results Announcement of Barclays PLC relating to the six months
ended 30 June 2020, as amended in part to comply with the requirements of Regulation G and Item 10(e) of Regulation S-K
promulgated by the US Securities and Exchange Commission (SEC), including the reconciliation of certain financial information to
comparable measures prepared in accordance with International Financial Reporting Standards (IFRS). The purpose of this
document is to provide such additional disclosure as required by Regulation G and Regulation S-K item 10(e), to delete certain
information not in compliance with SEC regulations and to include reconciliations of certain non-IFRS figures to the most directly
equivalent IFRS figures for the periods presented. This document does not update or otherwise supplement the information
contained in the previously published Results Announcement. Any reference to a website in this document is made for
informational purposes only, and information found at such websites is not incorporated by reference into this document.
An audit opinion has not been rendered in respect of this document.

-- 4 of 120 --

Table of Contents
2
Results Announcement Page
Notes 3
Performance Highlights 5
Group Finance Director’s Review 7
Results by Business
 Barclays UK 9
 Barclays International 12
 Head Office 16
Quarterly Results Summary 17
Quarterly Results by Business 18
Performance Management
 Margins and Balances 24
Risk Management
 Risk Management and Principal Risks 25
 Credit Risk 27
 Market Risk 44
 Treasury and Capital Risk 45
Condensed Consolidated Financial Statements 56
Financial Statement Notes 62
Appendix: Non-IFRS Performance Measures 87
Shareholder Information 98
Glossary of Terms 99
Capitalisation and Indebtedness 117
BARCLAYS PLC, 1 CHURCHILL PLACE, LONDON, E14 5HP, UNITED KINGDOM. TELEPHONE: +44 (0) 20 7116 1000. COMPANY NO. 48839.

-- 5 of 120 --

Notes
3
The terms Barclays or Group refer to Barclays PLC together with its subsidiaries. Unless otherwise stated, the income statement analysis compares the six
months ended 30 June 2020 to the corresponding six months of 2019 and balance sheet analysis as at 30 June 2020 with comparatives relating to 31
December 2019 and 30 June 2019. The abbreviations ‘£m’ and ‘£bn’ represent millions and thousands of millions of Pounds Sterling respectively; the
abbreviations ‘$m’ and ‘$bn’ represent millions and thousands of millions of US Dollars respectively; and the abbreviations ‘€m’ and ‘€bn’ represent millions
and thousands of millions of Euros respectively.
There are a number of key judgement areas, for example impairment calculations, which are based on models and which are subject to ongoing adjustment
and modifications. Reported numbers reflect best estimates and judgements at the given point in time.
Relevant terms that are used in this document but are not defined under applicable regulatory guidance or International Financial Reporting Standards (IFRS)
are explained in the results glossary that can be accessed at home.barclays/investor-relations/reports-and-events/latest-financial-results.
The information in this announcement, which was approved by the Board of Directors on 28 July 2020, does not comprise statutory accounts within the
meaning of Section 434 of the Companies Act 2006. Statutory accounts for the year ended 31 December 2019, which contained an unmodified audit report
under Section 495 of the Companies Act 2006 (which did not make any statements under Section 498 of the Companies Act 2006) have been delivered to the
Registrar of Companies in accordance with Section 441 of the Companies Act 2006.
Barclays is a frequent issuer in the debt capital markets and regularly meets with investors via formal road-shows and other ad hoc meetings. Consistent with
its usual practice, Barclays expects that from time to time over the coming quarter it will meet with investors globally to discuss these results and other
matters relating to the Group.
Non-IFRS performance measures
Barclays management believes that the non-IFRS performance measures included in this document provide valuable information to the readers of the
financial statements as they enable the reader to identify a more consistent basis for comparing the businesses’ performance between financial periods and
provide more detail concerning the elements of performance which the managers of these businesses are most directly able to influence or are relevant for
an assessment of the Group. They also reflect an important aspect of the way in which operating targets are defined and performance is monitored by
Barclays management. However, any non-IFRS performance measures in this document are not a substitute for IFRS measures and readers should consider
the IFRS measures as well. Refer to the appendix on pages 87 to 97 for further information and calculations of non-IFRS performance measures included
throughout this document, and the most directly comparable IFRS measures.
Key non-IFRS measures included in this document, and the most directly comparable IFRS measures, are:
– Attributable profit excluding litigation and conduct represents attributable profit excluding litigation and conduct charges. The comparable IFRS measure is
attributable profit. A reconciliation is provided on pages 89 to 96;
– Average allocated equity represents the average shareholders’ equity that is allocated to the businesses. The comparable IFRS measure is average equity. A
reconciliation is provided on pages 89 to 95;
– Average allocated tangible equity is calculated as the average of the previous month’s period end allocated tangible equity and the current month’s period
end allocated tangible equity. The average allocated tangible equity for the period is the average of the monthly averages within that period. Period end
allocated tangible equity is calculated as 13.0% (2019: 13.0%) of RWAs for each business, adjusted for capital deductions, excluding goodwill and intangible
assets, reflecting the assumptions the Group uses for capital planning purposes. Head Office allocated tangible equity represents the difference between the
Group’s tangible shareholders’ equity and the amounts allocated to businesses. The comparable IFRS measure is average equity. A reconciliation is provided
on pages 89 to 95;
– Average tangible shareholders’ equity is calculated as the average of the previous month’s period end tangible equity and the current month’s period end
tangible equity. The average tangible shareholders’ equity for the period is the average of the monthly averages within that period. The comparable IFRS
measure is average equity. A reconciliation is provided on pages 89 to 95;
– Basic earnings per share excluding litigation and conduct is calculated by dividing statutory profit after tax attributable to ordinary shareholders excluding
litigation and conduct charges, by the basic weighted average number of shares. The comparable IFRS measure is basic earnings per share. A reconciliation is
provided on pages 89 to 91;
– Cost: income ratio excluding litigation and conduct represents operating expenses excluding litigation and conduct charges, divided by total income. The
comparable IFRS measure is cost: income ratio. A reconciliation is provided on pages 89 to 95;
– Operating expenses excluding litigation and conduct represents operating expenses excluding litigation and conduct charges. The comparable IFRS measure
is operating expenses. A reconciliation is provided on pages 89 to 95;
– Pre-provision profits is calculated by excluding credit impairment charges from profit before tax. The comparable IFRS measure is profit before tax. A
reconciliation is provided on pages 89 to 91;
– Pre-provision profits excluding litigation and conduct is calculated by excluding litigation and conduct, and credit impairment charges from profit before tax.
The comparable IFRS measure is profit before tax. A reconciliation is provided on pages 89 to 91;
– Profit before tax excluding litigation and conduct represents profit before tax excluding litigation and conduct charges. The comparable IFRS measure is
profit before tax. A reconciliation is provided on pages 89 to 96;
– Return on average allocated equity represents the return on shareholders’ equity that is allocated to the businesses. The comparable IFRS measure is return
on equity. A reconciliation is provided on page 97;
– Return on average allocated tangible equity is calculated as the annualised profit after tax attributable to ordinary equity holders of the parent, as a
proportion of average allocated tangible equity. The comparable IFRS measure is return on equity. A reconciliation is provided on page 97;
– Return on average allocated tangible equity excluding litigation and conduct is calculated as the annualised profit after tax attributable to ordinary equity
holders of the parent excluding litigation and conduct charges, as a proportion of average allocated tangible equity. The comparable IFRS measure is return
on equity. A reconciliation is provided on page 97;
– Return on average tangible shareholders’ equity is calculated as the annualised profit after tax attributable to ordinary equity holders of the parent, as a
proportion of average shareholders’ equity excluding non-controlling interests and other equity instruments adjusted for the deduction of intangible assets
and goodwill. The comparable IFRS measure is return on equity. A reconciliation is provided on page 97; and

-- 6 of 120 --

Notes
4
– Tangible net asset value per share is calculated by dividing shareholders’ equity, excluding non-controlling interests and other equity instruments, less
goodwill and intangible assets, by the number of issued ordinary shares. The comparable IFRS measure is net asset value per share. A reconciliation is
provided on page 96.
Forward-looking statements
This document contains certain forward-looking statements within the meaning of Section 21E of the US Securities Exchange Act of 1934, as amended, and
Section 27A of the US Securities Act of 1933, as amended, with respect to the Group. Barclays cautions readers that no forward-looking statement is a
guarantee of future performance and that actual results or other financial condition or performance measures could differ materially from those contained in
the forward-looking statements. These forward-looking statements can be identified by the fact that they do not relate only to historical or current facts.
Forward-looking statements sometimes use words such as ‘may’, ‘will’, ‘seek’, ‘continue’, ‘aim’, ‘anticipate’, ‘target’, ‘projected’, ‘expect’, ‘estimate’, ‘intend’,
‘plan’, ‘goal’, ‘believe’, ‘achieve’ or other words of similar meaning. Forward-looking statements can be made in writing but also may be made verbally by
members of the management of the Group (including, without limitation, during management presentations to financial analysts) in connection with this
document. Examples of forward-looking statements include, among others, statements or guidance regarding or relating to the Group’s future financial
position, income growth, assets, impairment charges, provisions, business strategy, capital, leverage and other regulatory ratios, payment of dividends
(including dividend payout ratios and expected payment strategies), projected levels of growth in the banking and financial markets, projected costs or
savings, any commitments and targets, estimates of capital expenditures, plans and objectives for future operations, projected employee numbers, IFRS
impacts and other statements that are not historical fact. By their nature, forward-looking statements involve risk and uncertainty because they relate to
future events and circumstances. The forward-looking statements speak only as at the date on which they are made and such statements may be affected by
changes in legislation, the development of standards and interpretations under IFRS, including evolving practices with regard to the interpretation and
application of accounting and regulatory standards, the outcome of current and future legal proceedings and regulatory investigations, future levels of
conduct provisions, the policies and actions of governmental and regulatory authorities, geopolitical risks and the impact of competition. In addition, factors
including (but not limited to) the following may have an effect: capital, leverage and other regulatory rules applicable to past, current and future periods; UK,
US, Eurozone and global macroeconomic and business conditions; the effects of any volatility in credit markets; market related risks such as changes in
interest rates and foreign exchange rates; effects of changes in valuation of credit market exposures; changes in valuation of issued securities; volatility in
capital markets; changes in credit ratings of any entity within the Group or any securities issued by such entities; direct and indirect impacts of the
coronavirus (COVID-19) pandemic; instability as a result of the exit by the UK from the European Union and the disruption that may subsequently result in the
UK and globally; and the success of future acquisitions, disposals and other strategic transactions. A number of these influences and factors are beyond the
Group’s control. As a result, the Group’s actual financial position, future results, dividend payments, capital, leverage or other regulatory ratios or other
financial and non-financial metrics or performance measures may differ materially from the statements or guidance set forth in the Group’s forward-looking
statements. Additional risks and factors which may impact the Group’s future financial condition and performance are identified in our filings with the SEC
(including, without limitation, our Annual Report on Form 20-F for the fiscal year ended 31 December 2019 and our 2020 Interim Results Announcement for
the six months ended 30 June 2020 filed on Form 6-K), which are available on the SEC’s website at www.sec.gov.
Subject to our obligations under the applicable laws and regulations of any relevant jurisdiction, (including, without limitation, the UK and the US), in relation
to disclosure and ongoing information, we undertake no obligation to update publicly or revise any forward-looking statements, whether as a result of new
information, future events or otherwise.

-- 7 of 120 --

Performance Highlights
5
Open for business during the COVID-19 pandemic, helping support the economy
COVID-19 support
Supporting customers,
business, the community, and
our colleagues
 c.600k payment holidays1 provided to customers, including c.121k in UK mortgages, c.157k in UK
credit cards, c.106k in UK personal loans and point of sale finance, and c.216k in US credit cards
 Provided c.£22bn of COVID-19 support for UK businesses, including enabling c.£7.7bn of
government backed Bounce Back Loans1, lending c.£2.5bn under the CBILS programmes1,2 and
facilitating c.£11.7bn of commercial paper issuance1
 Helped businesses and institutions to access the global capital markets, including raising c.£620bn
of new issuance in the second quarter
 £45m of the £100m Community Aid Package distributed to charities and 817 branches remained
open throughout the COVID-19 pandemic, over three-quarters of the branch network
 70k of 88k colleagues working from home
Diversified business model delivered a resilient operating performance in H120
Despite the impacts of the COVID-19 pandemic, Barclays delivered a H120 Group profit before tax of £1.3bn (H119: £3.0bn), resulting in
a return on equity (RoE) of 2.5% (H119: 7.7%), a return on tangible equity (RoTE) of 2.9% (H119: 9.1%) and earnings per share (EPS) of
4.0p (H119: 12.1p). Pre-provision profits (profit before tax excluding credit impairment charges) increased 27% to £5.0bn, while credit
impairment charges increased to £3.7bn (H119: £0.9bn)
Income
Strong CIB income offsetting
challenges in Barclays UK and
CC&P
Group income of £11.6bn up 8% versus prior year
 Corporate and Investment Bank (CIB) income of £6.9bn up 31% versus prior year driven by a
standout performance in Markets
 Consumer, Cards and Payments (CC&P) income of £1.7bn down 21% versus prior year primarily
due to lower balances and consumer spending volumes
 Barclays UK income of £3.2bn down 11% versus prior year reflecting lower interest rates and UK
cards balances, COVID-19 customer support actions and the removal of certain fees
Costs
Improved cost: income ratio
Group total operating expenses of £6.6bn down 4% versus prior year
 Cost efficiencies and cost discipline contributed to positive cost: income jaws of 12% resulting in an
improved cost: income ratio of 57% (H119: 64%)
Credit impairment charges
Increased impairment
provisioning driving higher
coverage ratios across
portfolios
Credit impairment charges increased to £3.7bn (H119: £0.9bn), including £1.6bn in Q220
 The charge reflects £0.6bn in respect of single name wholesale loan charges in the period and
£2.4bn impact from revised IFRS 9 scenarios
 Impairment coverage ratio for the unsecured consumer lending portfolio increased to 12.0% (FY19:
8.1%). Coverage for exposures to selected industry sectors regarded as particularly vulnerable to
the COVID-19 pandemic increased to 4.0% (FY19: 2.3%)
Capital, liquidity and TNAV
Strong capital and liquidity
position
Common equity tier 1 (CET1) ratio of 14.2% (December 2019: 13.8%)
 The increase over the first half of the year reflects profits, regulatory measures and cancellation of
the full year 2019 dividend payment, partially offset by higher Risk Weighted Assets (RWAs)
 Headroom of 3.0% above revised Maximum Distributable Amount (MDA) hurdle, which has reduced
to 11.2%3
 Net asset value (NAV) per share was 331p (December 2019: 309p). Tangible net asset value (TNAV)
per share increased to 284p (December 2019: 262p)
Group outlook
Group outlook
Given the uncertain economic
outlook and low interest rate
environment, the second half of
the year is expected to
continue to be challenging
 Income in Barclays UK and CC&P is expected to gradually recover from Q220 levels, but certain
headwinds, including from the low interest rate environment, are likely to persist into 2021
 After a strong performance in H120 the CIB franchise is well positioned for the future
 Impairment in H220 is expected to remain above the level experienced in recent years, but to be
below the H120 impairment charge assuming no change in macroeconomic forecasts
 Continued focus on cost discipline, but short-term headwinds remain from spend on COVID-19
initiatives
 In H220 there may be headwinds to the CET1 ratio from procyclical effects on RWAs, and reduced
benefit from transitional relief on IFRS 9 impairment
 The Board will decide on future dividends and its capital returns policy at FY20
1 Payment holiday data as at 22 July 2020. Business lending and commercial paper issuance data as at 27 July 2020.
2 The Coronavirus Business Interruption Loan Scheme (CBILS) and the Coronavirus Large Business Interruption Loan Scheme programmes (together the CBILS programmes).
3 Barclays’ MDA hurdle reduced to 11.2% in July 2020, and will fluctuate through the cycle given recent regulatory changes.

-- 8 of 120 --

Performance Highlights
6
Barclays Group results
for the half year ended 30.06.20 30.06.19
£m £m % Change
Total income 11,621 10,790 8
Credit impairment charges (3,738) (928)
Net operating income 7,883 9,862 (20)
Operating expenses (6,563) (6,758) 3
Litigation and conduct (30) (114) 74
Total operating expenses (6,593) (6,872) 4
Other net (expenses)/income (18) 24
Profit before tax 1,272 3,014 (58)
Tax charge (113) (545) 79
Profit after tax 1,159 2,469 (53)
Non-controlling interests (37) (34) (9)
Other equity instrument holders (427) (363) (18)
Attributable profit 695 2,072 (66)
Performance measures
Return on average shareholders' equity 2.5% 7.7%
Return on average tangible shareholders' equity 2.9% 9.1%
Average shareholders' equity (£bn) 56.8 53.7
Average tangible shareholders' equity (£bn) 48.6 45.7
Cost: income ratio 57% 64%
Loan loss rate (bps) 207 54
Basic earnings per share 4.0p 12.1p
Dividend per share - 3.0p
Performance measures excluding litigation and conduct1
Profit before tax 1,302 3,128 (58)
Attributable profit 710 2,158 (67)
Return on average tangible shareholders' equity 2.9% 9.4%
Cost: income ratio 56% 63%
Basic earnings per share 4.1p 12.6p
As at 30.06.20 As at 31.12.19 As at 30.06.19
Balance sheet and capital management2 £bn £bn £bn
Net asset value per share 331p 309p 322p
Tangible net asset value per share 284p 262p 275p
Common equity tier 1 ratio 14.2% 13.8% 13.4%
Common equity tier 1 capital 45.4 40.8 42.9
Risk weighted assets 319.0 295.1 319.1
Average UK leverage ratio 4.7% 4.5% 4.7%
UK leverage ratio 5.2% 5.1% 5.1%
Funding and liquidity
Group liquidity pool (£bn) 298 211 238
Liquidity coverage ratio 186% 160% 156%
Loan: deposit ratio 76% 82% 82%
1 Refer to pages 87 to 96 for further information and calculations of performance measures excluding litigation and conduct.
2 Refer to pages 49 to 54 for further information on how capital, RWAs and leverage are calculated.

-- 9 of 120 --

Group Finance Director’s Review
7
Group performance
 RoE was 2.5% (H119: 7.7%). Statutory RoTE was 2.9% (H119: 9.1%) and statutory EPS was 4.0p (H119: 12.1p)
 Profit before tax was £1,272m (H119: £3,014m). Excluding litigation and conduct, profit before tax was £1,302m (H119:
£3,128m), as positive operating leverage from an 8% increase in income and 3% reduction in operating expenses was offset by
materially higher credit impairment charges
 Pre-provision profits increased 27% to £5,010m, benefitting from the Group’s diversified business model, as strong
performance in CIB more than offset income headwinds in Barclays UK and CC&P
 Total income increased 8% to £11,621m. Barclays UK income decreased 11% due to ongoing margin pressure, including COVID-
19 customer support actions, base rate reductions, lower UK cards interest earning lending (IEL) and overdraft balances, as well
as lower income due to the removal of certain fees in overdrafts and UK cards. Barclays International income increased 16%,
with CIB income up 31% and CC&P income down 21%. Within CIB, Markets income increased due to a strong performance
across FICC and Equities. Banking fees income increased reflecting a strong performance in debt and equity capital markets,
while there was a reduction in Corporate income driven by fair value losses, margin compression and carry costs on hedges.
CC&P income decreased primarily as a result of lower balances on co-branded cards and a c.£100m valuation loss on Barclays’
preference shares in Visa Inc.
 Credit impairment charges increased to £3,738m (H119: £928m). This increase primarily reflects £591m in respect of single
name wholesale loan charges and £2.4bn impact from revised IFRS 9 scenarios (the “COVID-19 scenarios”) reflecting forecast
deterioration in macroeconomic variables (including a prolonged period of heightened UK and US unemployment), partially
offset by the estimated impact of central bank, government and other support measures
 The Group cost: income ratio was 57% (H119: 64%). Operating expenses decreased 3% to £6,563m reflecting cost efficiencies
and continued cost discipline in the current environment. The Group delivered positive cost: income jaws of 11% which
resulted in the Group cost: income ratio, excluding litigation and conduct, reducing to 56% (H119: 63%). The Group accrued
compensation costs reflective of business performance, resulting in a compensation: income ratio of 32.2% (H119: 34.4%)
 The effective tax rate was 8.9% (H119: 18.1%). This reflects the tax benefit recognised for a re-measurement of UK deferred tax
assets as a result of the UK corporation tax rate being maintained at 19%. The Group’s effective tax rate for the full year is
expected to be around 20%, excluding litigation and conduct
 Attributable profit was £695m (H119: £2,072m). Excluding litigation and conduct, attributable profit was £710m (H119:
£2,158m), generating a RoTE of 2.9% (H119: 9.4%) and EPS of 4.1p (H119: 12.6p)
 Total assets increased to £1,385bn (December 2019: £1,140bn), primarily due to a £78bn increase in derivative assets (with a
corresponding increase in derivative liabilities), £52bn increase in cash collateral and settlement balances, and £26bn increase
in financial assets at fair value through the income statement. The low interest rate environment has resulted in significant
decreases in forward interest rate curves which coupled with increased client activity and the appreciation of period end USD
against GBP has resulted in rising asset values. Loans and advances have also increased by £16bn, which reflects the £7.1bn of
lending under the government backed Bounce Back Loan Scheme (BBLS) and the CBILS which Barclays UK has provided to
support businesses through the COVID-19 pandemic
 NAV per share was 331p (December 2019: 309p). TNAV per share increased to 284p (December 2019: 262p) reflecting 4.0p of
statutory EPS and positive reserve movements, including retirement benefit re-measurements and currency translation
reserves
Group capital and leverage
 The CET1 ratio increased to 14.2% (December 2019: 13.8%)
– CET1 capital increased by £4.6bn to £45.4bn reflecting resilient capital generation through £4.9bn of profits after tax,
excluding credit impairment charges and a £1.0bn increase due to the cancellation of the full year 2019 dividend
– Impairment charges of £3.7bn before tax were partially offset by a £1.3bn increase in IFRS 9 transitional relief after tax,
which was driven by £1.2bn in Q220 due to both the new impairment charges and the implementation of new regulatory
measures which allow for 100% relief on increases in stage 1 and stage 2 impairment throughout 2020 and 2021
– RWAs increased by £23.9bn to £319.0bn primarily due to higher market volatility and client activity within CIB as well as a
reduction in credit quality, partially offset by lower CC&P balances
 The average UK leverage ratio increased to 4.7% (December 2019: 4.5%) primarily driven by the increase in CET1 capital. The
average leverage exposure increased to £1,149bn (December 2019: £1,143bn)
 The UK leverage ratio increased to 5.2% (December 2019: 5.1%) primarily driven by the increase in CET1 capital, partially offset
by an increase in leverage exposure. The leverage exposure increased by £63bn to £1,071bn, primarily driven by an increase in
IFRS total assets, partially offset by the Prudential Regulation Authority’s (PRA) early adoption of CRR II settlement netting

-- 10 of 120 --

Group Finance Director’s Review
8
Group funding and liquidity
 The liquidity pool was £298bn (December 2019: £211bn) and the liquidity coverage ratio (LCR) remained significantly above the
100% regulatory requirement at 186% (December 2019: 160%), equivalent to a surplus of £135bn (December 2019: £78bn).
The increase in the liquidity pool, LCR and surplus is driven by a 12% growth in customer deposits and actions to maintain a
prudent funding and liquidity position in the current environment
 Wholesale funding outstanding, excluding repurchase agreements, was £181.9bn (December 2019: £147.1bn). The Group
issued £4.8bn equivalent of minimum requirement for own funds and eligible liabilities (MREL) instruments from Barclays PLC
(the Parent company) during the year. The Group is well advanced in its MREL issuance plans, with a Barclays PLC MREL ratio of
32.4% as at 30 June 2020 (December 2019: 31.2%) relative to an estimated requirement (including requisite buffers) of c.29.7%
by 1 January 2022
Other matters
 As at 30 June 2020, the Group held a provision of £774m relating to Payment Protection Insurance (PPI). Since the provision
increase in 2019, 70% of the items outstanding as at 30 September 2019 have been resolved (including invalid items) and
observations from these resolved complaints continue to support the provision level
Dividends and capital returns
 In response to a request from the PRA, and to preserve additional capital for use in serving Barclays customers and clients
through the extraordinary challenges presented by the COVID-19 pandemic, the Board agreed to cancel the 6.0p per ordinary
share full year 2019 dividend. The Board also decided that for 2020 Barclays would suspend its current capital returns policy
and accordingly will not undertake any interim ordinary share dividend payments, regulatory accruals of ordinary share
dividends, or share buybacks. The Board will decide on future dividends and its capital returns policy at year-end 2020
Outlook and guidance
 Given the uncertain economic outlook and low interest rate environment, the second half of the year is expected to continue to
be challenging
– Income in Barclays UK and CC&P is expected to gradually recover from Q220 levels, but certain headwinds including from
the low interest rate environment, are likely to persist into 2021
– The CIB performance in the first half benefitted from increased issuance activity and trading volumes, with the franchise
well positioned for the future
– Impairment in H220 is expected to remain above the level experienced in recent years, but to be below the H120 credit
impairment charge assuming no change in macroeconomic forecasts
 Continued focus on cost discipline, but short-term headwinds remain from spend on COVID-19 initiatives
 In H220 there may be headwinds to the Group’s CET1 ratio from procyclical effects on RWAs, and reduced benefit from
transitional relief on IFRS 9 impairment. However, the Group’s CET1 ratio will continue to be managed to maintain an
appropriate headroom above the MDA hurdle
 The Group continues to target a RoTE1 of >10% and cost: income ratio of <60% over time, but targets remain subject to change
depending on the evolution of the COVID-19 pandemic
Tushar Morzaria, Group Finance Director
1 Excluding litigation and conduct.

-- 11 of 120 --

Results by Business
9
Barclays UK Half year ended Half year ended
30.06.20 30.06.19
Income statement information £m £m % Change
Net interest income 2,637 2,907 (9)
Net fee, commission and other income 534 641 (17)
Total income 3,171 3,548 (11)
Credit impairment charges (1,064) (421)
Net operating income 2,107 3,127 (33)
Operating expenses (2,041) (2,021) (1)
Litigation and conduct (11) (44) 75
Total operating expenses (2,052) (2,065) 1
Other net income 13 -
Profit before tax 68 1,062 (94)
Attributable profit 52 750 (93)
As at 30.06.20 As at 31.12.19 As at 30.06.19
Balance sheet information £bn £bn £bn
Loans and advances to customers at amortised cost 202.0 193.7 189.1
Total assets 287.6 257.8 259.0
Customer deposits at amortised cost 225.7 205.5 200.9
Loan: deposit ratio 92% 96% 97%
Risk weighted assets 77.9 74.9 76.2
Half year ended Half year ended
Key facts 30.06.20 30.06.19
Average loan to value of mortgage portfolio1 52% 50%
Average loan to value of new mortgage lending1 68% 67%
Number of branches 904 972
Mobile banking active customers 8.7m 7.9m
30 day arrears rate - Barclaycard Consumer UK 2.0% 1.8%
Performance measures
Return on average allocated equity 0.8% 10.8%
Return on average allocated tangible equity 1.0% 14.5%
Average allocated equity (£bn) 13.8 13.9
Average allocated tangible equity (£bn) 10.2 10.3
Cost: income ratio 65% 58%
Loan loss rate (bps) 101 43
Net interest margin 2.69% 3.11%
Performance measures excluding litigation and conduct2 £m £m % Change
Profit before tax 79 1,106 (93)
Attributable profit 60 782 (92)
Return on average allocated tangible equity 1.2% 15.1%
Cost: income ratio 64% 57%
1 Average loan to value of mortgages is balance weighted and reflects both residential and buy-to-let (BTL) mortgage portfolios within the Home Loans portfolio.
2 Refer to pages 87 to 96 for further information and calculations of performance measures excluding litigation and conduct.

-- 12 of 120 --

Results by Business
10
Analysis of Barclays UK Half year ended Half year ended
30.06.20 30.06.19
Analysis of total income £m £m % Change
Personal Banking 1,794 1,910 (6)
Barclaycard Consumer UK 803 987 (19)
Business Banking 574 651 (12)
Total income 3,171 3,548 (11)
Analysis of credit impairment charges
Personal Banking (264) (88)
Barclaycard Consumer UK (697) (315)
Business Banking (103) (18)
Total credit impairment charges (1,064) (421)
As at 30.06.20 As at 31.12.19 As at 30.06.19
Analysis of loans and advances to customers at amortised cost £bn £bn £bn
Personal Banking 154.9 151.9 147.3
Barclaycard Consumer UK 11.5 14.7 15.1
Business Banking 35.6 27.1 26.7
Total loans and advances to customers at amortised cost 202.0 193.7 189.1
Analysis of customer deposits at amortised cost
Personal Banking 169.6 159.2 156.3
Barclaycard Consumer UK 0.1 - -
Business Banking 56.0 46.3 44.6
Total customer deposits at amortised cost 225.7 205.5 200.9

-- 13 of 120 --

Results by Business
11
Barclays UK continued to support customers during H120, increasing lending by £8.3bn, predominantly through £7.1bn of BBLS and
CBILS. Customer deposits grew by £20.2bn, reflecting the impact from payment holidays, lower customer spending levels and the
deposit of BBLS and CBILS loan proceeds, demonstrating franchise strength. Digital investment continues to transform customer
interactions, providing continuity of service and resilience through the lockdown. During H120 Barclays UK provided c.350k
payment holidays to customers across material portfolios. These comprised £0.7bn UK cards balances (5% of the portfolio), £0.6bn
UK personal loan balances (11% of the portfolio), and £14.9bn mortgage balances (10% of the portfolio).
Income statement – H120 compared to H119
 Profit before tax was £68m (H119: £1,062m). Profit before tax, excluding litigation and conduct, was £79m (H119: £1,106m).
RoE was 0.8% (H119: 10.8%). RoTE was 1.2% (H119: 15.1%) reflecting a challenging operating environment
 Total income decreased 11% to £3,171m. Net interest income reduced 9% to £2,637m (resulting in a lower net interest margin
(NIM) of 2.69% (H119: 3.11%)) reflecting COVID-19 customer support actions, the interval between Q120 base rate reductions
and deposit re-pricing, as well as ongoing lower UK cards IEL and overdraft balances. Net fee, commission and other income
decreased 17% to £534m, due to the removal of certain fees in overdrafts and UK cards, and planned lower debt sales
– Personal Banking income decreased 6% to £1,794m, reflecting deposit margin compression, COVID-19 customer support
actions, and lower overdraft balances and fees
– Barclaycard Consumer UK income decreased 19% to £803m as reduced borrowing and spend levels by customers resulted
in a lower level of IEL balances, as well as planned lower debt sales
– Business Banking income decreased 12% to £574m due to deposit margin compression, lower transactional fee volumes as
a result of COVID-19 and related customer support actions, partially offset by lending and deposit balance growth
 Credit impairment charges increased to £1,064m (H119: £421m) reflecting forecast deterioration in macroeconomic variables
in the COVID-19 scenarios, partially offset by the estimated impact of central bank, government and other support measures
 Operating expenses increased 1% to £2,041m as efficiency savings were more than offset by COVID-19 pandemic related costs
Balance sheet – 30 June 2020 compared to 31 December 2019
 Loans and advances to customers at amortised cost increased 4% to £202.0bn predominantly through £7.1bn of BBLS and CBILS
lending, £1.9bn of mortgage growth and the £2.2bn transfer of the Barclays Partner Finance portfolio from Barclays
International1 with effect from 1 April 2020, partially offset by lower UK cards balances
 Customer deposits at amortised cost increased 10% to £225.7bn due to lower spending levels, the impact of payment holidays,
as well as the deposit of BBLS and CBILS loan proceeds
 RWAs increased to £77.9bn (December 2019: £74.9bn) principally driven by the transfer of the Barclays Partner Finance
portfolio1 and growth in mortgages
1 Refer to Segmental reporting note page 63 for further information. The 2019 comparative figures have not been restated.

-- 14 of 120 --

Results by Business
12
Barclays International Half year ended Half year ended
30.06.20 30.06.19
Income statement information £m £m % Change
Net interest income 1,845 1,917 (4)
Net trading income 4,020 2,160 86
Net fee, commission and other income 2,789 3,396 (18)
Total income 8,654 7,473 16
Credit impairment charges (2,619) (492)
Net operating income 6,035 6,981 (14)
Operating expenses (4,405) (4,641) 5
Litigation and conduct (11) (30) 63
Total operating expenses (4,416) (4,671) 5
Other net income 10 31 (68)
Profit before tax 1,629 2,341 (30)
Attributable profit 997 1,620 (38)
As at 30.06.20 As at 31.12.19 As at 30.06.19
Balance sheet information £bn £bn £bn
Loans and advances at amortised cost 138.1 132.8 134.8
Trading portfolio assets 109.5 113.3 120.0
Derivative financial instrument assets 306.8 228.9 243.8
Financial assets at fair value through the income statement 154.3 128.4 154.7
Cash collateral and settlement balances 130.8 79.4 101.3
Other assets 236.3 178.6 196.8
Total assets 1,075.8 861.4 951.4
Deposits at amortised cost 241.2 210.0 212.0
Derivative financial instrument liabilities 307.6 228.9 243.0
Loan: deposit ratio 57% 63% 64%
Risk weighted assets 231.2 209.2 214.8
Half year ended Half year ended
Performance measures 30.06.20 30.06.19
Return on average allocated equity 6.0% 10.2%
Return on average allocated tangible equity 6.2% 10.5%
Average allocated equity (£bn) 33.1 31.9
Average allocated tangible equity (£bn) 32.4 30.8
Cost: income ratio 51% 63%
Loan loss rate (bps) 368 72
Net interest margin 3.67% 3.95%
Performance measures excluding litigation and conduct1 £m £m % Change
Profit before tax 1,640 2,371 (31)
Attributable profit 1,005 1,644 (39)
Return on average allocated tangible equity 6.2% 10.7%
Cost: income ratio 51% 62%
1 Refer to pages 87 to 96 for further information and calculations of performance measures excluding litigation and conduct.

-- 15 of 120 --

Results by Business
13
Analysis of Barclays International
Corporate and Investment Bank Half year ended Half year ended
30.06.20 30.06.19
Income statement information £m £m % Change
FICC 3,326 1,822 83
Equities 1,238 984 26
Markets 4,564 2,806 63
Advisory 239 353 (32)
Equity capital markets 247 187 32
Debt capital markets 881 727 21
Banking fees 1,367 1,267 8
Corporate lending 172 368 (53)
Transaction banking 830 859 (3)
Corporate 1,002 1,227 (18)
Total income 6,933 5,300 31
Credit impairment charges (1,320) (96)
Net operating income 5,613 5,204 8
Operating expenses (3,370) (3,479) 3
Litigation and conduct (3) (26) 88
Total operating expenses (3,373) (3,505) 4
Other net income 3 15 (80)
Profit before tax 2,243 1,714 31
Attributable profit 1,514 1,178 29
As at 30.06.20 As at 31.12.19 As at 30.06.19
Balance sheet information £bn £bn £bn
Loans and advances at amortised cost 104.9 92.0 92.1
Trading portfolio assets 109.3 113.3 119.9
Derivative financial instrument assets 306.7 228.8 243.7
Financial assets at fair value through the income statement 153.7 127.7 154.1
Cash collateral and settlement balances 129.7 78.5 100.4
Other assets 205.5 155.3 168.1
Total assets 1,009.8 795.6 878.3
Deposits at amortised cost 173.9 146.2 145.4
Derivative financial instrument liabilities 307.6 228.9 242.9
Risk weighted assets 198.3 171.5 175.9
Half year ended Half year ended
Performance measures 30.06.20 30.06.19
Return on average tangible equity 10.9% 9.2%
Return on average allocated tangible equity 11.0% 9.3%
Average allocated equity (£bn) 27.7 25.5
Average allocated tangible equity (£bn) 27.7 25.5
Cost: income ratio 49% 66%
Performance measures excluding litigation and conduct1 £m £m % Change
Profit before tax 2,246 1,740 29
Attributable profit 1,516 1,199 26
Return on average allocated tangible equity 11.0% 9.4%
Cost: income ratio 49% 66%
1 Refer to pages 87 to 96 for further information and calculations of performance measures excluding litigation and conduct.

-- 16 of 120 --

Results by Business
14
Analysis of Barclays International
Consumer, Cards and Payments Half year ended Half year ended
30.06.20 30.06.19
Income statement information £m £m % Change
Net interest income 1,176 1,385 (15)
Net fee, commission, trading and other income 545 788 (31)
Total income 1,721 2,173 (21)
Credit impairment charges (1,299) (396)
Net operating income 422 1,777 (76)
Operating expenses (1,035) (1,162) 11
Litigation and conduct (8) (4)
Total operating expenses (1,043) (1,166) 11
Other net income 7 16 (56)
(Loss)/profit before tax (614) 627
Attributable (loss)/profit (517) 442
As at 30.06.20 As at 31.12.19 As at 30.06.19
Balance sheet information £bn £bn £bn
Loans and advances at amortised cost 33.2 40.8 42.7
Total assets 66.0 65.8 73.1
Deposits at amortised cost 67.3 63.8 66.6
Risk weighted assets 32.9 37.7 38.9
Half year ended Half year ended
Key facts 30.06.20 30.06.19
30 day arrears rate – Barclaycard US 2.4% 2.4%
US cards customer FICO score distribution
<660 14% 14%
>660 86% 86%
Total number of Barclaycard payments clients c.368,000 383,382
Value of payments processed (£bn)1 156 174
Performance measures
Return on average allocated equity (19.2%) 13.8%
Return on average allocated tangible equity (21.9%) 16.6%
Average allocated equity (£bn) 5.4 6.4
Average allocated tangible equity (£bn) 4.7 5.3
Cost: income ratio 61% 54%
Loan loss rate (bps) 714 176
Performance measures excluding litigation and conduct2 £m £m % Change
(Loss)/profit before tax (606) 631
Attributable (loss)/profit (511) 445
Return on average allocated tangible equity (21.7%) 16.7%
Cost: income ratio 60% 53%
1 Includes £124bn (H119: £135bn) of merchant acquiring payments.
2 Refer to pages 87 to 96 for further information and calculations of performance measures excluding litigation and conduct.

-- 17 of 120 --

Results by Business
15
Barclays International continued to support its customers and clients through the COVID-19 pandemic by providing or facilitating
lending, through the range of support programmes which have been introduced, as well as enabling the raising of debt and equity
financing in the capital markets. Support actions, including over 200k payment holidays, have also been introduced to help
customers and clients through the difficulties they may be experiencing. Despite the challenging operating environment, Barclays
International delivered a RoTE of 6.2%, excluding litigation and conduct, reflecting the benefits of a diversified business model.
Income statement – H120 compared to H119
 Profit before tax was £1,629m. RoE was 6.0% (H119: 10.2%), CIB RoE was 10.9% (H119: 9.2%) and CC&P RoE was (19.2)% (H119:
13.8%). Profit before tax, excluding litigation and conduct, decreased 31% to £1,640m with a RoTE of 6.2% (H119: 10.7%),
reflecting a RoTE of 11.0% (H119: 9.4%) in CIB and (21.7)% (H119: 16.7%) in CC&P
 Total income increased to £8,654m (H119: £7,473m)
– CIB income increased 31% to £6,933m
– Markets income of £4,564m (H119: £2,806m) was the best ever first half of the year on a comparable basis1. FICC
income increased 83% to £3,326m driven by strong performances in macro and credit, reflecting increased client
activity and spread widening. Equities income increased 26% to £1,238m driven by cash and derivatives due to higher
levels of client activity and volatility. This Markets performance reflected an increase in market share in Q1202
– Banking fees income increased 8% to £1,367m due to a strong performance in debt and equity capital markets,
representing the best ever first half of the year on a comparable basis for these businesses1, partially offset by lower fee
income in advisory which was impacted by a reduced fee pool3
– Within Corporate, Transaction banking income decreased 3% to £830m as deposit balance growth was more than offset
by margin compression. Corporate lending income decreased by 53% to £172m reflecting the impact of c.£180m of
losses on fair value lending positions and c.£50m of losses on mark-to-market and carry costs on related hedges in H120
– CC&P income decreased 21% to £1,721m as the impacts of the COVID-19 pandemic resulted in lower balances on co-
branded cards, margin compression and reduced payments activity. Q220 included a c.£100m valuation loss on Barclays’
preference shares in Visa Inc. resulting from the Q220 Supreme Court ruling concerning charges paid by merchants
 Credit impairment charges increased to £2,619m (H119: £492m)
– CIB credit impairment charges increased to £1,320m (H119: £96m), reflecting £591m in respect of single name wholesale
loan charges and impacts from the COVID-19 scenarios, partially offset by the estimated impact of central bank,
government and other support measures
– CC&P credit impairment charges increased to £1,299m (H119: £396m) reflecting forecast deterioration in macroeconomic
variables in the COVID-19 scenarios, partially offset by the estimated impact of central bank, government and other support
measures
 Operating expenses decreased 5% to £4,405m
– CIB operating expenses decreased 3% to £3,370m due to cost efficiencies and discipline in the current environment
– CC&P operating expenses decreased 11% to £1,035m reflecting cost efficiencies and lower marketing spend due to the
impacts of the COVID-19 pandemic
Balance sheet – 30 June 2020 compared to 31 December 2019
 Loans and advances increased £5.3bn to £138.1bn due to increased lending within CIB, partially offset by lower card balances in
CC&P
 Derivative financial instrument assets and liabilities increased £77.9bn to £306.8bn and £78.7bn to £307.6bn respectively
driven by a decrease in major interest rate curves and increased trading volumes
 Cash collateral and settlements increased £51.4bn to £130.8bn predominantly due to increased activity
 Financial assets at fair value through the income statement increased £25.9bn to £154.3bn driven by increased secured lending
 Other assets increased £57.7bn to £236.3bn predominantly due to an increase in cash at central banks and securities within the
liquidity pool
 Deposits at amortised cost increased £31.2bn to £241.2bn due to CIB clients increasing liquidity
 RWAs increased to £231.2bn (December 2019: £209.2bn) primarily due to increased market volatility, client activity and a
reduction in credit quality within CIB, partially offset by lower CC&P balances
1 Period covering Q114 – Q220. Pre 2014 financials were not restated following re-segmentation in Q116.
2 Data Source: Coalition, Q120 Competitor Analysis. Market share represents Barclays share of the total industry Revenue Pool. Analysis is based on Barclays internal
business structure and internal revenues.
3 Data source: Dealogic for the period covering 1 January to 30 June 2020.

-- 18 of 120 --

Results by Business
16
Head Office Half year ended Half year ended
30.06.20 30.06.19
Income statement information £m £m % Change
Net interest income (259) (206) (26)
Net fee, commission and other income 55 (25)
Total income (204) (231) 12
Credit impairment charges (55) (15)
Net operating income (259) (246) (5)
Operating expenses (117) (96) (22)
Litigation and conduct (8) (40) 80
Total operating expenses (125) (136) 8
Other net expenses (41) (7)
Loss before tax (425) (389) (9)
Attributable loss (354) (298) (19)
As at 30.06.20 As at 31.12.19 As at 30.06.19
Balance sheet information £bn £bn £bn
Total assets 21.7 21.0 22.4
Risk weighted assets 9.9 11.0 28.1
Half year ended Half year ended
Performance measures 30.06.20 30.06.19
Average allocated equity (£bn) 9.9 7.9
Average allocated tangible equity (£bn) 6.0 4.6
Performance measures excluding litigation and conduct1 £m £m % Change
Loss before tax (417) (349) (19)
Attributable loss (355) (268) (32)
Income statement – H120 compared to H119
 Loss before tax, excluding litigation and conduct, was £417m (H119: £349m). Including litigation and conduct charges of £8m
(H119: £40m), loss before tax was £425m (H119: £389m)
 Total income was an expense of £204m (H119: £231m), which included mark-to-market losses on legacy investments, treasury
items and funding costs of legacy capital instruments, partially offset by hedge accounting gains and recognition of dividends on
Barclays’ stake in Absa Group Limited
 Credit impairment charges increased to £55m (H119: £15m) due to impacts from the COVID-19 scenarios on the Italian home
loan portfolio, partially offset by the estimated impact of central bank, government and other support measures
 Operating expenses were £117m (H119: £96m), which included £45m of charitable donations from Barclays’ COVID-19
Community Aid Package
 Other net expenses were £41m (H119: £7m), which included a fair value loss on an investment in an associate
Balance sheet – 30 June 2020 compared to 31 December 2019
 RWAs decreased to £9.9bn (December 2019: £11.0bn) driven by the reduction in value of Barclays’ stake in Absa Group Limited
1 Refer to pages 87 to 96 for further information and calculations of performance measures excluding litigation and conduct.

-- 19 of 120 --

Quarterly Results Summary
17
Barclays Group
Q220 Q120 Q419 Q319 Q219 Q119 Q418 Q318
Income statement information £m £m £m £m £m £m £m £m
Net interest income 1,892 2,331 2,344 2,445 2,360 2,258 2,296 2,388
Net fee, commission and other income 3,446 3,952 2,957 3,096 3,178 2,994 2,777 2,741
Total income 5,338 6,283 5,301 5,541 5,538 5,252 5,073 5,129
Credit impairment charges (1,623) (2,115) (523) (461) (480) (448) (643) (254)
Net operating income 3,715 4,168 4,778 5,080 5,058 4,804 4,430 4,875
Operating costs (3,310) (3,253) (3,308) (3,293) (3,501) (3,257) (3,624) (3,329)
UK bank levy - - (226) - - - (269) -
Operating expenses (3,310) (3,253) (3,534) (3,293) (3,501) (3,257) (3,893) (3,329)
Guaranteed Minimum Pensions (GMP) charge - - - - - - (140) -
Litigation and conduct (20) (10) (167) (1,568) (53) (61) (60) (105)
Total operating expenses (3,330) (3,263) (3,701) (4,861) (3,554) (3,318) (4,093) (3,434)
Other net (expenses)/income (26) 8 20 27 27 (3) 37 20
Profit before tax 359 913 1,097 246 1,531 1,483 374 1,461
Tax charge (42) (71) (189) (269) (297) (248) (75) (192)
Profit/(loss) after tax 317 842 908 (23) 1,234 1,235 299 1,269
Non-controlling interests (21) (16) (42) (4) (17) (17) (83) (43)
Other equity instrument holders (206) (221) (185) (265) (183) (180) (230) (176)
Attributable profit/(loss) 90 605 681 (292) 1,034 1,038 (14) 1,050
Performance measures
Return on average shareholders' equity 0.6% 4.4% 5.0% (2.1%) 7.6% 7.8% (0.1%) 8.0%
Return on average tangible shareholders' equity 0.7% 5.1% 5.9% (2.4%) 9.0% 9.2% (0.1%) 9.4%
Average shareholders' equity (£bn) 58.4 55.2 54.5 56.4 54.0 53.2 52.2 52.5
Average tangible shareholders' equity (£bn) 50.2 47.0 46.4 48.4 46.2 45.2 44.3 44.6
Cost: income ratio 62% 52% 70% 88% 64% 63% 81% 67%
Loan loss rate (bps) 179 223 60 52 56 54 77 30
Basic earnings/(loss) per share 0.5p 3.5p 3.9p (1.7p) 6.0p 6.1p (0.1p) 6.1p
Performance measures excluding
litigation and conduct1 £m £m £m £m £m £m £m £m
Profit before tax 379 923 1,264 1,814 1,584 1,544 434 1,566
Attributable profit 106 604 803 1,233 1,074 1,084 48 1,135
Return on average tangible shareholders' equity 0.8% 5.1% 6.9% 10.2% 9.3% 9.6% 0.4% 10.2%
Cost: income ratio 62% 52% 67% 59% 63% 62% 79% 65%
Basic earnings per share 0.6p 3.5p 4.7p 7.2p 6.3p 6.3p 0.3p 6.6p
Balance sheet and capital management2 £bn £bn £bn £bn £bn £bn £bn £bn
Total assets 1,385.1 1,444.3 1,140.2 1,290.4 1,232.8 1,193.5 1,133.3 1,170.8
Net asset value per share 331p 332p 309p 320p 322p 312p 309p 306p
Tangible net asset value per share 284p 284p 262p 274p 275p 266p 262p 260p
Common equity tier 1 ratio 14.2% 13.1% 13.8% 13.4% 13.4% 13.0% 13.2% 13.2%
Common equity tier 1 capital 45.4 42.5 40.8 41.9 42.9 41.4 41.1 41.7
Risk weighted assets 319.0 325.6 295.1 313.3 319.1 319.7 311.9 316.2
Average UK leverage ratio 4.7% 4.5% 4.5% 4.6% 4.7% 4.6% 4.5% 4.6%
Average UK leverage exposure 1,148.7 1,176.2 1,142.8 1,171.2 1,134.6 1,105.5 1,110.0 1,119.0
UK leverage ratio 5.2% 4.5% 5.1% 4.8% 5.1% 4.9% 5.1% 4.9%
UK leverage exposure 1,071.1 1,178.7 1,007.7 1,099.8 1,079.4 1,065.0 998.6 1,063.5
Funding and liquidity
Group liquidity (£bn) 298 237 211 226 238 232 227 213
Liquidity coverage ratio 186% 155% 160% 151% 156% 160% 169% 161%
Loan: deposit ratio 76% 79% 82% 82% 82% 80% 83% 83%
1 Refer to pages 87 to 96 for further information and calculations of performance measures excluding litigation and conduct.
2 Refer to pages 49 to 54 for further information on how capital, RWAs and leverage are calculated.

-- 20 of 120 --

Quarterly Results by Business
18
Barclays UK
Q220 Q120 Q419 Q319 Q219 Q119 Q418 Q318
Income statement information £m £m £m £m £m £m £m £m
Net interest income 1,225 1,412 1,478 1,503 1,438 1,469 1,513 1,529
Net fee, commission and other income 242 292 481 343 333 308 350 367
Total income 1,467 1,704 1,959 1,846 1,771 1,777 1,863 1,896
Credit impairment charges (583) (481) (190) (101) (230) (191) (296) (115)
Net operating income 884 1,223 1,769 1,745 1,541 1,586 1,567 1,781
Operating costs (1,018) (1,023) (1,023) (952) (1,022) (999) (1,114) (988)
UK bank levy - - (41) - - - (46) -
Operating expenses (1,018) (1,023) (1,064) (952) (1,022) (999) (1,160) (988)
Litigation and conduct (6) (5) (58) (1,480) (41) (3) (15) (54)
Total operating expenses (1,024) (1,028) (1,122) (2,432) (1,063) (1,002) (1,175) (1,042)
Other net income/(expenses) 13 - - - (1) 1 (2) 1
(Loss)/profit before tax (127) 195 647 (687) 477 585 390 740
Attributable (loss)/profit (123) 175 438 (907) 328 422 241 510
Balance sheet information £bn £bn £bn £bn £bn £bn £bn £bn
Loans and advances to customers at amortised
cost 202.0 195.7 193.7 193.2 189.1 187.5 187.6 186.7
Total assets 287.6 267.5 257.8 257.9 259.0 253.1 249.7 252.0
Customer deposits at amortised cost 225.7 207.5 205.5 203.3 200.9 197.3 197.3 195.8
Loan: deposit ratio 92% 96% 96% 97% 97% 96% 96% 96%
Risk weighted assets 77.9 77.7 74.9 76.8 76.2 76.6 75.2 74.8
Performance measures
Return on average allocated equity (3.6%) 5.1% 12.7% (26.1%) 9.5% 12.2% 7.1% 14.9%
Return on average allocated tangible equity1 (4.8%) 6.9% 17.0% (34.9%) 12.7% 16.3% 9.6% 20.1%
Average allocated equity (£bn) 13.9 13.7 13.8 13.9 13.8 13.9 13.6 13.7
Average allocated tangible equity (£bn)1 10.3 10.1 10.3 10.4 10.3 10.4 10.1 10.1
Cost: income ratio 70% 60% 57% 132% 60% 56% 63% 55%
Loan loss rate (bps) 111 96 38 20 47 40 61 24
Net interest margin 2.48% 2.91% 3.03% 3.10% 3.05% 3.18% 3.20% 3.22%
Performance measures excluding
litigation and conduct2 £m £m £m £m £m £m £m £m
(Loss)/profit before tax (121) 200 705 793 518 588 405 794
Attributable (loss)/profit (118) 178 481 550 358 424 253 558
Return on average allocated tangible equity1 (4.6%) 7.0% 18.7% 21.2% 13.9% 16.4% 10.1% 22.0%
Cost: income ratio 69% 60% 54% 52% 58% 56% 62% 52%
1 Q120 has been restated to reflect allocated tangible equity being calculated as 13.0% of RWAs for each business, adjusted for capital deductions, excluding goodwill
and intangible assets.
2 Refer to pages 87 to 96 for further information and calculations of performance measures excluding litigation and conduct.

-- 21 of 120 --

Quarterly Results by Business
19
Analysis of Barclays UK Q220 Q120 Q419 Q319 Q219 Q119 Q418 Q318
Analysis of total income £m £m £m £m £m £m £m £m
Personal Banking 826 968 1,064 1,035 946 964 998 1,021
Barclaycard Consumer UK 367 436 533 472 497 490 522 551
Business Banking 274 300 362 339 328 323 343 324
Total income 1,467 1,704 1,959 1,846 1,771 1,777 1,863 1,896
Analysis of credit impairment (charges)/releases
Personal Banking (130) (134) (71) (36) (36) (52) (44) (8)
Barclaycard Consumer UK (396) (301) (108) (49) (175) (140) (250) (88)
Business Banking (57) (46) (11) (16) (19) 1 (2) (19)
Total credit impairment charges (583) (481) (190) (101) (230) (191) (296) (115)
Analysis of loans and advances to customers at
amortised cost £bn £bn £bn £bn £bn £bn £bn £bn
Personal Banking 154.9 153.4 151.9 150.1 147.3 145.9 146.0 145.4
Barclaycard Consumer UK 11.5 13.6 14.7 14.9 15.1 15.0 15.3 15.3
Business Banking 35.6 28.7 27.1 28.2 26.7 26.6 26.3 26.0
Total loans and advances to customers at
amortised cost 202.0 195.7 193.7 193.2 189.1 187.5 187.6 186.7
Analysis of customer deposits at amortised cost
Personal Banking 169.6 161.4 159.2 157.9 156.3 154.1 154.0 153.4
Barclaycard Consumer UK 0.1 - - - - - - -
Business Banking 56.0 46.1 46.3 45.4 44.6 43.2 43.3 42.4
Total customer deposits at amortised cost 225.7 207.5 205.5 203.3 200.9 197.3 197.3 195.8

-- 22 of 120 --

Quarterly Results by Business
20
Barclays International
Q220 Q120 Q419 Q319 Q219 Q119 Q418 Q318
Income statement information £m £m £m £m £m £m £m £m
Net interest income 847 998 965 1,059 1,017 900 984 965
Net trading income 1,660 2,360 929 1,110 1,016 1,144 837 1,103
Net fee, commission and other income 1,503 1,286 1,558 1,581 1,870 1,526 1,400 1,222
Total income 4,010 4,644 3,452 3,750 3,903 3,570 3,221 3,290
Credit impairment charges (1,010) (1,609) (329) (352) (247) (245) (354) (143)
Net operating income 3,000 3,035 3,123 3,398 3,656 3,325 2,867 3,147
Operating costs (2,186) (2,219) (2,240) (2,282) (2,435) (2,206) (2,441) (2,277)
UK bank levy - - (174) - - - (210) -
Operating expenses (2,186) (2,219) (2,414) (2,282) (2,435) (2,206) (2,651) (2,277)
Litigation and conduct (11) - (86) - (11) (19) (33) (32)
Total operating expenses (2,197) (2,219) (2,500) (2,282) (2,446) (2,225) (2,684) (2,309)
Other net income 4 6 17 21 13 18 32 12
Profit before tax 807 822 640 1,137 1,223 1,118 215 850
Attributable profit/(loss) 468 529 397 799 832 788 (21) 687
Balance sheet information £bn £bn £bn £bn £bn £bn £bn £bn
Loans and advances at amortised cost 138.1 167.0 132.8 138.1 134.8 130.9 127.2 132.4
Trading portfolio assets 109.5 101.6 113.3 119.4 120.0 117.2 104.0 124.6
Derivative financial instrument assets 306.8 341.5 228.9 286.0 243.8 217.3 222.1 214.8
Financial assets at fair value through the income
statement 154.3 188.4 128.4 158.0 154.7 153.5 144.7 147.8
Cash collateral and settlement balances 130.8 153.2 79.4 112.5 101.3 97.8 74.3 94.3
Other assets 236.3 201.5 178.6 195.6 196.8 202.3 189.8 186.3
Total assets 1,075.8 1,153.2 861.4 1,009.6 951.4 919.0 862.1 900.2
Deposits at amortised cost 241.2 263.3 210.0 217.6 212.0 215.5 197.2 200.3
Derivative financial instrument liabilities 307.6 338.8 228.9 283.3 243.0 213.5 219.6 213.7
Loan: deposit ratio 57% 63% 63% 63% 64% 61% 65% 66%
Risk weighted assets 231.2 237.9 209.2 223.1 214.8 216.1 210.7 214.6
Performance measures
Return on average allocated equity 5.5% 6.6% 5.0% 9.6% 10.3% 10.0% (0.3%) 8.5%
Return on average allocated tangible equity1 5.6% 6.8% 5.1% 9.9% 10.7% 10.4% (0.3%) 8.8%
Average allocated equity (£bn) 34.2 31.9 31.9 33.3 32.1 31.6 32.4 32.5
Average allocated tangible equity (£bn)1 33.5 31.2 30.9 32.2 31.1 30.5 31.3 31.1
Cost: income ratio 55% 48% 72% 61% 63% 62% 83% 70%
Loan loss rate (bps) 284 377 96 99 72 73 107 41
Net interest margin 3.43% 3.93% 4.29% 4.10% 3.91% 3.99% 3.98% 3.87%
Performance measures excluding
litigation and conduct2 £m £m £m £m £m £m £m £m
Profit before tax 818 822 726 1,137 1,234 1,137 248 882
Attributable profit 476 529 461 801 840 804 13 713
Return on average allocated tangible equity1 5.7% 6.8% 6.0% 10.0% 10.8% 10.6% 0.2% 9.2%
Cost: income ratio 55% 48% 70% 61% 62% 62% 82% 69%
1 Q120 has been restated to reflect allocated tangible equity being calculated as 13.0% of RWAs for each business, adjusted for capital deductions, excluding goodwill
and intangible assets.
2 Refer to pages 87 to 96 for further information and calculations of performance measures excluding litigation and conduct.

-- 23 of 120 --

Quarterly Results by Business
21
Analysis of Barclays International
Corporate and Investment Bank Q220 Q120 Q419 Q319 Q219 Q119 Q418 Q318
Income statement information £m £m £m £m £m £m £m £m
FICC 1,468 1,858 726 816 920 902 570 688
Equities 674 564 409 494 517 467 375 471
Markets 2,142 2,422 1,135 1,310 1,437 1,369 945 1,159
Advisory 84 155 202 221 221 132 242 151
Equity capital markets 185 62 56 86 104 83 53 55
Debt capital markets 463 418 322 381 373 354 330 313
Banking fees 732 635 580 688 698 569 625 519
Corporate lending 61 111 202 195 216 152 243 197
Transaction banking 381 449 397 424 444 415 412 416
Corporate 442 560 599 619 660 567 655 613
Other - - - - - - (74) (56)
Total income 3,316 3,617 2,314 2,617 2,795 2,505 2,151 2,235
Credit impairment (charges)/releases (596) (724) (30) (31) (44) (52) (35) 3
Net operating income 2,720 2,893 2,284 2,586 2,751 2,453 2,116 2,238
Operating costs (1,680) (1,690) (1,691) (1,712) (1,860) (1,619) (1,835) (1,712)
UK bank levy - - (156) - - - (188) -
Operating expenses (1,680) (1,690) (1,847) (1,712) (1,860) (1,619) (2,023) (1,712)
Litigation and conduct (3) - (79) (4) (7) (19) (23) (32)
Total operating expenses (1,683) (1,690) (1,926) (1,716) (1,867) (1,638) (2,046) (1,744)
Other net income 3 - 1 12 3 12 15 4
Profit before tax 1,040 1,203 359 882 887 827 85 498
Attributable profit/(loss) 694 820 193 609 596 582 (84) 431
Balance sheet information £bn £bn £bn £bn £bn £bn £bn £bn
Loans and advances at amortised cost 104.9 128.2 92.0 95.8 92.1 90.6 86.4 93.3
Trading portfolio assets 109.3 101.5 113.3 119.3 119.9 117.2 104.0 124.5
Derivative financial instruments assets 306.7 341.4 228.8 286.0 243.7 217.3 222.1 214.8
Financial assets at fair value through the income
statement 153.7 187.8 127.7 157.3 154.1 152.9 144.2 147.3
Cash collateral and settlement balances 129.7 152.2 78.5 111.6 100.4 96.9 73.4 93.3
Other assets 205.5 171.4 155.3 171.5 168.1 163.2 160.4 153.8
Total assets 1,009.8 1,082.5 795.6 941.5 878.3 838.1 790.5 827.0
Deposits at amortised cost 173.9 198.4 146.2 152.1 145.4 151.4 136.3 137.6
Derivative financial instrument liabilities 307.6 338.7 228.9 283.2 242.9 213.5 219.6 213.7
Risk weighted assets 198.3 201.7 171.5 184.9 175.9 176.6 170.9 175.9
Performance measures
Return on average allocated equity 9.5% 12.5% 3.0% 9.1% 9.2% 9.3% (1.3%) 6.6%
Return on average allocated tangible equity1 9.6% 12.5% 3.0% 9.1% 9.2% 9.3% (1.3%) 6.6%
Average allocated equity (£bn) 29.1 26.2 25.9 26.9 25.8 25.2 26.0 26.2
Average allocated tangible equity (£bn)1 29.0 26.2 25.8 26.9 25.8 25.1 26.0 25.9
Cost: income ratio 51% 47% 83% 66% 67% 65% 95% 78%
Performance measures excluding
litigation and conduct2 £m £m £m £m £m £m £m £m
Profit before tax 1,043 1,203 438 886 894 846 108 530
Attributable profit/(loss) 696 820 251 614 601 598 (57) 456
Return on average allocated tangible equity1 9.6% 12.5% 3.9% 9.2% 9.3% 9.5% (0.9%) 7.0%
Cost: income ratio 51% 47% 80% 65% 67% 65% 94% 77%
1 Q120 has been restated to reflect allocated tangible equity being calculated as 13.0% of RWAs for each business, adjusted for capital deductions, excluding goodwill
and intangible assets.
2 Refer to pages 87 to 96 for further information and calculations of performance measures excluding litigation and conduct.

-- 24 of 120 --

Quarterly Results by Business
22
Analysis of Barclays International
Consumer, Cards and Payments Q220 Q120 Q419 Q319 Q219 Q119 Q418 Q318
Income statement information £m £m £m £m £m £m £m £m
Net interest income 513 663 717 720 720 665 664 691
Net fee, commission, trading and other income 181 364 421 413 388 400 406 364
Total income 694 1,027 1,138 1,133 1,108 1,065 1,070 1,055
Credit impairment charges (414) (885) (299) (321) (203) (193) (319) (146)
Net operating income 280 142 839 812 905 872 751 909
Operating costs (506) (529) (549) (570) (575) (587) (606) (565)
UK bank levy - - (18) - - - (22) -
Operating expenses (506) (529) (567) (570) (575) (587) (628) (565)
Litigation and conduct (8) - (7) 4 (4) - (10) -
Total operating expenses (514) (529) (574) (566) (579) (587) (638) (565)
Other net income 1 6 16 9 10 6 17 8
(Loss)/profit before tax (233) (381) 281 255 336 291 130 352
Attributable (loss)/profit (226) (291) 204 190 236 206 63 256
Balance sheet information £bn £bn £bn £bn £bn £bn £bn £bn
Loans and advances at amortised cost 33.2 38.8 40.8 42.3 42.7 40.3 40.8 39.1
Total assets 66.0 70.7 65.8 68.1 73.1 80.9 71.6 73.2
Deposits at amortised cost 67.3 64.9 63.8 65.5 66.6 64.1 60.9 62.7
Risk weighted assets 32.9 36.2 37.7 38.2 38.9 39.5 39.8 38.7
Performance measures
Return on average allocated equity (17.7%) (20.7%) 13.6% 11.8% 14.9% 12.8% 3.9% 16.3%
Return on average allocated tangible equity1 (20.2%) (23.5%) 15.9% 14.2% 17.8% 15.4% 4.8% 19.8%
Average allocated equity (£bn) 5.1 5.7 6.0 6.4 6.3 6.4 6.4 6.3
Average allocated tangible equity (£bn)1 4.5 5.0 5.1 5.3 5.3 5.4 5.3 5.2
Cost: income ratio 74% 52% 50% 50% 52% 55% 60% 54%
Loan loss rate (bps) 455 846 273 283 180 182 290 138
Performance measures excluding
litigation and conduct2 £m £m £m £m £m £m £m £m
(Loss)/profit before tax (225) (381) 288 251 340 291 140 352
Attributable (loss)/profit (220) (291) 210 187 239 206 70 257
Return on average allocated tangible equity1 (19.6%) (23.5%) 16.3% 14.0% 18.0% 15.4% 5.4% 19.9%
Cost: income ratio 73% 52% 50% 50% 52% 55% 59% 54%
1 Q120 has been restated to reflect allocated tangible equity being calculated as 13.0% of RWAs for each business, adjusted for capital deductions, excluding goodwill
and intangible assets.
2 Refer to pages 87 to 96 for further information and calculations of performance measures excluding litigation and conduct.

-- 25 of 120 --

Quarterly Results by Business
23
Head Office
Q220 Q120 Q419 Q319 Q219 Q119 Q418 Q318
Income statement information £m £m £m £m £m £m £m £m
Net interest income (180) (79) (99) (117) (95) (111) (201) (106)
Net fee, commission and other income 41 14 (11) 62 (41) 16 190 49
Total income (139) (65) (110) (55) (136) (95) (11) (57)
Credit impairment (charges)/releases (30) (25) (4) (8) (3) (12) 7 4
Net operating expenses (169) (90) (114) (63) (139) (107) (4) (53)
Operating costs (106) (11) (45) (59) (44) (52) (69) (64)
UK bank levy - - (11) - - - (13) -
Operating expenses (106) (11) (56) (59) (44) (52) (82) (64)
GMP charge - - - - - - (140) -
Litigation and conduct (3) (5) (23) (88) (1) (39) (12) (19)
Total operating expenses (109) (16) (79) (147) (45) (91) (234) (83)
Other net (expenses)/income (43) 2 3 6 15 (22) 7 7
Loss before tax (321) (104) (190) (204) (169) (220) (231) (129)
Attributable loss (255) (99) (154) (184) (126) (172) (234) (147)
Balance sheet information £bn £bn £bn £bn £bn £bn £bn £bn
Total assets 21.7 23.6 21.0 22.9 22.4 21.4 21.5 18.6
Risk weighted assets 9.9 10.0 11.0 13.4 28.1 27.0 26.0 26.8
Performance measures
Average allocated equity (£bn) 10.3 9.6 8.8 9.2 8.1 7.7 6.2 6.4
Average allocated tangible equity (£bn)1 6.4 5.6 5.2 5.8 4.8 4.3 2.9 3.4
Performance measures excluding
litigation and conduct2 £m £m £m £m £m £m £m £m
Loss before tax (318) (99) (167) (116) (168) (181) (219) (110)
Attributable loss (252) (103) (139) (118) (124) (144) (218) (136)
1 Q120 has been restated to reflect allocated tangible equity being calculated as 13.0% of RWAs for each business, adjusted for capital deductions, excluding goodwill
and intangible assets.
2 Refer to pages 87 to 96 for further information and calculations of performance measures excluding litigation and conduct.

-- 26 of 120 --

Performance Management
24
Margins and balances
Half year ended 30.06.20 Half year ended 30.06.19
Net interest
income
Average
customer
assets
Net interest
margin
Net interest
income
Average
customer
assets
Net interest
margin
£m £m % £m £m %
Barclays UK 2,637 197,023 2.69 2,907 188,377 3.11
Barclays International1 1,848 101,286 3.67 1,947 99,478 3.95
Total Barclays UK and Barclays International 4,485 298,309 3.02 4,854 287,855 3.40
Other2 (262) (236)
Total Barclays Group 4,223 4,618
1 Barclays International margins include interest earning lending balances within the investment banking business.
2 Other includes Head Office and non-lending related investment banking businesses not included in Barclays International margins.
The Group’s combined product and equity structural hedge notional as at 30 June 2020 was £174bn, with an average duration of
2.5 to 3 years. Group net interest income includes gross structural hedge contributions of £0.9bn (H119: £0.9bn) and net structural
hedge contributions of £0.6bn (H119: £0.2bn). Gross structural hedge contributions represent the absolute level of interest earned
from the fixed receipts on the basket of swaps in the structural hedge, while the net structural hedge contributions represent the
net interest earned on the difference between the structural hedge rate and prevailing floating rates.
The Group net interest margin decreased 38bps to 3.02%. Barclays UK net interest margin decreased 42bps to 2.69% reflecting
COVID-19 customer support actions, the customer communications interval between Q120 base rate reductions and deposit re-
pricing, as well as a change in business mix due to balance growth in Mortgages and ongoing lower UK cards IEL and overdraft
balances. Barclays International net interest margin decreased 28bps to 3.67% reflecting a change in the business mix of lower
cards balances and increased lending in the CIB.
Quarterly analysis for Barclays UK and Barclays International
Net interest
income
Average
customer
assets
Net interest
margin
Three months ended 30.06.20 £m £m %
Barclays UK 1,225 199,039 2.48
Barclays International1 868 101,706 3.43
Total Barclays UK and Barclays International 2,093 300,745 2.80
Three months ended 31.03.20
Barclays UK 1,412 195,204 2.91
Barclays International1 980 100,171 3.93
Total Barclays UK and Barclays International 2,392 295,375 3.26
Three months ended 31.12.19
Barclays UK 1,478 193,610 3.03
Barclays International1 1,036 95,819 4.29
Total Barclays UK and Barclays International 2,514 289,429 3.45
Three months ended 30.09.19
Barclays UK 1,503 192,262 3.10
Barclays International1 1,038 100,589 4.10
Total Barclays UK and Barclays International 2,541 292,851 3.44
Three months ended 30.06.19
Barclays UK 1,438 189,172 3.05
Barclays International1 980 100,645 3.91
Total Barclays UK and Barclays International 2,418 289,817 3.35
1 Barclays International margins include interest earning lending balances within the investment banking business.

-- 27 of 120 --

Risk Management
25
Risk management and principal risks
The roles and responsibilities of the business groups, Risk and Compliance, in the management of risk in the firm are defined in the
Enterprise Risk Management Framework. The purpose of the framework is to identify the principal risks of the Group, the process
by which the Group sets its appetite for these risks in its business activities, and the consequent limits which it places on related
risk taking.
The framework identifies eight principal risks: credit risk; market risk; treasury and capital risk; operational risk; model risk; conduct
risk; reputation risk; and legal risk. Further detail on these risks and how they are managed is available in the Barclays PLC Annual
Report 2019 filed on Form 20-F (pages 90 to 107) or online at home.barclays/annualreport. There have been no significant changes
to these principal risks or previously identified material existing and emerging risks in the period, save that details of an additional
material risk identified in H120 which potentially impacts more than one principal risk are set out below.
The following section also gives an overview of credit risk, market risk, and treasury and capital risk for the period.
Risks relating to the impact of COVID-19
The COVID-19 pandemic has had, and continues to have, a material impact on businesses around the world and the economic
environments in which they operate. There are a number of factors associated with the pandemic and its impact on global
economies that could have a material adverse effect on (among other things) the profitability, capital and liquidity of financial
institutions such as Barclays.
The COVID-19 pandemic has caused disruption to the Group’s customers, suppliers and staff globally. Most jurisdictions in which
the Group operates have implemented severe restrictions on the movement of their respective populations, with a resultant
significant impact on economic activity in those jurisdictions. These restrictions are being determined by the governments of
individual jurisdictions (including through the implementation of emergency powers) and impacts (including the timing of
implementation and any subsequent lifting of restrictions) may vary from jurisdiction to jurisdiction. It remains unclear how this will
evolve through 2020 (including whether there will be subsequent waves of the COVID-19 pandemic and whether and in what
manner previously lifted restrictions will be re-imposed) and the Group continues to monitor the situation closely. However,
despite the COVID-19 contingency plans established by the Group, its ability to conduct business may be adversely affected by
disruptions to its infrastructure, business processes and technology services, resulting from the unavailability of staff due to illness
or the failure of third parties to supply services. This may cause significant customer detriment, costs to reimburse losses incurred
by the Group’s customers, potential litigation costs (including regulatory fines, penalties and other sanctions), and reputational
damage.
In many of the jurisdictions in which the Group operates, schemes have been initiated by central banks, national governments and
regulators to provide financial support to parts of the economy most impacted by the COVID-19 pandemic. These schemes have
been designed and implemented at pace, meaning lenders (including Barclays) continue to address operational issues which have
arisen in connection with the implementation of the schemes, including resolving the interaction between the schemes and
existing law and regulation. In addition, the details of how these schemes will impact the Group’s customers and therefore the
impact on the Group remains uncertain at this stage. However, certain actions (such as the introduction of payment holidays for
certain consumer lending products or the cancellation or waiver of fees associated with certain products) may negatively impact
the effective interest rate earned on certain of the Group’s portfolios and lower fee income being earned on certain products.
Lower interest rates globally will negatively impact net interest income earned on certain of the Group’s portfolios. Both of these
factors may in turn negatively impact the Group’s profitability. Furthermore, the introduction of, and participation in, central-bank
supported loan and other financing schemes introduced as a result of the COVID-19 pandemic may negatively impact the Group’s
RWAs, level of impairment and, in turn, capital position (particularly when any transitional relief applied to the calculation of RWAs
and impairment expires). This may be exacerbated if the Group is required by any government or regulator to offer forbearance or
additional financial relief to borrowers.
As these schemes and other financial support schemes provided by national governments (such as job retention and furlough
schemes) expire, are withdrawn or are no longer supported, the Group may experience a higher volume of defaults and
delinquencies in certain portfolios and may initiate collection and enforcement actions to recover defaulted debts. Where
defaulting borrowers are harmed by the Group’s conduct, this may give rise to civil legal proceedings, including class actions,
regulatory censure, potentially significant fines and other sanctions, and reputational damage. Other legal disputes may also arise
between the Group and defaulting borrowers relating to matters such as breaches or enforcement of legal rights or obligations
arising under loan and other credit agreements. Adverse findings in any such matters may result in the Group’s rights not being
enforced as intended. For further details on legal risk and legal, competition and regulatory matters, refer to Note 20 on page 80.
The actions taken by various governments and central banks, in particular in the United Kingdom and the United States, may
indicate a view on the potential severity of any economic downturn and post recovery environment, which from a commercial,
regulatory and risk perspective could be significantly different to past crises and persist for a prolonged period. The COVID-19
pandemic has led to a weakening in gross domestic product (GDP) in most jurisdictions in which the Group operates and an
expectation of higher unemployment and lower house prices in those same jurisdictions. These factors all have a significant impact
on the modelling of expected credit losses (ECL) by the Group. As a result, the Group has experienced higher ECLs during the first
half of 2020 compared to prior periods and this trend may continue in the second half of 2020. The economic environment remains

-- 28 of 120 --

Risk Management
26
uncertain and future impairment charges may be subject to further volatility (including from changes to macroeconomic variable
forecasts) depending on the longevity of the COVID-19 pandemic and related containment measures, as well as the longer term
effectiveness of central bank, government and other support measures. For further details on macroeconomic variables used in the
calculation of ECLs, refer to page 34. In addition, ECLs may be adversely impacted by increased levels of default for single name
exposures in certain sectors directly impacted by the COVID-19 pandemic (such as the oil and gas, retail, airline, and hospitality and
leisure sectors).
Furthermore, the Group relies on models to support a broad range of business and risk management activities, including informing
business decisions and strategies, measuring and limiting risk, valuing exposures (including the calculation of impairment),
conducting stress testing and assessing capital adequacy. Models are, by their nature, imperfect and incomplete representations of
reality because they rely on assumptions and inputs, and so they may be subject to errors affecting the accuracy of their outputs
and/or misused. This may be exacerbated when dealing with unprecedented scenarios, such as the COVID-19 pandemic, due to the
lack of reliable historical reference points and data. For further details on model risk, refer to page 98 of the Barclays PLC Annual
Report 2019 filed on Form 20-F.
The disruption to economic activity globally caused by the COVID-19 pandemic could adversely impact the Group’s other assets
such as goodwill and intangibles, and the value of Barclays PLC’s investments in subsidiaries. It could also impact the Group’s
income due to lower lending and transaction volumes due to volatility or weakness in the capital markets. Other potential risks
include credit rating migration which could negatively impact the Group’s RWAs and capital position, and potential liquidity stress
due to (among other things) increased customer drawdowns, notwithstanding the significant initiatives that governments and
central banks have put in place to support funding and liquidity. Furthermore, a significant increase in the utilisation of credit cards
by Barclaycard customers could have a negative impact on the Group’s RWAs and capital position.
Central bank and government actions and other support measures taken in response to the COVID-19 pandemic may also create
restrictions in relation to capital. For example, on 31 March 2020 in response to a request from the PRA and to preserve additional
capital for use in serving Barclays’ customers and clients, the Board agreed to cancel the 6.0p per ordinary share full year 2019
dividend that was due for payment on 3 April 2020. In addition, the Board decided that for 2020 Barclays PLC will not undertake
any interim ordinary share dividend payments, accrual of ordinary share dividends, or share buybacks. Restrictions imposed by
governments and/or regulators may further limit management’s flexibility in managing the business and taking action in relation to
capital distributions and capital allocation.
Any and all such events mentioned above could have a material adverse effect on the Group’s business, financial condition, results
of operations, prospects, liquidity, capital position and credit ratings (including potential credit rating agency changes of outlooks or
ratings), as well as on the Group’s customers, employees and suppliers.

-- 29 of 120 --

Credit Risk
27
Loans and advances at amortised cost by stage
The table below presents an analysis of loans and advances at amortised cost by gross exposure, impairment allowance,
impairment charge and coverage ratio by stage allocation and business segment as at 30 June 2020. Also included are off-balance
sheet loan commitments and financial guarantee contracts by gross exposure, impairment allowance and coverage ratio by stage
allocation as at 30 June 2020.
Impairment allowance under IFRS 9 considers both the drawn and the undrawn counterparty exposure. For retail portfolios, the
total impairment allowance is allocated to the drawn exposure to the extent that the allowance does not exceed the exposure, as
ECL is not reported separately. Any excess is reported on the liability side of the balance sheet as a provision. For wholesale
portfolios, the impairment allowance on the undrawn exposure is reported on the liability side of the balance sheet as a provision.
Gross exposure Impairment allowance Net
exposure	Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3 Total
As at 30.06.20 £m £m £m £m £m £m £m £m £m
Barclays UK 147,369 26,022 2,613 176,004 327 1,672 1,129 3,128 172,876
Barclays International 17,714 6,200 1,838 25,752 427 1,335 1,400 3,162 22,590
Head Office 4,649 660 916 6,225 8 54 354 416 5,809
Total Barclays Group retail 169,732 32,882 5,367 207,981 762 3,061 2,883 6,706 201,275
Barclays UK 28,658 5,562 1,131 35,351 24 88 133 245 35,106
Barclays International 76,750 38,205 2,571 117,526 237 802 934 1,973 115,553
Head Office 2,977 - 38 3,015 - - 37 37 2,978
Total Barclays Group
wholesale1 108,385 43,767 3,740 155,892 261 890 1,104 2,255 153,637
Total loans and advances at
amortised cost 278,117 76,649 9,107 363,873 1,023 3,951 3,987 8,961 354,912
Off-balance sheet loan
commitments and financial
guarantee contracts2
284,807 63,327 1,569 349,703 122 571 48 741 348,962
Total3 562,924 139,976 10,676 713,576 1,145 4,522 4,035 9,702 703,874
As at 30.06.20 Half year ended 30.06.20
Coverage ratio Loan impairment charge and loan loss rate4
Stage 1 Stage 2 Stage 3 Total
Loan impairment
charge Loan loss rate
% % % % £m bps
Barclays UK 0.2 6.4 43.2 1.8 875 100
Barclays International 2.4 21.5 76.2 12.3 1,230 961
Head Office 0.2 8.2 38.6 6.7 55 178
Total Barclays Group retail 0.4 9.3 53.7 3.2 2,160 209
Barclays UK 0.1 1.6 11.8 0.7 102 58
Barclays International 0.3 2.1 36.3 1.7 910 156
Head Office - - 97.4 1.2 - -
Total Barclays Group
wholesale1 0.2 2.0 29.5 1.4 1,012 131
Total loans and advances at
amortised cost 0.4 5.2 43.8 2.5 3,172 175
Off-balance sheet loan
commitments and financial
guarantee contracts2
- 0.9 2.0 0.2 409
Other financial assets subject
to impairment3 157
Total4 0.2 3.2 37.6 1.4 3,738
1 Includes Wealth and Private Banking exposures measured on an individual basis, and excludes Business Banking exposures that are managed on a collective basis.
The net impact is a difference in total exposure of £1,195m of balances reported as wholesale loans on page 29 in the Loans and advances at amortised cost by
product disclosure.
2 Excludes loan commitments and financial guarantees of £7.4bn carried at fair value.
3 Other financial assets subject to impairment not included in the table above include cash collateral and settlement balances, financial assets at fair value through
other comprehensive income and other assets. These have a total gross exposure of £215.6bn and impairment allowance of £176m. This comprises £37m ECL on
£209.2bn stage 1 assets, £24m on £6.3bn stage 2 fair value through other comprehensive income assets, cash collateral and settlement balances and £115m on
£115m stage 3 other assets.
4 H120 loan impairment charge represents six months of impairment charge, annualised to calculate the loan loss rate. The loan loss rate for H120 is 207bps after
applying the total impairment charge of £3,738m.

-- 30 of 120 --

Credit Risk
28
Gross exposure Impairment allowance Net
exposure	Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3 Total
As at 31.12.19 £m £m £m £m £m £m £m £m £m
Barclays UK 143,097 23,198 2,446 168,741 198 1,277 974 2,449 166,292
Barclays International 27,886 4,026 1,875 33,787 352 774 1,359 2,485 31,302
Head Office 4,803 500 826 6,129 5 36 305 346 5,783
Total Barclays Group retail 175,786 27,724 5,147 208,657 555 2,087 2,638 5,280 203,377
Barclays UK 27,891 2,397 1,124 31,412 16 38 108 162 31,250
Barclays International 92,615 8,113 1,615 102,343 136 248 447 831 101,512
Head Office 2,974 - 37 3,011 - - 35 35 2,976
Total Barclays Group
wholesale1 123,480 10,510 2,776 136,766 152 286 590 1,028 135,738
Total loans and advances at
amortised cost 299,266 38,234 7,923 345,423 707 2,373 3,228 6,308 339,115
Off-balance sheet loan
commitments and financial
guarantee contracts2
321,140 19,185 935 341,260 97 170 55 322 340,938
Total3 620,406 57,419 8,858 686,683 804 2,543 3,283 6,630 680,053
As at 31.12.19 Year ended 31.12.19
Coverage ratio Loan impairment charge and loan loss rate4
Stage 1 Stage 2 Stage 3 Total
Loan impairment
charge Loan loss rate
% % % % £m bps
Barclays UK 0.1 5.5 39.8 1.5 661 39
Barclays International 1.3 19.2 72.5 7.4 999 296
Head Office 0.1 7.2 36.9 5.6 27 44
Total Barclays Group retail 0.3 7.5 51.3 2.5 1,687 81
Barclays UK 0.1 1.6 9.6 0.5 33 11
Barclays International 0.1 3.1 27.7 0.8 113 11
Head Office - - 94.6 1.2 - -
Total Barclays Group
wholesale1 0.1 2.7 21.3 0.8 146 11
Total loans and advances at
amortised cost 0.2 6.2 40.7 1.8 1,833 53
Off-balance sheet loan
commitments and financial
guarantee contracts2
- 0.9 5.9 0.1 71
Other financial assets subject
to impairment3 8
Total4 0.1 4.4 37.1 1.0 1,912
1 Includes Wealth and Private Banking exposures measured on an individual basis, and excludes Business Banking exposures that are managed on a collective basis.
The net impact is a difference in total exposure of £6,434m of balances reported as wholesale loans on page 29 in the Loans and advances at amortised cost by
product disclosure.
2 Excludes loan commitments and financial guarantees of £17.7bn carried at fair value.
3 Other financial assets subject to impairment not included in the table above include cash collateral and settlement balances, financial assets at fair value through
other comprehensive income and other assets. These have a total gross exposure of £149.3bn and impairment allowance of £24m. This comprises £12m ECL on
£148.5bn stage 1 assets, £2m on £0.8bn stage 2 fair value through other comprehensive income assets, cash collateral and settlement balances and £10m on £10m
stage 3 other assets.
4 The loan loss rate is 55bps after applying the total impairment charge of £1,912m.

-- 31 of 120 --

Credit Risk
29
Loans and advances at amortised cost by product
The table below presents a breakdown of loans and advances at amortised cost and the impairment allowance with stage
allocation by asset classification.
Stage 2
As at 30.06.20 Stage 1
Not past
due
<=30 days
past due
>30 days
past due Total Stage 3 Total
Gross exposure £m £m £m £m £m £m £m
Home loans 134,612 17,464 1,765 1,042 20,271 2,258 157,141
Credit cards, unsecured loans and other retail lending 35,829 11,825 361 557 12,743 3,463 52,035
Wholesale loans 107,676 39,631 3,291 713 43,635 3,386 154,697
Total 278,117 68,920 5,417 2,312 76,649 9,107 363,873
Impairment allowance
Home loans 22 47 15 21 83 397 502
Credit cards, unsecured loans and other retail lending 768 2,515 146 286 2,947 2,535 6,250
Wholesale loans 233 812 80 29 921 1,055 2,209
Total 1,023 3,374 241 336 3,951 3,987 8,961
Net exposure
Home loans 134,590 17,417 1,750 1,021 20,188 1,861 156,639
Credit cards, unsecured loans and other retail lending 35,061 9,310 215 271 9,796 928 45,785
Wholesale loans 107,443 38,837 3,193 684 42,714 2,331 152,488
Total 277,094 65,564 5,158 1,976 72,698 5,120 354,912
Coverage ratio % % % % % % %
Home loans - 0.3 0.8 2.0 0.4 17.6 0.3
Credit cards, unsecured loans and other retail lending 2.1 21.3 40.4 51.3 23.1 73.2 12.0
Wholesale loans 0.2 2.0 3.0 4.1 2.1 31.2 1.4
Total 0.4 4.9 4.8 14.5 5.2 43.8 2.5
As at 31.12.19
Gross exposure £m £m £m £m £m £m £m
Home loans 135,713 14,733 1,585 725 17,043 2,155 154,911
Credit cards, unsecured loans and other retail lending 46,012 9,759 496 504 10,759 3,409 60,180
Wholesale loans 117,541 9,374 374 684 10,432 2,359 130,332
Total 299,266 33,866 2,455 1,913 38,234 7,923 345,423
Impairment allowance
Home loans 22 37 14 13 64 346 432
Credit cards, unsecured loans and other retail lending 542 1,597 159 251 2,007 2,335 4,884
Wholesale loans 143 284 9 9 302 547 992
Total 707 1,918 182 273 2,373 3,228 6,308
Net exposure
Home loans 135,691 14,696 1,571 712 16,979 1,809 154,479
Credit cards, unsecured loans and other retail lending 45,470 8,162 337 253 8,752 1,074 55,296
Wholesale loans 117,398 9,090 365 675 10,130 1,812 129,340
Total 298,559 31,948 2,273 1,640 35,861 4,695 339,115
Coverage ratio % % % % % % %
Home loans - 0.3 0.9 1.8 0.4 16.1 0.3
Credit cards, unsecured loans and other retail lending 1.2 16.4 32.1 49.8 18.7 68.5 8.1
Wholesale loans 0.1 3.0 2.4 1.3 2.9 23.2 0.8
Total 0.2 5.7 7.4 14.3 6.2 40.7 1.8
Total customers on payment holidays amounted to £21.9bn in balances, of which 69% are in Stage 1. If these customers moved from
Stage 1 to Stage 2, it would result in an estimated ECL impact of £214m. Staging criteria are broadly consistent with the criteria
outlined in the Barclays PLC Annual Report 2019.

-- 32 of 120 --

Credit Risk
30
Loans and advances at amortised cost by selected sectors
The table below presents a breakdown of loans and advances at amortised cost and the impairment allowance, with gross
exposure and stage allocation for selected industry sectors within the wholesale loans portfolio. The industry sectors have been
selected based upon the level of management focus they have received following the onset of the COVID-19 pandemic.
Gross exposure Impairment allowance
Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3 Total
As at 30.06.20 £m £m £m £m £m £m £m £m
Air travel 1,018 462 69 1,549 - 14 25 39
Hospitality and leisure 3,567 3,600 236 7,403 18 121 75 214
Oil and gas 1,427 2,389 407 4,223 19 99 185 303
Retail 2,954 2,260 297 5,511 37 46 101 184
Shipping 355 369 6 730 1 8 3 12
Transportation 818 358 119 1,295 4 21 46 71
Total 10,139 9,438 1,134 20,711 79 309 435 823
Total of Wholesale exposures 9% 22% 33% 13% 34% 34% 41% 37%
Gross exposure Impairment allowance
Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3 Total
As at 31.12.19 £m £m £m £m £m £m £m £m
Air travel 194 31 26 251 - - 24 24
Hospitality and leisure 4,321 851 199 5,371 8 18 29 55
Oil and gas 2,539 612 136 3,287 8 24 47 79
Retail 3,395 777 207 4,379 11 24 85 120
Shipping 357 52 7 416 1 - 3 4
Transportation 873 82 89 1,044 5 5 54 64
Total 11,679 2,405 664 14,748 33 71 242 346
Total of Wholesale exposures 10% 23% 28% 11% 23% 24% 44% 35%
The coverage ratio for selected sectors has increased from 2.3% as at 31 December 2019 to 4.0% as at 30 June 2020. Exposure to UK
commercial real estate of £9.0bn, excluding government backed schemes, was in line with 31 December 2019 (£9.1bn). Coverage
increased from 0.56% to 0.85% in the period.

-- 33 of 120 --

Credit Risk
31
Movement in gross exposures and impairment allowance including provisions for loan
commitments and financial guarantees
The following tables present a reconciliation of the opening to the closing balance of the exposure and impairment allowance. An
explanation of the terms 12-month ECL, lifetime ECL and credit-impaired is included in the Barclays PLC Annual Report 2019 filed on
Form 20-F on page 225. Transfers between stages in the table have been reflected as if they had taken place at the beginning of the
year. The movements are measured over a 6-month period.
Loans and advances at amortised cost
Stage 1 Stage 2 Stage 3 Total
Gross
exposure ECL
Gross
exposure ECL
Gross
exposure ECL
Gross
exposure ECL
Home loans £m £m £m £m £m £m £m £m
As at 1 January 2020 135,713 22 17,043 64 2,155 346 154,911 432
Transfers from Stage 1 to Stage 2 (7,161) (1) 7,161 1 - - - -
Transfers from Stage 2 to Stage 1 2,985 7 (2,985) (7) - - - -
Transfers to Stage 3 (99) - (288) (8) 387 8 - -
Transfers from Stage 3 24 - 112 1 (136) (1) - -
Business activity in the year 9,928 1 277 1 - - 10,205 2
Net drawdowns, repayments, net re-
measurement and movement due to exposure
and risk parameter changes
(2,752) (6) (355) 32 (2) 62 (3,109) 88
Final repayments (4,026) (1) (694) (1) (137) (9) (4,857) (11)
Disposals - - - - - - - -
Write-offs1 - - - - (9) (9) (9) (9)
As at 30 June 20202 134,612 22 20,271 83 2,258 397 157,141 502
Credit cards, unsecured loans and other retail lending
As at 1 January 2020 46,012 542 10,759 2,007 3,409 2,335 60,180 4,884
Transfers from Stage 1 to Stage 2 (6,228) (124) 6,228 124 - - - -
Transfers from Stage 2 to Stage 13 2,977 465 (2,977) (465) - - - -
Transfers to Stage 3 (261) (12) (796) (325) 1,057 337 - -
Transfers from Stage 3 36 10 62 9 (98) (19) - -
Business activity in the year 3,645 45 215 44 15 6 3,875 95
Net drawdowns, repayments, net re-
measurement and movement due to exposure
and risk parameter changes3
(6,800) (128) (410) 1,595 136 814 (7,074) 2,281
Final repayments (2,059) (22) (155) (22) (125) (36) (2,339) (80)
Disposals4 (1,493) (8) (183) (20) (86) (57) (1,762) (85)
Write-offs1 - - - - (845) (845) (845) (845)
As at 30 June 20202 35,829 768 12,743 2,947 3,463 2,535 52,035 6,250
1 In H120, gross write-offs amounted to £953m (H119: £951m) and post write-off recoveries amounted to £15m (H119: £73m). Net write-offs represent gross write-
offs less post write-off recoveries and amounted to £938m (H119: £878m).
2 Other financial assets subject to impairment excluded from the tables above include cash collateral and settlement balances, financial assets at fair value through
other comprehensive income and other assets. These have a total gross exposure of £215.6bn (December 2019: £149.3bn) and impairment allowance of £176m
(December 2019: £24m). This comprises £37m ECL (December 2019: £12m) on £209.2bn Stage 1 assets (December 2019: £148.5m), £24m (December 2019: £2m) on
£6.3bn Stage 2 fair value through other comprehensive income assets, cash collateral and settlement assets (December 2019: £0.8bn) and £115m (December 2019:
£10m) on £115m Stage 3 other assets (December 2019: £10m).
3 Transfers and risk parameter changes include a £253m net release in ECL arising from a reclassification of £2.4bn gross loans and advances from Stage 2 to Stage 1
in Credit cards, unsecured loans and other retail lending resulting from a review of probability of default models in the period. Barclays continually reviews the
output of models to determine appropriateness of the ECL calculation, including reviews of model monitoring, external benchmarking and experience of model
operation over an extended period of time.
4 Disposals reported within Credit cards, unsecured loans and other retail lending portfolio include sale of motor financing business within the Barclays Partner Finance
business.

-- 34 of 120 --

Credit Risk
32
Loans and advances at amortised cost
Stage 1 Stage 2 Stage 3 Total
Gross
exposure ECL
Gross
exposure ECL
Gross
exposure ECL
Gross
exposure ECL
Wholesale loans £m £m £m £m £m £m £m £m
As at 1 January 2020 117,541 143 10,432 302 2,359 547 130,332 992
Transfers from Stage 1 to Stage 2 (27,187) (63) 27,187 63 - - - -
Transfers from Stage 2 to Stage 1 2,076 20 (2,076) (20) - - - -
Transfers to Stage 3 (832) (3) (653) (44) 1,485 47 - -
Transfers from Stage 3 251 9 250 7 (501) (16) - -
Business activity in the year 23,797 22 4,316 213 42 12 28,155 247
Net drawdowns, repayments, net re-
measurement and movement due to exposure
and risk parameter changes
15,311 124 5,831 415 360 601 21,502 1,140
Final repayments (23,281) (19) (1,643) (15) (260) (37) (25,184) (71)
Disposals - - (9) - - - (9) -
Write-offs1 - - - - (99) (99) (99) (99)
As at 30 June 20202 107,676 233 43,635 921 3,386 1,055 154,697 2,209
Reconciliation of ECL movement to impairment charge/(release) for the period £m
Home loans 79
Credit cards, unsecured loans and other retail lending 2,296
Wholesale loans 1,316
ECL movement excluding assets derecognised due to disposals and write-offs 3,691
Recoveries and reimbursements3 (294)
Exchange and other adjustments4 (225)
Impairment charge on loan commitments and other financial guarantees 409
Impairment charge on other financial assets2 157
As at 30 June 2020 3,738
1 In H120, gross write-offs amounted to £953m (H119: £951m) and post write-off recoveries amounted to £15m (H119: £73m). Net write-offs represent gross write-
offs less post write-off recoveries and amounted to £938m (H119: £878m).
2 Other financial assets subject to impairment excluded from the tables above include cash collateral and settlement balances, financial assets at fair value through
other comprehensive income and other assets. These have a total gross exposure of £215.6bn (December 2019: £149.3bn) and impairment allowance of £176m
(December 2019: £24m). This comprises £37m ECL (December 2019: £12m) on £209.2bn Stage 1 assets (December 2019: £148.5m), £24m (December 2019: £2m) on
£6.3bn Stage 2 fair value through other comprehensive income assets, cash collateral and settlement assets (December 2019: £0.8bn) and £115m (December 2019:
£10m) on £115m Stage 3 other assets (December 2019: £10m).
3 Recoveries and reimbursements includes a net gain in relation to reimbursements from financial guarantee contracts held with third parties of £279m and post write
off recoveries of £15m.
4 Includes foreign exchange and interest and fees in suspense.

-- 35 of 120 --

Credit Risk
33
Loan commitments and financial guarantees
Stage 1 Stage 2 Stage 3 Total
Gross
exposure ECL
Gross
exposure ECL
Gross
exposure ECL
Gross
exposure ECL
Home loans £m £m £m £m £m £m £m £m
As at 1 January 2020 9,542 - 500 - 4 - 10,046 -
Net transfers between stages (93) - 93 - - - - -
Business activity in the year 136 - - - - - 136 -
Net drawdowns, repayments, net re-
measurement and movement due to exposure
and risk parameter changes
(875) - (6) - (1) - (882) -
Limit management (117) - (16) - - - (133) -
As at 30 June 2020 8,593 - 571 - 3 - 9,167 -
Credit cards, unsecured loans and other retail lending
As at 1 January 2020 125,759 35 6,238 71 250 14 132,247 120
Net transfers between stages (4,914) 39 4,613 (38) 301 (1) - -
Business activity in the year 4,012 2 94 1 1 1 4,107 4
Net drawdowns, repayments, net re-
measurement and movement due to exposure
and risk parameter changes
9,357 (4) 248 123 (312) 8 9,293 127
Limit management (5,402) (1) (277) (1) (34) (3) (5,713) (5)
As at 30 June 2020 128,812 71 10,916 156 206 19 139,934 246
Wholesale loans
As at 1 January 2020 185,839 62 12,447 99 681 41 198,967 202
Net transfers between stages (38,868) (22) 37,836 15 1,032 7 - -
Business activity in the year 24,882 7 3,389 30 107 - 28,378 37
Net drawdowns, repayments, net re-
measurement and movement due to exposure
and risk parameter changes
11,805 11 1,026 289 (221) (19) 12,610 281
Limit management (36,256) (7) (2,858) (18) (239) - (39,353) (25)
As at 30 June 2020 147,402 51 51,840 415 1,360 29 200,602 495

-- 36 of 120 --

Credit Risk
34
Measurement uncertainty
The Group uses a five-scenario model to calculate ECL. Absent the conditions surrounding the COVID-19 pandemic, a Baseline
scenario is typically generated based on an external consensus forecast assembled from key sources, including HM Treasury (short-
and medium-term forecasts), Bloomberg (based on median of economic forecasts) and the Urban Land Institute (for US House
Prices). In addition, two adverse scenarios (Downside 1 and Downside 2) and two favourable scenarios (Upside 1 and Upside 2) are
derived, with associated probability weightings. The adverse scenarios are typically calibrated to a similar severity to internal stress
tests, whilst also considering IFRS 9 specific sensitivities and non-linearity Downside 2 is typically benchmarked to the Bank of
England’s annual cyclical scenarios and to the most severe scenario from Moody’s inventory, but is not designed to be the same.
The favourable scenarios are generally calibrated to be symmetric to the adverse scenarios, subject to a ceiling calibrated to
relevant recent favourable benchmark scenarios. The scenarios include eight economic variables (GDP, unemployment, House Price
Index (HPI) and base rates in both the UK and US markets), and expanded variables using statistical models based on historical
correlations. The upside and downside shocks are designed to evolve over a five-year stress horizon, with all five scenarios
converging to a steady state after approximately eight years. To calculate ECL a probability weight is assigned to each scenario.
Following the onset of the COVID-19 pandemic, the Group generated a Baseline scenario in March 2020 that reflected the most
recent economic forecasts available in the market (combined with internal assumptions) and estimated impacts from significant
support measures taken by Barclays, central banks and governments across the Group’s key markets. This scenario assumed a
strong contraction in GDP and a sharp rise in unemployment in 2020 across both the UK and US, and required a recalibration of
probability weights. This scenario was superseded by a further revised Baseline scenario generated in June 2020, based broadly on
the latest economic forecasts which recognise some impacts from the various support measures still in place across the Group’s key
markets. Upside and downside scenarios were also regenerated in June 2020 (together with the revised Baseline scenario, the
“COVID-19 scenarios”). The downside scenarios reflect slower economic growth than the Baseline with social distancing measures
continuing to drag GDP. Economic growth begins to recover later in 2020 in Downside 1 but only in 2021 in the Downside 2
scenario. The upside scenarios reflect a faster rebound in economic growth than the Baseline with a sharp decrease in infection
rates and an almost fully reopened economy. Scenario weights were also revised in June 2020 with greater weight being applied to
the tail scenarios (Upside 2 and Downside 2). This reflects the significant range of uncertainty in the economic environment
compared to previous quarters given the conditions surrounding the COVID-19 pandemic.
The economic environment remains uncertain and future impairment charges may be subject to further volatility (including from
changes to macroeconomic variable forecasts) depending on the longevity of the COVID-19 pandemic and related containment
measures, as well as the longer term effectiveness of central bank, government and other support measures.
The tables below show the key macroeconomic variables used in the COVID-19 Baseline scenario and the probability weights
applied to each respective scenario.

-- 37 of 120 --

Credit Risk
35
Baseline average macroeconomic variables used in the calculation of ECL
2020 2021 2022
Expected Worst
Point
As at 30.06.20 % % % %
UK GDP1 (8.7) 6.1 2.9 (51.4)
UK unemployment2 6.6 6.5 4.4 8.0
UK HPI3 0.6 2.0 - (1.5)
UK bank rate 0.2 0.1 0.1 0.1
US GDP1 (4.2) 4.4 (0.3) (30.4)
US unemployment4 9.3 7.6 5.5 13.4
US HPI5 1.1 1.8 (0.8) (1.9)
US federal funds rate 0.5 0.3 0.3 0.3
As at 31.03.20
UK GDP1 (8.0) 6.3 1.3 (51.5)
UK unemployment2 6.7 4.5 3.7 8.0
UK HPI3 (3.5) 2.6 2.7 (6.5)
UK bank rate 0.1 0.3 0.3 0.1
US GDP1 (6.4) 4.4 3.2 (45.0)
US unemployment4 12.9 7.5 3.8 17.0
US HPI5 - 0.7 0.8 (0.3)
US federal funds rate 0.3 0.3 0.3 0.3
1 Average Real GDP seasonally adjusted change in year (31.03.20 based on Barclays Global Economic Forecasts); expected worst point is the minimum seasonally
adjusted quarterly annualised rate.
2 Average UK unemployment rate 16-year+.
3 Change in average yearly UK HPI = Halifax All Houses, All Buyers index, relative to prior year end; worst point is based on cumulative drawdown in year relative to
prior year end.
4 Average US civilian unemployment rate 16-year+.
5 Change in average yearly US HPI = FHFA house price index, relative to prior year end; worst point is based on cumulative drawdown in year relative to prior year end.
(31.03.20 based on QoQ average growth rates).
Scenario probability weighting
Upside 2 Upside 1 Baseline Downside 1 Downside 2
% % % % %
As at 30.06.20
Scenario probability weighting 20.3 22.4 25.4 17.5 14.4
As at 31.03.20
Scenario probability weighting 5.0 20.8 46.7 21.0 6.5
As at 31.12.19
Scenario probability weighting 10.1 23.1 40.8 22.7 3.3

-- 38 of 120 --

Credit Risk
36
Macroeconomic variables (specific bases)1
Upside 2 Upside 1 Baseline Downside 1 Downside 2
As at 30.06.20 % % % % %
UK GDP2 32.7 26.4 5.4 1.6 1.2
UK unemployment3 3.5 3.6 4.9 9.6 10.9
UK HPI4 45.3 27.2 2.3 (15.0) (33.4)
UK bank rate3 0.1 0.1 0.2 0.3 0.2
US GDP2 19.1 13.5 3.3 2.0 (3.1)
US unemployment3 4.1 4.4 6.3 15.4 18.7
US HPI4 32.3 20.9 2.3 (8.8) (19.7)
US federal funds rate3 0.3 0.3 0.3 0.4 0.4
As at 31.12.19
UK GDP2 4.2 2.9 1.6 0.2 (4.7)
UK unemployment3 3.4 3.8 4.2 5.7 8.7
UK HPI4 46.0 32.0 3.1 (8.2) (32.4)
UK bank rate3 0.5 0.5 0.7 2.8 4.0
US GDP2 4.2 3.3 1.9 0.4 (3.4)
US unemployment3 3.0 3.5 3.9 5.3 8.5
US HPI4 37.1 23.3 3.0 0.5 (19.8)
US federal funds rate3 1.5 1.5 1.7 3.0 3.5
As at 30.06.19
UK GDP2 4.5 3.1 1.7 0.3 (4.1)
UK unemployment3 3.4 3.9 4.3 5.7 8.8
UK HPI4 46.4 32.6 3.2 (0.5) (32.1)
UK bank rate3 0.8 0.8 1.0 2.5 4.0
US GDP2 4.8 3.7 2.1 0.4 (3.3)
US unemployment3 3.0 3.4 3.7 5.2 8.4
US HPI4 36.9 30.2 4.1 - (17.4)
US federal funds rate3 2.3 2.3 2.7 3.0 3.5
1 UK GDP = Real GDP growth seasonally adjusted; UK unemployment = UK unemployment rate 16-year+; UK HPI = Halifax All Houses, All Buyers Index; US GDP = Real
GDP growth seasonally adjusted; US unemployment = US civilian unemployment rate 16-year+; US HPI = FHFA house price index. Forecast period based on 20
quarters from Q3 2020.
2 Upside scenario is the highest annual average growth rate based on seasonally adjusted quarterly annualised rate; 5-year average in Baseline; downside is the
lowest annual average growth rate based on seasonally adjusted quarterly annualised rate.
3 Lowest yearly average in Upside scenarios; 5-year average in Baseline; highest yearly average in Downside scenarios.
4 Cumulative growth (trough to peak) in Upside scenarios; 5-year average in Baseline; cumulative fall (peak-to-trough) in Downside scenarios.

-- 39 of 120 --

Credit Risk
37
Macroeconomic variables (5-year averages)1
Upside 2 Upside 1 Baseline Downside 1 Downside 2
As at 30.06.20 % % % % %
UK GDP 8.9 7.2 5.4 5.2 2.8
UK unemployment 4.0 4.3 4.9 6.2 7.2
UK HPI 7.8 5.0 2.3 (1.4) (5.5)
UK bank rate 0.4 0.3 0.2 0.1 0.1
US GDP 5.9 4.4 3.3 2.7 1.8
US unemployment 4.4 5.1 6.3 8.4 10.9
US HPI 5.8 3.9 2.3 (0.5) (3.1)
US federal funds rate 0.6 0.5 0.3 0.3 0.3
As at 31.12.19
UK GDP 3.2 2.4 1.6 0.8 (0.7)
UK unemployment 3.5 3.9 4.2 5.4 7.7
UK HPI 7.9 5.7 3.1 (1.1) (6.5)
UK bank rate 0.5 0.5 0.7 2.5 3.7
US GDP 3.5 2.8 1.9 1.0 (0.5)
US unemployment 3.1 3.6 3.9 5.0 7.5
US HPI 6.5 4.3 3.0 1.3 (3.7)
US federal funds rate 1.6 1.7 1.7 2.9 3.4
As at 30.06.19
UK GDP 3.4 2.6 1.7 0.9 (0.6)
UK unemployment 3.7 4.0 4.3 5.1 7.9
UK HPI 7.9 5.8 3.2 0.9 (6.4)
UK bank rate 0.8 0.8 1.0 2.3 3.7
US GDP 3.7 3.0 2.1 1.1 (0.5)
US unemployment 3.1 3.5 3.7 4.7 7.4
US HPI 6.5 5.4 4.1 2.4 (2.6)
US federal funds rate 2.3 2.3 2.7 3.0 3.4
1 UK GDP = Real GDP growth seasonally adjusted; UK unemployment = UK unemployment rate 16-year+; UK HPI = Halifax All Houses, All Buyers Index; US GDP = Real
GDP growth seasonally adjusted; US unemployment = US civilian unemployment rate 16-year+; US HPI = FHFA house price index. For GDP and HPI, numbers
represent average of seasonally adjusted quarterly annualised rates. Forecast period based on 20 quarters from Q3 2020.

-- 40 of 120 --

Credit Risk
38
The following table provides a breakdown of the key drivers of the Group’s loan impairment charge.
Drivers of loan impairment charge
Q120 Q220 Total
£m £m £m
Impairment charge generated using scenarios before COVID-19 370 424 794
Single name wholesale loan charges 405 186 591
Loan impairment charge prior to impact of COVID-19 scenarios 775 610 1,385
Impact of COVID-19 scenarios and weights 1,190 1,163 2,353
Specific charge in respect of exposures to selected sectors 300 (150) 150
Incorporation of provision for UK economic uncertainty (150) - (150)
Total loan impairment charge 2,115 1,623 3,738
The impact of the COVID-19 scenarios and weighting adjustments has resulted in a £2,353m increase in ECL from the pre-COVID
scenarios, primarily driven by forecasts for a prolonged period of UK and US unemployment.
Estimated effects from the significant support measures provided by Barclays, central banks and governments across the Group’s
key markets as a result of the COVID-19 pandemic have been factored into the calculation of the Group’s loan impairment charge.
The £300m provision taken in Q120 in respect of oil price risk has been released given the Q2 rebound in oil prices and residual risk
on the energy sector has been recognised in a Q2 charge of c.£150m under the COVID-19 scenarios and weights. A specific charge
of £150m in respect of exposures to selected sectors represents additional provisions taken in Q220 in response to the current
slowdown, in particular in the hospitality and retail sectors.
The £150m provision for UK economic uncertainty held at the year-end was incorporated within the updated scenarios in Q1.
ECL under 100% weighted scenarios for modelled portfolios
The table below shows the ECL assuming scenarios have been 100% weighted. Model exposures are allocated to a stage based on
the individual scenario rather than through a probability-weighted approach as required for Barclays reported impairment
allowances. As a result, it is not possible to back solve to the final reported weighted ECL from the individual scenarios as a balance
may be assigned to a different stage dependent on the scenario. Model exposure uses exposure at default (EAD) values and is not
directly comparable to gross exposure used in prior disclosures. For Credit cards, unsecured loans and other retail lending, an
average EAD measure is used (12 month or lifetime, depending on stage allocation in each scenario). Therefore, the model
exposure movement into Stage 2 is higher than the corresponding Stage 1 reduction.
All ECL using a model is included, with the exception of Treasury assets (£30m of ECL), non-modelled exposures and management
adjustments.
Model exposures allocated to Stage 3 do not change in any of the scenarios as the transition criteria relies only on observable
evidence of default as at 30 June 2020 and not on macroeconomic scenarios.
The Downside 2 scenario represents a global recession with substantial falls in both UK and US GDP. Unemployment in UK and US
markets rises to 11% and 19% respectively and there are substantial falls in asset prices including housing.
Under the Downside 2 scenario, model exposure moves between stages as the economic environment weakens. This can be seen
in the movement of £50bn of model exposure into Stage 2 between the Weighted and Downside 2 scenario. ECL increases in Stage
2 predominantly due to unsecured portfolios as economic conditions deteriorate.

-- 41 of 120 --

Credit Risk
39
Scenarios
As at 30.06.20 Weighted Upside 2 Upside 1 Baseline Downside 1 Downside 2
Stage 1 Model Exposure (£m)
Home loans 125,380 128,154 127,314 126,404 122,433 112,937
Credit cards, unsecured loans and other retail lending 58,303 63,114 62,525 61,361 58,654 55,410
Wholesale loans 122,594 144,825 145,491 140,318 115,054 93,598
Stage 1 Model ECL (£m)
Home loans 15 7 8 10 25 273
Credit cards, unsecured loans and other retail lending 592 558 612 636 665 649
Wholesale loans 293 330 317 293 283 271
Stage 1 Coverage (%)
Home loans - - - - - 0.2
Credit cards, unsecured loans and other retail lending 1.0 0.9 1.0 1.0 1.1 1.2
Wholesale loans 0.2 0.2 0.2 0.2 0.2 0.3
Stage 2 Model Exposure (£m)
Home loans 20,058 17,284 18,124 19,034 23,005 32,501
Credit cards, unsecured loans and other retail lending 23,620 14,746 17,298 21,270 26,748 32,457
Wholesale loans 67,528 45,296 44,631 49,804 75,067 96,523
Stage 2 Model ECL (£m)
Home loans 75 48 48 55 70 194
Credit cards, unsecured loans and other retail lending 3,715 2,124 2,643 3,527 4,950 6,562
Wholesale loans 2,385 1,378 1,484 1,873 3,349 4,790
Stage 2 Coverage (%)
Home loans 0.4 0.3 0.3 0.3 0.3 0.6
Credit cards, unsecured loans and other retail lending 15.7 14.4 15.3 16.6 18.5 20.2
Wholesale loans 3.5 3.0 3.3 3.8 4.5 5.0
Stage 3 Model Exposure (£m)
Home loans 1,750 1,750 1,750 1,750 1,750 1,750
Credit cards, unsecured loans and other retail lending 2,928 2,928 2,928 2,928 2,928 2,928
Wholesale loans1 1,864 1,864 1,864 1,864 1,864 1,864
Stage 3 Model ECL (£m)
Home loans 330 271 273 315 380 465
Credit cards, unsecured loans and other retail lending 2,346 2,277 2,309 2,345 2,392 2,449
Wholesale loans1 91 80 83 93 96 109
Stage 3 Coverage (%)
Home loans 18.9 15.5 15.6 18.0 21.7 26.6
Credit cards, unsecured loans and other retail lending 80.1 77.8 78.9 80.1 81.7 83.6
Wholesale loans1 4.9 4.3 4.5 5.0 5.2 5.8
Total Model ECL (£m)
Home loans 420 326 329 380 475 932
Credit cards, unsecured loans and other retail lending 6,653 4,959 5,564 6,508 8,007 9,660
Wholesale loans1 2,769 1,788 1,884 2,259 3,728 5,170
Total Model ECL 9,842 7,073 7,777 9,147 12,210 15,762
1 Material wholesale loan defaults are individually assessed across different recovery strategies.
Reconciliation to total ECL £m
Total model ECL 9,842
ECL from individually assessed impairments on stage 3 loans 1,026
ECL from non-modelled and other management adjustments1 (1,166)
Total ECL 9,702
1 Management adjustments of £1.2bn materially reflect estimated impacts from the significant support measures provided by Barclays, central banks and
governments across the Group’s key markets as a result of the COVID-19 pandemic. Some impacts from these support measures are recognised in the COVID-19
scenarios used to calculate modelled ECL. However, given the uncertain economic environment and the unprecedented policy response to the pandemic,
management have reviewed the output of the models across key portfolios to assess the appropriateness of the total ECL and to more fully estimate the impact given
the longevity of support measures. Such assessments are inherently uncertain and actual credit losses may differ from the ECL depending on the evolution of the
COVID-19 pandemic.

-- 42 of 120 --

Credit Risk
40
The dispersion of results around the Baseline is an indication of uncertainty around future projections. The disclosure highlights the
results of the alternative scenarios enabling the reader to understand the extent of the impact on exposure and ECL from the
upside/downside scenarios. Consequently, the use of five scenarios with associated weightings results in a total weighted ECL uplift
from the Baseline ECL of 8%.

-- 43 of 120 --

Credit Risk
41
Scenarios
As at 31.12.19 Weighted Upside 2 Upside 1 Baseline Downside 1 Downside 2
Stage 1 Model Exposure (£m)
Home loans 137,929 139,574 138,992 138,249 136,454 132,505
Credit cards, unsecured loans and other retail lending 68,619 69,190 69,012 68,388 68,309 67,015
Wholesale loans 160,544 162,717 162,058 161,111 157,720 143,323
Stage 1 Model ECL (£m)
Home loans 6 4 5 5 7 19
Credit cards, unsecured loans and other retail lending 505 490 495 495 511 528
Wholesale loans 209 162 174 188 271 297
Stage 1 Coverage (%)
Home loans - - - - - -
Credit cards, unsecured loans and other retail lending 0.7 0.7 0.7 0.7 0.7 0.8
Wholesale loans 0.1 0.1 0.1 0.1 0.2 0.2
Stage 2 Model Exposure (£m)
Home loans 16,889 15,245 15,826 16,570 18,364 22,314
Credit cards, unsecured loans and other retail lending 13,406 11,449 12,108 13,075 15,663 19,615
Wholesale loans 15,947 13,773 14,433 15,380 18,770 33,168
Stage 2 Model ECL (£m)
Home loans 41 33 34 36 47 170
Credit cards, unsecured loans and other retail lending 1,844 1,412 1,562 1,771 2,384 4,285
Wholesale loans 414 285 323 374 579 1,427
Stage 2 Coverage (%)
Home loans 0.2 0.2 0.2 0.2 0.3 0.8
Credit cards, unsecured loans and other retail lending 13.8 12.3 12.9 13.5 15.2 21.8
Wholesale loans 2.6 2.1 2.2 2.4 3.1 4.3
Stage 3 Model Exposure (£m)
Home loans 1,670 1,670 1,670 1,670 1,670 1,670
Credit cards, unsecured loans and other retail lending 3,008 3,008 3,008 3,008 3,008 3,008
Wholesale loans1 1,489 1,489 1,489 1,489 1,489 1,489
Stage 3 Model ECL (£m)
Home loans 268 262 264 266 272 316
Credit cards, unsecured loans and other retail lending 2,198 2,154 2,174 2,195 2,235 2,292
Wholesale loans1 118 111 114 117 127 128
Stage 3 Coverage (%)
Home loans 16.0 15.7 15.8 15.9 16.3 18.9
Credit cards, unsecured loans and other retail lending 73.1 71.6 72.3 73.0 74.3 76.2
Wholesale loans1 7.9 7.4 7.6 7.9 8.5 8.6
Total Model ECL (£m)
Home loans 315 299 303 307 326 505
Credit cards, unsecured loans and other retail lending 4,547 4,056 4,231 4,461 5,130 7,105
Wholesale loans1 741 558 611 679 977 1,852
Total Model ECL 5,603 4,913 5,145 5,447 6,433 9,462
1 Material wholesale loan defaults are individually assessed across different recovery strategies.
Reconciliation to total ECL1 £m
Total model ECL 5,603
ECL from individually assessed impairments on stage 3 loans 419
ECL from non-modelled and other management adjustments 608
Total ECL 6,630
1 The table has been re-presented to separately show the impact of individually assessed impairments of £419m. This was included in the Barclays PLC Annual Report
2019 with non-modelled and other adjustments of £268m. Non-modelled and other adjustments are now disclosed within the other management adjustments
category of £608m.

-- 44 of 120 --

Credit Risk
42
Analysis of specific portfolios and asset types
Secured home loans
The UK home loan portfolio primarily comprises first lien mortgages and accounts for 92% (December 2019: 92%) of the Group’s
total home loans balance.
Home loans principal portfolios Barclays UK
As at
30.06.20
As at
31.12.19
Gross loans and advances (£m) 145,205 143,259
90 day arrears rate, excluding recovery book (%) 0.2 0.2
Annualised gross charge-off rate - 180 days past due (%) 0.5 0.6
Recovery book proportion of outstanding balances (%) 0.6 0.5
Recovery book impairment coverage ratio (%) 3.5 5.3
Average marked to market LTV
Balance weighted (%) 51.5 51.1
Valuation weighted (%) 37.5 37.3
New lending
Half year ended
30.06.20
Half year ended
30.06.19
New home loan completions (£m) 9,977 11,097
New home loans proportion > 90% LTV (%) 3.7 3.9
Average LTV on new home loans: balance weighted (%) 68.4 67.1
Average LTV on new home loans: valuation weighted (%) 60.0 58.9
Home loans principal portfolios – distribution of balances by LTV1,2
Distribution of balances Distribution of impairment allowance Coverage ratio
Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3 Total
Barclays UK % % % % % % % % % % % %
As at 30.06.20
<=75% 73.3 12.3 0.6 86.2 10.4 22.4 32.0 64.8 - 0.1 2.5 -
>75% and <=90% 11.5 1.0 - 12.5 3.0 13.7 9.0 25.7 - 0.7 14.6 0.1
>90% and <=100% 1.1 0.1 - 1.2 0.4 1.6 2.0 4.0 - 1.0 26.5 0.2
>100% 0.1 - - 0.1 0.1 1.3 4.1 5.5 0.1 2.8 39.6 3.0
As at 31.12.19
<=75% 76.0 10.7 0.7 87.4 4.2 15.4 28.5 48.1 - 0.1 2.2 -
>75% and <=90% 10.4 0.7 - 11.1 2.7 11.5 12.6 26.8 - 0.9 19.7 0.1
>90% and <=100% 1.3 0.1 - 1.4 0.8 2.5 4.9 8.2 - 1.8 54.4 0.3
>100% 0.1 - - 0.1 0.2 4.1 12.6 16.9 0.2 8.7 107.4 9.0
1 Portfolio mark to market based on the most updated valuation including recovery book balances. Updated valuations reflect the application of the latest HPI
available as at 30 June 2020.
2 The average LTV of the customers taking payment holidays is 57%. Of the customers taking payment holidays, 35% of customers are in less than 60% LTV bucket,
40% in 60%-80% LTV bucket and 25% in greater than 80% LTV bucket.
The change in impairment coverage by loan to value ratio in the period is due to the impact of the change in economic assumptions
and scenario weights, reflecting the COVID-19 crisis. This has resulted in a redistribution of the impairment stock by loan to value
segment for the UK Mortgage portfolio with no change in overall impairment coverage for this portfolio.
During H120, a total of 120k payment holidays were provided to customers. At 30 June 2020, the book value of the portfolio where
payment holidays have been granted was £14.9bn, representing 10.3% of the portfolio.
Head Office: Italian home loans and advances at amortised cost remained broadly stable at £6.1bn (2019: £6.0bn). The portfolio is
secured on residential property with an average balance weighted mark to market LTV of 63.1% (2019: 64.4%). 90-day arrears
remained broadly stable at 1.9% (2019: 1.8%), gross charge-off rates increased slightly to 1.1% (2019: 0.8%).

-- 45 of 120 --

Credit Risk
43
Credit cards, unsecured loans and other retail lending
The principal portfolios listed below accounted for 86% (December 2019: 87%) of the Group’s total credit cards, unsecured loans
and other retail lending.
Principal portfolios
Gross exposure
30 day arrears
rate, excluding
recovery book
90 day arrears
rate, excluding
recovery book
Annualised
gross write-off
rate
Annualised net
write-off rate
As at 30.06.20 £m % % % %
Barclays UK
UK cards 13,639 2.0 1.0 2.6 2.6
UK personal loans 5,526 2.4 1.4 2.9 2.7
Barclays Partner Finance1 2,286 0.8 0.4 1.2 1.2
Barclays International
US cards 19,505 2.4 1.4 5.1 5.1
Germany consumer lending 3,570 1.6 0.8 1.0 0.9
As at 31.12.19
Barclays UK
UK cards 16,457 1.7 0.8 1.6 1.6
UK personal loans 6,139 2.1 1.0 3.2 2.9
Barclays International
US cards 22,041 2.7 1.4 4.5 4.4
Barclays Partner Finance1 4,134 0.9 0.3 1.7 1.7
Germany consumer lending 3,558 1.7 0.7 2.1 1.3
1 On 1 April 2020, the Barclays Partner Finance business moved from Barclays International to Barclays UK. The 2019 comparative figures have not been restated.
UK cards: 30 and 90 day arrears rates increased by 0.3% and 0.2% respectively. The majority of the increase was driven by a £2.8bn
reduction in balances, and prior to payment holidays being initiated, lower collections capacity in the first few weeks of the COVID-
19 related lockdown. During H120, a total of 151k payment holidays were provided to customers. At 30 June 2020, the book value
of the portfolio where payment holidays have been granted was £664m, representing 4.9% of the portfolio.
UK personal loans: 30 and 90 day arrears rates increased by 0.3% and 0.4% respectively, driven by a 10% reduction in overall
balances, coupled with lower collections capacity prior to payment holidays being initiated in the first few weeks of the COVID-19
related lockdown. During H120, a total of 74k payment holidays were provided to customers. At 30 June 2020, the book value of
the portfolio where payment holidays have been granted was £609m, representing 11.0% of the portfolio.
Barclays Partner Finance: The marginal improvement in the 30 day arrears rate was primarily a result of the sale of the motor
financing business, and since the introduction of payment holidays, lower flows into delinquency. 90 day arrears rate slightly
worsened as prior to payment holidays being initiated, there was lower collections capacity in the first few weeks of the COVID-19
related lockdown. During H120, a total of 13k payment holidays were provided to customers. At 30 June 2020, the book value of
the portfolio where payment holidays have been granted was £43m, representing 1.9% of the portfolio.
US cards: 30 day arrears rate decreased due to payment holidays granted to customers impacted by COVID-19 which reduced the
delinquency entrance rate and overall flow through delinquency. During H120, a total of 213k payment holidays were provided to
customers. At 30 June 2020, the book value of the portfolio where payment holidays have been granted was £567m, representing
2.9% of the portfolio.
Germany consumer lending: The improvement in the 30 day arrears rate was primarily driven by payment deferrals offered by
Germany in Q220. During H120, a total of 8k payment holidays were provided to customers. At 30 June 2020, the book value of the
portfolio where payment holidays have been granted was £98m, representing 2.7% of the portfolio.

-- 46 of 120 --

Market Risk
44
Analysis of management value at risk (VaR)
The table below shows the total management VaR on a diversified basis by risk factor. Total management VaR includes all trading
positions in CIB and Treasury and it is calculated with a one-day holding period.
Limits are applied against each risk factor VaR as well as total management VaR, which are then cascaded further by risk managers
to each business.
Management VaR (95%) by asset class
Half year ended 30.06.20 Half year ended 31.12.19 Half year ended 30.06.19
Average High1 Low1 Average High1 Low1 Average High1 Low1
£m £m £m £m £m £m £m £m £m
Credit risk 22 38 10 13 17 11 11 14 8
Interest rate risk 9 17 6 7 11 5 5 9 3
Equity risk 15 35 6 11 22 5 9 16 5
Basis risk 10 16 7 9 11 7 8 9 6
Spread risk 5 9 3 4 5 3 4 5 3
Foreign exchange risk 5 7 2 3 5 2 3 5 2
Commodity risk 1 1 - 1 2 - 1 1 -
Inflation risk 1 2 1 1 2 1 2 3 2
Diversification effect1 (33) n/a n/a (24) n/a n/a (22) n/a n/a
Total management VaR 35 57 18 25 29 18 21 26 17
1 Diversification effects recognise that forecast losses from different assets or businesses are unlikely to occur concurrently, hence the expected aggregate loss is lower
than the sum of the expected losses from each area. Historical correlations between losses are taken into account in making these assessments. The high and low
VaR figures reported for each category did not necessarily occur on the same day as the high and low VaR reported as a whole. Consequently, a diversification effect
balance for the high and low VaR figures would not be meaningful and is therefore omitted from the above table.
Average management VaR increased 40% to £35m in H120 (H219: £25m) as elevated market volatility resulted in an increase in
credit and equity risk.

-- 47 of 120 --

Treasury and Capital Risk
45
The Group has a comprehensive Key Risk Control Framework for managing its liquidity risk. The Liquidity Framework meets the PRA
standards and is designed to maintain liquidity resources that are sufficient in amount and quality, and a funding profile that is
appropriate to meet the Group’s Liquidity Risk Appetite (LRA). The Liquidity Framework is delivered via a combination of policy
formation, review and governance, analysis, stress testing, limit setting and monitoring.
Liquidity risk stress testing
The liquidity risk stress assessment measures the potential contractual and contingent stress outflows under a range of scenarios,
which are then used to determine the size of the liquidity pool that is immediately available to meet anticipated outflows if a stress
occurs. The short-term scenarios include a 30 day Barclays-specific stress event, a 90 day market-wide stress event and a 30 day
combined scenario consisting of both a Barclays specific and market-wide stress event. The Group also runs a long-term liquidity
stress test, which measures the anticipated outflows over a 12 month market-wide scenario.
The CRR (as amended by CRR II) Liquidity Coverage ratio (LCR) requirement takes into account the relative stability of different
sources of funding and potential incremental funding requirements in a stress. The LCR is designed to promote short-term
resilience of a bank’s liquidity risk profile by holding sufficient high quality liquid assets to survive an acute stress scenario lasting
for 30 days.
As at 30 June 2020, the Group held eligible liquid assets in excess of 100% of net stress outflows to its internal and external
regulatory requirements.
Liquidity coverage ratio
As at 30.06.20 As at 31.12.19
£bn £bn
Eligible liquidity buffer 291 206
Net stress outflows (156) (128)
Surplus 135 78
Liquidity coverage ratio 186% 160%
The Group plans to maintain its surplus to the internal and regulatory stress requirements at an efficient level, while considering
risks to market funding conditions and its liquidity position. The continuous reassessment of these risks may lead to execution of
appropriate actions to resize the liquidity pool. Given the heightened uncertainty in the current environment, the Group has taken
actions to maintain its liquidity surplus at an elevated level. Over time, and as risks dissipate, it is likely the liquidity surplus will fall
back from its current elevated level.

-- 48 of 120 --

Treasury and Capital Risk
46
Composition of the Group liquidity pool
As at 30.06.20 As at 31.12.19
Liquidity pool
Liquidity pool of which CRR LCR eligible3
Liquidity pool	Cash Level 1 Level 2A
£bn £bn £bn £bn £bn
Cash and deposits with central banks1 200 196 - - 153
Government bonds2
AAA to AA- 41 - 39 1 31
A+ to A- 23 - 17 6 2
BBB+ to BBB- 5 - 5 - 3
Total government bonds 69 - 61 7 36
Other
Government guaranteed issuers, PSEs and GSEs 11 - 9 1 9
International organisations and MDBs 9 - 9 - 7
Covered bonds 8 - 6 2 6
Other 1 - - - -
Total other 29 - 24 3 22
Total as at 30 June 2020 298 196 85 10 211
Total as at 31 December 2019 211 150 50 3
1 Includes cash held at central banks and surplus cash at central banks related to payment schemes. Over 99% (December 2019: over 98%) was placed with the Bank
of England, US Federal Reserve, European Central Bank, Bank of Japan and Swiss National Bank.
2 Of which over 80% (December 2019: over 67%) comprised UK, US, French, German, Japanese, Swiss and Dutch securities.
3 The LCR eligible liquidity pool is adjusted for trapped liquidity and other regulatory deductions. It also incorporates other CRR (as amended by CRR II) qualifying
assets that are not eligible under Barclays’ internal risk appetite.
The Group liquidity pool increased to £298bn as at 30 June 2020 (December 2019: £211bn) driven by a 12% growth in customer
deposit and actions to maintain a prudent funding and liquidity position in the current environment. During H120, the month-end
liquidity pool ranged from £218bn to £306bn (H219: £211bn to £256bn), and the month-end average balance was £257bn (H219:
£235bn). The liquidity pool is held unencumbered and is not used to support payment or clearing requirements. Such requirements
are treated as part of our regular business funding. The liquidity pool is intended to offset stress outflows, and comprises the above
cash and unencumbered assets.
As at 30 June 2020, 65% (December 2019: 67%) of the liquidity pool was located in Barclays Bank PLC, 21% (December 2019: 20%)
in Barclays Bank UK PLC and 6% (December 2019: 6%) in Barclays Bank Ireland PLC. The residual portion of the liquidity pool is held
outside of these entities, predominantly in US subsidiaries, to meet entity-specific stress outflows and local regulatory
requirements. To the extent the use of this residual portion of the liquidity pool is restricted due to local regulatory requirements, it
is assumed to be unavailable to the rest of the Group in calculating the LCR.
The composition of the pool is subject to limits set by the Board and the independent liquidity risk, credit risk and market risk
functions. In addition, the investment of the liquidity pool is monitored for concentration by issuer, currency and asset type. Given
returns generated by these highly liquid assets, the risk and reward profile is continuously managed.
Deposit funding
As at 30.06.20 As at 31.12.19
Loans and
advances at
amortised cost
Deposits at
amortised cost
Loan: deposit
ratio1
Loan: deposit
ratio1
Funding of loans and advances £bn £bn % %
Barclays UK 208 226 92% 96%
Barclays International 138 241 57% 63%
Head Office 9 -
Barclays Group 355 467 76% 82%
1 The loan: deposit ratio is calculated as loans and advances at amortised cost divided by deposits at amortised cost.

-- 49 of 120 --

Treasury and Capital Risk
47
Funding structure and funding relationships
The basis for liquidity risk management is a funding structure that reduces the probability of a liquidity stress leading to an inability
to meet funding obligations as they fall due. The Group’s overall funding strategy is to develop a diversified funding base
(geographically, by type and by counterparty) and maintain access to a variety of alternative funding sources, to provide protection
against unexpected fluctuations, while minimising the cost of funding.
Within this, the Group aims to align the sources and uses of funding. As such, retail and corporate loans and advances are largely
funded by deposits in the relevant entities, with the surplus primarily funding the liquidity pool. The majority of reverse repurchase
agreements are matched by repurchase agreements. Derivative liabilities and assets are largely matched. A substantial proportion
of balance sheet derivative positions qualify for counterparty netting and the remaining portions are largely offset when netted
against cash collateral received and paid. Wholesale debt and equity is used to fund residual assets.
These funding relationships as at 30 June 2020 are summarised below:
As at
30.06.20
As at
31.12.19
As at
30.06.20
As at
31.12.19
Assets £bn £bn Liabilities and equity £bn £bn
Loans and advances at amortised cost1 347 335 Deposits at amortised cost 467 416
Group liquidity pool 298 211 <1 Year wholesale funding 70 41
>1 Year wholesale funding 112 106
Reverse repurchase agreements, trading
portfolio assets, cash collateral and settlement
balances 383 298
Repurchase agreements, trading portfolio
liabilities, cash collateral and settlement
balances 306 247
Derivative financial instruments 307 229 Derivative financial instruments 308 229
Other assets2 50 67 Other liabilities 52 35
Equity 70 66
Total assets 1,385 1,140 Total liabilities and equity 1,385 1,140
1 Adjusted for liquidity pool debt securities reported at amortised cost of £8bn (December 2019: £4bn).
2 Other assets include fair value assets that are not part of reverse repurchase agreements or trading portfolio assets, and other asset categories.

-- 50 of 120 --

Treasury and Capital Risk
48
Composition of wholesale funding
Wholesale funding outstanding (excluding repurchase agreements) was £181.9bn (December 2019: £147.1bn). In H120, the Group
issued £4.8bn of MREL eligible instruments from Barclays PLC (the Parent company) in a range of tenors and currencies.
Our operating companies also access wholesale funding markets to maintain their stable and diversified funding bases. Barclays
Bank PLC continued to issue in the shorter-term and medium-term notes markets, and also issued a $1.75bn two-year senior bond
in May. In addition, Barclays Bank UK PLC continued to issue in the shorter-term markets.
Wholesale funding of £69.6bn (December 2019: £40.6bn) matures in less than one year, representing 38% (December 2019: 28%)
of total wholesale funding outstanding. This includes £25.0bn (December 2019: £16.3bn) related to term funding2. Although not a
requirement, the liquidity pool exceeded wholesale funding maturing in less than one year by £228bn (December 2019: £170bn).
Maturity profile of wholesale funding1,2
<1 1-3 3-6 6-12 <1 1-2 2-3 3-4 4-5 >5
month months months months year years years years years years Total
£bn £bn £bn £bn £bn £bn £bn £bn £bn £bn £bn
Barclays PLC (the Parent company)
Senior unsecured (public benchmark) - 0.3 - 2.6 2.9 2.8 5.2 7.2 6.3 14.0 38.4
Senior unsecured (privately placed) - - - 0.1 0.1 0.2 - 0.3 - 0.5 1.1
Subordinated liabilities - - - - - - - - 1.0 7.6 8.6
Barclays Bank PLC (including subsidiaries)
Certificates of deposit and commercial
paper 3.9 9.8 10.4 6.2 30.3 0.9 0.4 0.1 - - 31.7
Asset backed commercial paper 3.2 3.9 1.6 0.3 9.0 - - - - - 9.0
Senior unsecured (public benchmark) - - - 3.1 3.1 1.6 0.1 1.2 - 1.7 7.7
Senior unsecured (privately placed)3 0.6 3.2 2.5 4.6 10.9 6.8 6.6 4.6 5.8 22.8 57.5
Asset backed securities 0.5 - 0.1 - 0.6 0.6 1.1 0.4 0.3 1.6 4.6
Subordinated liabilities - 0.2 0.9 4.9 6.0 1.3 2.4 - 0.1 1.5 11.3
Barclays Bank UK PLC (including
subsidiaries)
Certificates of deposit and commercial
paper 3.7 1.3 0.2 0.1 5.3 - - - - - 5.3
Covered bonds - - - 0.9 0.9 2.3 1.7 - - 1.3 6.2
Asset backed securities 0.5 - - - 0.5 - - - - - 0.5
Total as at 30 June 2020 12.4 18.7 15.7 22.8 69.6 16.5 17.5 13.8 13.5 51.0 181.9
Of which secured 4.2 3.9 1.7 1.2 11.0 2.9 2.8 0.4 0.3 2.9 20.3
Of which unsecured 8.2 14.8 14.0 21.6 58.6 13.6 14.7 13.4 13.2 48.1 161.6
Total as at 31 December 2019 4.5 11.6 9.4 15.1 40.6 19.8 12.1 15.1 11.6 47.9 147.1
Of which secured 1.6 5.3 2.3 0.5 9.7 0.9 2.5 2.4 0.9 3.2 19.6
Of which unsecured 2.9 6.3 7.1 14.6 30.9 18.9 9.6 12.7 10.7 44.7 127.5
1 The composition of wholesale funds comprises the balance sheet reported financial liabilities at fair value, debt securities in issue and subordinated liabilities. It does
not include participation in the central bank facilities reported within repurchase agreements and other similar secured borrowing.
2 Term funding comprises public benchmark and privately placed senior unsecured notes, covered bonds, asset-backed securities and subordinated debt where the
original maturity of the instrument is more than 1 year.
3 Includes structured notes of £48.5bn, of which £8.9bn matures within one year.

-- 51 of 120 --

Treasury and Capital Risk
49
Capital
The Group’s Overall Capital Requirement for CET1 is 11.2% comprising a 4.5% Pillar 1 minimum, a 2.5% Capital Conservation Buffer
(CCB), a 1.5% Global Systemically Important Institution (G-SII) buffer, a 2.7% Pillar 2A requirement and a 0.0% Countercyclical
Capital Buffer (CCyB).
The Group’s CCyB is based on the buffer rate applicable for each jurisdiction in which the Group has exposures. On 11 March 2020,
the Financial Policy Committee set the CCyB rate for UK exposures at 0% with immediate effect. The buffer rates set by other
national authorities for non-UK exposures are not currently material. Overall, this results in a 0.0% CCyB for the Group.
The Group’s Pillar 2A requirement as per the PRA’s Individual Capital Requirement applicable from 23 July 2020 has been revised to
4.8% of which at least 56.25% needs to be met with CET1 capital, equating to approximately 2.7% of RWAs. The Pillar 2A
requirement is subject to at least annual review and has been set as a nominal capital amount. This is based on a point in time
assessment and the requirement (when expressed as a proportion of RWAs) will change depending on the total RWAs at each
reporting period.
On 27 June 2019, CRR II came into force amending CRR. As an amending regulation, the existing provisions of CRR apply unless they
are amended by CRR II. Certain aspects of CRR II are dependent on final technical standards to be issued by the European Banking
Authority (EBA) and adopted by the European Commission as well as UK implementation of the rules.
On 27 June 2020, CRR was further amended to accelerate specific CRR II measures and implement a new IFRS 9 transitional relief
calculation. Previously due to be implemented in June 2021, the accelerated measures primarily relate to the CRR leverage
calculation to include additional settlement netting and limited changes to the calculation of RWAs. For UK leverage calculations,
the PRA early adopted the CRR II settlement netting measure in April 2020.
The IFRS 9 transitional arrangements have been extended by two years and a new modified calculation has been introduced. 100%
relief will be applied to increases in stage 1 and stage 2 provisions from 1 January 2020 throughout 2020 and 2021; 75% in 2022;
50% in 2023; 25% in 2024 with no relief applied from 2025. The phasing out of transitional relief on the “day 1” impact of IFRS 9 as
well as increases in stage 1 and stage 2 provisions between 1 January 2018 and 31 December 2019 under the modified calculation
remain unchanged and continue to be subject to 70% transitional relief throughout 2020; 50% for 2021; 25% for 2022 and with no
relief applied from 2023.
Also impacting own funds from 30 June 2020 until 31 December 2020 inclusive are amendments to the regulatory technical
standards on prudential valuation which include an increase to diversification factors applied to certain additional valuation
adjustments.
The disclosures in the following section reflect Barclays’ interpretation of the current rules and guidance.

-- 52 of 120 --

Treasury and Capital Risk
50
Capital ratios1,2,3
As at As at As at
30.06.20 31.03.20 31.12.19
CET1 14.2% 13.1% 13.8%
Tier 1 (T1) 17.8% 16.6% 17.7%
Total regulatory capital 21.7% 20.4% 21.6%
Capital resources £m £m £m
Total equity excluding non-controlling interests per the balance sheet 68,304 68,369 64,429
Less: other equity instruments (recognised as AT1 capital) (10,871) (10,871) (10,871)
Adjustment to retained earnings for foreseeable dividends (44) (49) (1,096)
Other regulatory adjustments and deductions
Additional value adjustments (PVA) (1,517) (1,847) (1,746)
Goodwill and intangible assets (8,154) (8,197) (8,109)
Deferred tax assets that rely on future profitability excluding temporary differences (444) (294) (479)
Fair value reserves related to gains or losses on cash flow hedges (1,914) (1,709) (1,002)
Gains or losses on liabilities at fair value resulting from own credit (233) (389) 260
Defined benefit pension fund assets (2,094) (3,603) (1,594)
Direct and indirect holdings by an institution of own CET1 instruments (50) (50) (50)
Adjustment under IFRS 9 transitional arrangements 2,459 1,215 1,126
Other regulatory adjustments (62) (57) (55)
CET1 capital 45,380 42,518 40,813
AT1 capital
Capital instruments and related share premium accounts 10,871 10,871 10,871
Qualifying AT1 capital (including minority interests) issued by subsidiaries 691 753 687
Other regulatory adjustments and deductions (80) (130) (130)
AT1 capital 11,482 11,494 11,428
T1 capital 56,862 54,012 52,241
T2 capital
Capital instruments and related share premium accounts 9,028 8,423 7,650
Qualifying T2 capital (including minority interests) issued by subsidiaries 3,396 4,013 3,984
Credit risk adjustments (excess of impairment over expected losses) 36 196 16
Other regulatory adjustments and deductions (160) (250) (250)
Total regulatory capital 69,162 66,394 63,641
Total RWAs 318,987 325,631 295,131
1 CET1, T1 and T2 capital, and RWAs are calculated applying the transitional arrangements of the CRR as amended by CRR II applicable as at the reporting date. This
includes IFRS 9 transitional arrangements and the grandfathering of CRR and CRR II non-compliant capital instruments.
2 The fully loaded CET1 ratio, as is relevant for assessing against the conversion trigger in Barclays PLC AT1 securities, was 13.5%, with £42.9bn of CET1 capital and
£318.0bn of RWAs calculated without applying the transitional arrangements of the CRR as amended by CRR II applicable as at the reporting date.
3 The Barclays PLC CET1 ratio, as is relevant for assessing against the conversion trigger in Barclays Bank PLC T2 Contingent Capital Notes, was 14.2%. For this
calculation CET1 capital and RWAs are calculated applying the transitional arrangements under the CRR, including the IFRS 9 transitional arrangements. The benefit
of the Financial Services Authority (FSA) October 2012 interpretation of the transitional provisions, relating to the implementation of CRD IV, expired in December
2017.

-- 53 of 120 --

Treasury and Capital Risk
51
Movement in CET1 capital Three months Six months
ended ended
30.06.20 30.06.20
£m £m
Opening CET1 capital 42,518 40,813
Profit for the period attributable to equity holders 296 1,122
Own credit relating to derivative liabilities 172 3
Dividends paid and foreseen (201) 625
Increase in retained regulatory capital generated from earnings 267 1,750
Net impact of share schemes 344 288
Fair value through other comprehensive income reserve 399 (378)
Currency translation reserve 223 1,220
Other reserves 3 (3)
Increase in other qualifying reserves 969 1,127
Pension remeasurements within reserves (1,345) 645
Defined benefit pension fund asset deduction 1,509 (500)
Net impact of pensions 164 145
Additional value adjustments (PVA) 330 229
Goodwill and intangible assets 43 (45)
Deferred tax assets that rely on future profitability excluding those arising from temporary differences (150) 35
Adjustment under IFRS 9 transitional arrangements 1,244 1,333
Other regulatory adjustments (5) (7)
Increase in regulatory capital due to adjustments and deductions 1,462 1,545
Closing CET1 capital 45,380 45,380
CET1 capital increased £4.6bn to £45.4bn (December 2019: £40.8bn).
£1.1bn of capital generated from profits, and a £1.0bn increase due to the cancellation of the full year 2019 dividend were partially
offset by £0.4bn of AT1 coupons paid. Other movements in the period were:
 A £0.4bn decrease in the fair value through other comprehensive income reserve driven by a decrease in the Absa Group
Limited share price
 A £1.2bn increase in the currency translation reserve mainly driven by the appreciation of period end USD against GBP
 A £0.1bn increase as a result of movements in pensions, largely due to an additional £250m investment by the UKRF in
non-transferrable listed senior fixed rate notes, backed by UK gilts
 A £0.2bn increase due to a reduction in PVA which includes the temporary increase to diversification factors applied to
certain additional valuation adjustments
 A £1.3bn increase in the IFRS 9 transitional relief after tax which was driven by £1.2bn in Q220 following new impairment
charges and the implementation of new regulatory measures which allow for 100% relief on increases in stage 1 and
stage 2 impairment throughout 2020 and 2021

-- 54 of 120 --

Treasury and Capital Risk
52
RWAs by risk type and business
Credit risk Counterparty credit risk Market risk
Operational
risk
Total
RWAs
Std IRB Std IRB
Settlement
risk CVA Std IMA
As at 30.06.20 £m £m £m £m £m £m £m £m £m £m
Barclays UK 7,428 58,048 359 - - 48 122 - 11,851 77,856
Corporate and Investment Bank 27,032 77,983 11,879 20,472 218 3,871 12,830 22,638 21,387 198,310
Consumer, Cards and Payments 21,901 3,168 157 46 - 27 - 95 7,539 32,933
Barclays International 48,933 81,151 12,036 20,518 218 3,898 12,830 22,733 28,926 231,243
Head Office 3,578 6,183 - - - - - - 127 9,888
Barclays Group 59,939 145,382 12,395 20,518 218 3,946 12,952 22,733 40,904 318,987
As at 31.03.20
Barclays UK 5,835 59,451 311 - - 28 202 - 11,851 77,678
Corporate and Investment Bank 30,620 71,993 15,611 19,756 1,022 3,309 14,036 24,010 21,390 201,747
Consumer, Cards and Payments 25,205 3,085 132 31 - 21 - 151 7,536 36,161
Barclays International 55,825 75,078 15,743 19,787 1,022 3,330 14,036 24,161 28,926 237,908
Head Office 3,706 6,212 - - - - - - 127 10,045
Barclays Group 65,366 140,741 16,054 19,787 1,022 3,358 14,238 24,161 40,904 325,631
As at 31.12.19
Barclays UK 5,189 57,455 235 - - 23 178 - 11,821 74,901
Corporate and Investment Bank 25,749 62,177 12,051 16,875 276 2,470 12,854 17,626 21,475 171,553
Consumer, Cards and Payments 27,209 2,706 92 37 - 11 - 103 7,532 37,690
Barclays International 52,958 64,883 12,143 16,912 276 2,481 12,854 17,729 29,007 209,243
Head Office 5,104 5,754 - - - - - - 129 10,987
Barclays Group 63,251 128,092 12,378 16,912 276 2,504 13,032 17,729 40,957 295,131
Movement analysis of RWAs
Credit risk
Counterparty
credit risk Market risk Operational risk Total RWAs
£m £m £m £m £m
Opening RWAs (as at 31.12.19) 191,343 32,070 30,761 40,957 295,131
Book size (1,161) 3,786 10,064 (53) 12,636
Acquisitions and disposals (33) - - - (33)
Book quality 6,502 491 - - 6,993
Model updates 1,846 182 - - 2,028
Methodology and policy 1,881 548 (5,140) - (2,711)
Foreign exchange movements1 4,943 - - - 4,943
Closing RWAs (as at 30.06.20) 205,321 37,077 35,685 40,904 318,987
1 Foreign exchange movements does not include foreign exchange for counterparty credit risk or market risk.
RWA increased £23.9bn to £319.0bn:
 Book size increased RWAs £12.6bn primarily due to higher market volatility and an increase in client activity compared to
year-end 2019
 Book quality increased RWAs £7.0bn due to a reduction in credit quality primarily within CIB
 Model updates increased RWAs £2.0bn primarily due to modelled risk weights recalibrations
 Methodology and policy decreased RWAs £2.7bn primarily due to the removal of a Risk Not In VaR (RNIV) and the
reduction in capital requirements related to VaR backtesting exceptions
 Foreign exchange movements increased RWAs £4.9bn due to the appreciation of period end USD against GBP

-- 55 of 120 --

Treasury and Capital Risk
53
Leverage ratio and exposures
The Group is subject to a leverage ratio requirement of 3.8% as at 30 June 2020. This comprises the 3.25% minimum requirement, a
G-SII additional leverage ratio buffer (G-SII ALRB) of 0.53% and a countercyclical leverage ratio buffer (CCLB) of 0.0%. Although the
leverage ratio is expressed in terms of T1 capital, 75% of the minimum requirement, equating to 2.4375%, needs to be met with
CET1 capital. In addition, the G-SII ALRB must be covered solely with CET1 capital. The CET1 capital held against the 0.53% G-SII
ALRB was £6.0bn.
The Group is required to disclose an average UK leverage ratio which is based on capital on the last day of each month in the
quarter and an exposure measure for each day in the quarter. The Group is also required to disclose a UK leverage ratio based on
capital and exposure on the last day of the quarter. Both approaches exclude qualifying claims on central banks from the leverage
exposures and include the PRA’s early adoption of CRR II settlement netting.
Leverage ratios1,2
As at
30.06.20
As at
31.03.20
As at
31.12.19
£m £m £m
Average UK leverage ratio 4.7% 4.5% 4.5%
Average T1 capital3 54,548 53,274 51,823
Average UK leverage exposure 1,148,720 1,176,198 1,142,819
UK leverage ratio 5.2% 4.5% 5.1%
CET1 capital 45,380 42,518 40,812
AT1 capital 10,791 10,741 10,741
T1 capital3 56,171 53,259 51,553
UK leverage exposure 1,071,138 1,178,708 1,007,721
UK leverage exposure
Accounting assets
Derivative financial instruments 307,258 342,120 229,236
Derivative cash collateral 77,063 85,321 56,589
Securities financing transactions (SFTs) 160,015 185,725 111,307
Loans and advances and other assets 840,781 831,130 743,097
Total IFRS assets 1,385,117 1,444,296 1,140,229
Regulatory consolidation adjustments (1,982) (4,841) (1,170)
Derivatives adjustments
Derivatives netting (279,151) (309,585) (207,756)
Adjustments to cash collateral (67,718) (70,758) (48,464)
Net written credit protection 14,442 19,994 13,784
Potential future exposure (PFE) on derivatives 123,468 126,503 119,118
Total derivatives adjustments (208,959) (233,846) (123,318)
SFTs adjustments 21,226 34,271 18,339
Regulatory deductions and other adjustments (18,297) (14,615) (11,984)
Weighted off-balance sheet commitments 108,436 102,499 105,289
Qualifying central bank claims (173,033) (149,056) (119,664)
Settlement netting (41,370) - -
UK leverage exposure2 1,071,138 1,178,708 1,007,721
1 Fully loaded average UK leverage ratio was 4.6%, with £53.0bn of T1 capital and £1,147bn of leverage exposure. Fully loaded UK leverage ratio was 5.0%, with
£53.7bn of T1 capital and £1,069bn of leverage exposure. Fully loaded UK leverage ratios are calculated without applying the transitional arrangements of the CRR
as amended by CRR II applicable as at the reporting date.
2 Capital and leverage measures are calculated applying the transitional arrangements of the CRR as amended by CRR II applicable as at the reporting date.
3 T1 capital is calculated in line with the PRA Handbook.

-- 56 of 120 --

Treasury and Capital Risk
54
The average UK leverage ratio increased to 4.7% (December 2019: 4.5%), driven by an increase in T1 capital. The leverage exposure
increased by £6bn to £1,149bn, primarily driven by SFTs and loans and advances and other assets, partially offset by the PRA’s early
adoption of CRR II settlement netting.
The UK leverage ratio increased to 5.2% (December 2019: 5.1%), driven by an increase in T1 capital. The UK leverage exposure
increased by £63bn to £1,071bn, primarily driven by SFTs and loans and advances and other assets, partially offset by the PRA’s
early adoption of CRR II settlement netting.
The Group also discloses a CRR leverage ratio1 within its additional regulatory disclosures prepared in accordance with EBA
guidelines on disclosure under Part Eight of the CRR (see Barclays PLC Pillar 3 Report H1 2020, expected to be published on 14
August 2020 and which will be available at home.barclays/investor-relations/reports-and-events/latest-financial-results).
1 CRR leverage ratio as amended by CRR II applicable as at the reporting date.

-- 57 of 120 --

Treasury and Capital Risk
55
MREL
CRR II requirements relating to own funds and eligible liabilities came into effect from 27 June 2019. Eligible liabilities have been
calculated reflecting the Group’s interpretation of the current rules and guidance. Certain aspects of CRR II are dependent on final
technical standards to be issued by the EBA and adopted by the European Commission as well as UK implementation of the rules.
The Group is required to meet the higher of: (i) the MREL set by the Bank of England; and (ii) the requirements in CRR II, both of
which have RWA and leverage based requirements. MREL is subject to phased implementation and will be fully implemented by 1
January 2022, at which time the Group’s indicative MREL is expected to be two times the sum of its Pillar 1 and Pillar 2A
requirements, as set by the Bank of England. In addition, CET1 capital cannot be counted towards both MREL and the capital
buffers, meaning that the buffers will effectively be applied above both the Pillar 1 and Pillar 2A requirements relating to own funds
and eligible liabilities. The Bank of England will review the MREL calibration by the end of 2020, including assessing the proposal for
Pillar 2A recapitalisation, which may drive a different 1 January 2022 MREL than currently proposed.
Own funds and eligible liabilities ratios1
As at
30.06.20
As at
31.03.20
As at
31.12.19
CET1 capital 14.2% 13.1% 13.8%
AT1 capital instruments and related share premium accounts2 3.4% 3.3% 3.6%
T2 capital instruments and related share premium accounts2 2.8% 2.6% 2.5%
Eligible liabilities 12.0% 10.3% 11.2%
Total Barclays PLC (the Parent company) own funds and eligible liabilities 32.4% 29.3% 31.2%
Qualifying AT1 capital (including minority interests) issued by subsidiaries 0.2% 0.2% 0.2%
Qualifying T2 capital (including minority interests) issued by subsidiaries 1.1% 1.2% 1.3%
Total own funds and eligible liabilities, including eligible Barclays Bank PLC instruments 33.7% 30.7% 32.8%
Own funds and eligible liabilities1 £m £m £m
CET1 capital 45,380 42,518 40,813
AT1 capital instruments and related share premium accounts2 10,791 10,741 10,741
T2 capital instruments and related share premium accounts2 8,904 8,369 7,416
Eligible liabilities 38,308 33,674 33,025
Total Barclays PLC (the Parent company) own funds and eligible liabilities 103,383 95,302 91,995
Qualifying AT1 capital (including minority interests) issued by subsidiaries 691 753 687
Qualifying T2 capital (including minority interests) issued by subsidiaries 3,396 4,013 3,984
Total own funds and eligible liabilities, including eligible Barclays Bank PLC instruments 107,470 100,068 96,666
Total RWAs1 318,987 325,631 295,131
1 CET1, T1 and T2 capital, and RWAs are calculated applying the transitional arrangements of the CRR as amended by CRR II applicable as at the reporting date. This
includes IFRS 9 transitional arrangements and the grandfathering of CRR and CRR II non-compliant capital instruments.
2 Includes other AT1 capital regulatory adjustments and deductions of £80m (December 2019: £130m), and other T2 credit risk adjustments and deductions of £124m
(December 2019: £234m).

-- 58 of 120 --

Condensed Consolidated Financial Statements
56
Condensed consolidated income statement (unaudited)
Half year
ended
Half year
ended
30.06.20 30.06.19
Notes1 £m £m
Interest and similar income 6,437 7,496
Interest and similar expense (2,214) (2,878)
Net interest income 4,223 4,618
Fee and commission income 3 4,399 4,484
Fee and commission expense 3 (1,090) (1,150)
Net fee and commission income 3 3,309 3,334
Net trading income 4,198 2,124
Net investment income (136) 662
Other income 27 52
Total income 11,621 10,790
Credit impairment charges (3,738) (928)
Net operating income 7,883 9,862
Staff costs 4 (4,053) (4,264)
Infrastructure, administration and general expenses 5 (2,510) (2,494)
Litigation and conduct (30) (114)
Operating expenses (6,593) (6,872)
Share of post-tax results of associates and joint ventures (31) 14
Profit on disposal of subsidiaries, associates and joint ventures 13 10
Profit before tax 1,272 3,014
Tax charge 6 (113) (545)
Profit after tax 1,159 2,469
Attributable to:
Equity holders of the parent 695 2,072
Other equity instrument holders 427 363
Total equity holders of the parent 1,122 2,435
Non-controlling interests 7 37 34
Profit after tax 1,159 2,469
Earnings per share p p
Basic earnings per ordinary share 8 4.0 12.1
Diluted earnings per ordinary share 8 3.9 11.9
1 For notes to the Financial Statements see pages 62 to 86.

-- 59 of 120 --

Condensed Consolidated Financial Statements
57
Condensed consolidated statement of comprehensive income (unaudited)
Half year ended Half year ended
30.06.20 30.06.19
Notes1 £m £m
Profit after tax 1,159 2,469
Other comprehensive income/(loss) that may be recycled to profit or loss:2
Currency translation reserve 18 1,220 177
Fair value through other comprehensive income reserve 18 137 380
Cash flow hedging reserve 18 912 528
Other 18 (6) -
Other comprehensive income that may be recycled to profit 2,263 1,085
Other comprehensive income/(loss) not recycled to profit or loss:2
Retirement benefit remeasurements 15 645 (140)
Fair value through other comprehensive income reserve 18 (515) 125
Own credit 18 496 44
Other comprehensive income not recycled to profit 626 29
Other comprehensive income for the period 2,889 1,114
Total comprehensive income for the period 4,048 3,583
Attributable to:
Equity holders of the parent 4,011 3,549
Non-controlling interests 37 34
Total comprehensive income for the period 4,048 3,583
1 For notes to the Financial Statements see pages 62 to 86.
2 Reported net of tax.

-- 60 of 120 --

Condensed Consolidated Financial Statements
58
Condensed consolidated balance sheet (unaudited)
As at As at
30.06.20 31.12.19
Assets Notes1 £m £m
Cash and balances at central banks 194,452 150,258
Cash collateral and settlement balances 134,945 83,256
Loans and advances at amortised cost 12 354,912 339,115
Reverse repurchase agreements and other similar secured lending 22,224 3,379
Trading portfolio assets 110,062 114,195
Financial assets at fair value through the income statement 158,975 133,086
Derivative financial instruments 10 307,258 229,236
Financial assets at fair value through other comprehensive income 79,764 65,750
Investments in associates and joint ventures 720 721
Goodwill and intangible assets 8,163 8,119
Property, plant and equipment 4,239 4,215
Current tax assets 556 412
Deferred tax assets 6 2,671 3,290
Retirement benefit assets 15 2,848 2,108
Other assets 3,328 3,089
Total assets 1,385,117 1,140,229
Liabilities
Deposits at amortised cost 12 466,913 415,787
Cash collateral and settlement balances 112,907 67,341
Repurchase agreements and other similar secured borrowing 19,144 14,517
Debt securities in issue 103,970 76,369
Subordinated liabilities 13 19,886 18,156
Trading portfolio liabilities 51,606 36,916
Financial liabilities designated at fair value 221,460 204,326
Derivative financial instruments 10 307,891 229,204
Current tax liabilities 322 313
Deferred tax liabilities 6 23 23
Retirement benefit liabilities 15 371 348
Other liabilities 8,471 8,505
Provisions 14 2,612 2,764
Total liabilities 1,315,576 1,074,569
Equity
Called up share capital and share premium 16 4,620 4,594
Other reserves 18 6,996 4,760
Retained earnings 45,817 44,204
Shareholders' equity attributable to ordinary shareholders of the parent 57,433 53,558
Other equity instruments 17 10,871 10,871
Total equity excluding non-controlling interests 68,304 64,429
Non-controlling interests 7 1,237 1,231
Total equity 69,541 65,660
Total liabilities and equity 1,385,117 1,140,229
1 For notes to the Financial Statements see pages 62 to 86.

-- 61 of 120 --

Condensed Consolidated Financial Statements
59
Condensed consolidated statement of changes in equity (unaudited)
Called up
share capital
and share
premium1
Other equity
instruments1
Other
reserves1
Retained
earnings Total
Non-
controlling
interests2
Total
equity
Half year ended 30.06.20 £m £m £m £m £m £m £m
Balance as at 1 January 2020 4,594 10,871 4,760 44,204 64,429 1,231 65,660
Profit after tax - 427 - 695 1,122 37 1,159
Currency translation movements - - 1,220 - 1,220 - 1,220
Fair value through other comprehensive
income reserve - - (378) - (378) - (378)
Cash flow hedges - - 912 - 912 - 912
Retirement benefit remeasurements - - - 645 645 - 645
Own credit - - 496 - 496 - 496
Other - - - (6) (6) - (6)
Total comprehensive income for the period - 427 2,250 1,334 4,011 37 4,048
Equity settled share schemes 26 - - 603 629 - 629
Other equity instruments coupons paid - (427) - - (427) - (427)
Vesting of shares under employee share
schemes - - (14) (327) (341) - (341)
Dividends paid - - - - - (37) (37)
Other movements - - - 3 3 6 9
Balance as at 30 June 2020 4,620 10,871 6,996 45,817 68,304 1,237 69,541
Half year ended 31.12.19
Balance as at 1 July 2019 4,494 12,123 6,403 44,556 67,576 1,221 68,797
Profit after tax - 450 - 389 839 46 885
Currency translation movements - - (721) - (721) - (721)
Fair value through other comprehensive
income reserve - - (434) - (434) - (434)
Cash flow hedges - - (186) - (186) - (186)
Retirement benefit remeasurements - - - (54) (54) - (54)
Own credit - - (296) - (296) - (296)
Other - - - 16 16 - 16
Total comprehensive income for the period - 450 (1,637) 351 (836) 46 (790)
Issue of new ordinary shares 23 - - - 23 - 23
Equity settled share schemes 77 - - 237 314 - 314
Issue and exchange of other equity
instruments - (1,266) - (406) (1,672) - (1,672)
Other equity instruments coupons paid - (450) - - (450) - (450)
Vesting of shares under employee share
schemes - - (6) (20) (26) - (26)
Dividends paid - - - (517) (517) (46) (563)
Other movements - 14 - 3 17 10 27
Balance as at 31 December 2019 4,594 10,871 4,760 44,204 64,429 1,231 65,660
1 Details of share capital, other equity instruments and other reserves are shown on pages 77 to 79.
2 Details of non-controlling interests are shown on page 66.

-- 62 of 120 --

Condensed Consolidated Financial Statements
60
Condensed consolidated statement of changes in equity (unaudited)
Called up
share capital
and share
premium1
Other equity
instruments1
Other
reserves1
Retained
earnings Total
Non-
controlling
interests2
Total
equity
Half year ended 30.06.19 £m £m £m £m £m £m £m
Balance as at 1 January 2019 4,311 9,632 5,153 43,460 62,556 1,223 63,779
Profit after tax - 363 - 2,072 2,435 34 2,469
Currency translation movements - - 177 - 177 - 177
Fair value through other comprehensive
income reserve - - 505 - 505 - 505
Cash flow hedges - - 528 - 528 - 528
Retirement benefit remeasurements - - - (140) (140) - (140)
Own credit - - 44 - 44 - 44
Total comprehensive income for the period - 363 1,254 1,932 3,549 34 3,583
Issue of new ordinary shares 159 - - - 159 - 159
Equity settled share schemes 24 - - 241 265 - 265
Issue and exchange of other equity
instruments - 2,504 - - 2,504 - 2,504
Other equity instruments coupons paid - (363) - - (363) - (363)
Vesting of shares under employee share
schemes - - (4) (384) (388) - (388)
Dividends paid - - - (684) (684) (34) (718)
Other movements - (13) - (9) (22) (2) (24)
Balance as at 30 June 2019 4,494 12,123 6,403 44,556 67,576 1,221 68,797
1 Details of share capital, other equity instruments and other reserves are shown on pages 77 to 79.
2 Details of non-controlling interests are shown on page 66.

-- 63 of 120 --

Condensed Consolidated Financial Statements
61
Condensed consolidated cash flow statement (unaudited)
Half year
ended
Half year
ended
30.06.20 30.06.19
£m £m
Profit before tax 1,272 3,014
Adjustment for non-cash items (1,112) (297)
Net increase in loans and advances at amortised cost (19,431) (11,333)
Net increase in deposits at amortised cost 51,126 18,758
Net increase in debt securities in issue 24,183 8,529
Changes in other operating assets and liabilities 4,757 (15,487)
Corporate income tax paid (351) (260)
Net cash from operating activities 60,444 2,924
Net cash from investing activities (11,599) (17,075)
Net cash from financing activities 3,133 (610)
Effect of exchange rates on cash and cash equivalents 7,814 652
Net increase/(decrease) in cash and cash equivalents 59,792 (14,109)
Cash and cash equivalents at beginning of the period 183,387 211,166
Cash and cash equivalents at end of the period 243,179 197,057

-- 64 of 120 --

Financial Statement Notes
62
1. Basis of preparation
These condensed consolidated interim financial statements for the six months ended 30 June 2020 have been prepared in
accordance with the DTR of the UK FCA and with IAS 34, Interim Financial Reporting, as published by the International Accounting
Standards Board (IASB) and adopted by the EU. The condensed consolidated interim financial statements should be read in
conjunction with the annual financial statements for the year ended 31 December 2019, which have been prepared in accordance
with IFRSs as published by the IASB and as adopted by the EU.
The accounting policies and methods of computation used in these condensed consolidated interim financial statements are the
same as those used in the Barclays PLC Annual Report 2019.
1. Going concern
The financial statements are prepared on a going concern basis, as the Directors are satisfied that the Group and parent company
have the resources to continue in business for the foreseeable future. In making this assessment, the Directors have considered a
wide range of information relating to present and future conditions, including future projections of profitability, cash flows, capital
requirements and capital resources. The future conditions considered included an assessment of internally generated stress
scenarios assuming a prolonged economic stress and impact on the future operational and financial performance of the Group.
2. Other disclosures
The Credit risk disclosures on pages 27 to 41 form part of these interim financial statements.

-- 65 of 120 --

Financial Statement Notes
63
2. Segmental reporting
Analysis of results by business
Barclays
UK
Barclays
International
Head
Office
Barclays
Group
Half year ended 30.06.20 £m £m £m £m
Total income 3,171 8,654 (204) 11,621
Credit impairment charges (1,064) (2,619) (55) (3,738)
Net operating income/(expenses) 2,107 6,035 (259) 7,883
Operating expenses (2,041) (4,405) (117) (6,563)
Litigation and conduct (11) (11) (8) (30)
Total operating expenses (2,052) (4,416) (125) (6,593)
Other net income/(expenses)1 13 10 (41) (18)
Profit/(loss) before tax 68 1,629 (425) 1,272
As at 30.06.20 £bn £bn £bn £bn
Total assets 287.6 1,075.8 21.7 1,385.1
Barclays
UK
Barclays
International
Head
Office
Barclays
Group
Half year ended 30.06.19 £m £m £m £m
Total income 3,548 7,473 (231) 10,790
Credit impairment charges (421) (492) (15) (928)
Net operating income/(expenses) 3,127 6,981 (246) 9,862
Operating expenses (2,021) (4,641) (96) (6,758)
Litigation and conduct (44) (30) (40) (114)
Total operating expenses (2,065) (4,671) (136) (6,872)
Other net income/(expenses)1 - 31 (7) 24
Profit/(loss) before tax 1,062 2,341 (389) 3,014
As at 31.12.19 £bn £bn £bn £bn
Total assets 257.8 861.4 21.0 1,140.2
1 Other net income/(expenses) represents the share of post-tax results of associates and joint ventures, profit (or loss) on disposal of subsidiaries, associates and joint
ventures and gains on acquisitions.
On 1 April 2020, assets of £2.2bn relating to the Barclays Partner Finance business were moved from Barclays International to
Barclays UK, with net operating income of £19m and loss before tax of £5m subsequently recognised in Barclays UK in Q220. In the
half year ended 30 June 2019, Barclays Partner Finance generated net operating income of £76m and profit before tax of £23m.
The 2019 comparative figures have not been restated.
Split of income by geographic region1 Half year ended Half year ended
30.06.20 30.06.19
£m £m
UK 5,989 5,873
Europe 1,199 788
Americas 3,776 3,591
Africa and Middle East 20 40
Asia 637 498
Total 11,621 10,790
1 The geographical analysis is now based on the location of office where the transactions are recorded, whereas in the prior year it was based on counterparty
location. The approach was changed at year-end 2019 and is better aligned to the geographical view of the business following the implementation of structural
reform. Prior year comparatives have been restated.

-- 66 of 120 --

Financial Statement Notes
64
3. Net fee and commission income
Fee and commission income is disaggregated below and includes a total for fees in scope of IFRS 15, Revenue from Contracts with
Customers:
Barclays UK
Barclays
International Head Office Total
Half year ended 30.06.20 £m £m £m £m
Fee type
Transactional 386 1,157 - 1,543
Advisory 79 306 1 386
Brokerage and execution 102 685 - 787
Underwriting and syndication - 1,468 - 1,468
Other 38 115 2 155
Total revenue from contracts with customers 605 3,731 3 4,339
Other non-contract fee income - 60 - 60
Fee and commission income 605 3,791 3 4,399
Fee and commission expense (148) (940) (2) (1,090)
Net fee and commission income 457 2,851 1 3,309
Barclays UK
Barclays
International Head Office Total
Half year ended 30.06.19 £m £m £m £m
Fee type
Transactional 523 1,353 - 1,876
Advisory 88 406 - 494
Brokerage and execution 101 536 - 637
Underwriting and syndication - 1,240 - 1,240
Other 45 131 7 183
Total revenue from contracts with customers 757 3,666 7 4,430
Other non-contract fee income - 54 - 54
Fee and commission income 757 3,720 7 4,484
Fee and commission expense (187) (957) (6) (1,150)
Net fee and commission income 570 2,763 1 3,334
Transactional fees are service charges on deposit accounts, cash management services and transactional processing fees. This
includes interchange and merchant fee income generated from credit and bank card usage.
Advisory fees are generated from asset management services and advisory services related to mergers, acquisitions and financial
restructuring.
Brokerage and execution fees are earned for executing client transactions with exchanges and over-the-counter markets and
assisting clients in clearing transactions.
Underwriting and syndication fees are earned for the distribution of client equity or debt securities and the arrangement and
administration of a loan syndication. This includes commitment fees to provide loan financing.

-- 67 of 120 --

Financial Statement Notes
65
4. Staff costs
Half year ended Half year ended
30.06.20 30.06.19
Compensation costs £m £m
Current year bonus charges 476 456
Deferred bonus charge 269 226
Commissions and other incentives 4 34
Performance costs 749 716
Salaries 2,153 2,195
Social security costs 317 315
Post-retirement benefits 268 251
Other compensation costs 254 232
Total compensation costs 3,741 3,709
Other resourcing costs
Outsourcing 175 257
Redundancy and restructuring 39 49
Temporary staff costs 58 173
Other 40 76
Total other resourcing costs 312 555
Total staff costs 4,053 4,264
Barclays Group compensation costs as a % of total income 32.2 34.4
No material awards have yet been granted in relation to the 2020 bonus pool as decisions regarding incentive awards are not taken
by the Remuneration Committee until the performance for the full year can be assessed. The current year bonus charge for the first
six months represents an accrual for estimated costs in accordance with accounting requirements.
5. Infrastructure, administration and general expenses
Half year ended Half year ended
30.06.20 30.06.19
Infrastructure costs £m £m
Property and equipment 757 691
Depreciation and amortisation 751 729
Lease payments 26 21
Impairment of property, equipment and intangible assets 32 29
Total infrastructure costs 1,566 1,470
Administration and general expenses
Consultancy, legal and professional fees 270 284
Marketing and advertising 158 212
Other administration and general expenses 516 528
Total administration and general expenses 944 1,024
Total infrastructure, administration and general expenses 2,510 2,494

-- 68 of 120 --

Financial Statement Notes
66
6. Tax
The tax charge for H120 was £113m (H119: £545m), representing an effective tax rate of 8.9% (H119: 18.1%). The effective tax rate
for H120 was lower than H119, reflecting the tax benefit recognised for the re-measurement of UK deferred tax assets through the
income statement as a result of the UK corporation tax rate being maintained at 19%.
Included in the tax charge is a credit of £112m (H119: £96m) in respect of payments made on AT1 instruments that are classified as
equity for accounting purposes.
As at As at
30.06.20 31.12.19
Deferred tax assets and liabilities £m £m
USA 2,168 2,052
UK - 818
Other territories 503 420
Deferred tax assets 2,671 3,290
Deferred tax liabilities (23) (23)
Analysis of deferred tax assets
Temporary differences 2,174 2,767
Tax losses 497 523
Deferred tax assets 2,671 3,290
7. Non-controlling interests
Profit attributable to
non-controlling interests
Equity attributable to
non-controlling interests
Half year ended Half year ended As at As at
30.06.20 30.06.19 30.06.20 31.12.19
£m £m £m £m
Barclays Bank PLC issued:
- Preference shares 28 27 529 529
- Upper T2 instruments 9 7 691 691
Other non-controlling interests - - 17 11
Total 37 34 1,237 1,231

-- 69 of 120 --

Financial Statement Notes
67
8. Earnings per share
Half year
ended
Half year
ended
30.06.20 30.06.19
£m £m
Profit attributable to ordinary equity holders of the parent 695 2,072
m m
Basic weighted average number of shares in issue 17,294 17,178
Number of potential ordinary shares 319 200
Diluted weighted average number of shares 17,613 17,378
p p
Basic earnings per ordinary share 4.0 12.1
Diluted earnings per ordinary share 3.9 11.9
9. Dividends on ordinary shares
In response to a request from the PRA, and to preserve additional capital for use in serving Barclays customers and clients through
the extraordinary challenges presented by the COVID-19 pandemic, the Board agreed to cancel the 6.0p per ordinary share full year
2019 dividend. The Board also decided that for 2020 Barclays would suspend its current capital returns policy and accordingly will
not undertake any interim ordinary share dividend payments, regulatory accruals of ordinary share dividends, or share buybacks.
The Board will decide on future dividends and its capital returns policy at year-end 2020.
Half year ended 30.06.20 Half year ended 30.06.19
Per share Total Per share Total
Dividends paid during the period p £m p £m
Full year dividend paid during period - - 4.0 684

-- 70 of 120 --

Financial Statement Notes
68
10. Derivative financial instruments
Contract
notional
amount
Fair value
Assets Liabilities
As at 30.06.20 £m £m £m
Foreign exchange derivatives 5,730,348 67,755 (68,502)
Interest rate derivatives 44,652,771 199,378 (191,435)
Credit derivatives 906,573 6,739 (6,955)
Equity and stock index and commodity derivatives 1,072,400 33,186 (40,120)
Derivative assets/(liabilities) held for trading 52,362,092 307,058 (307,012)
Derivatives in hedge accounting relationships
Derivatives designated as cash flow hedges 57,497 55 (10)
Derivatives designated as fair value hedges 126,692 145 (822)
Derivatives designated as hedges of net investments 709 - (47)
Derivative assets/(liabilities) designated in hedge accounting relationships 184,898 200 (879)
Total recognised derivative assets/(liabilities) 52,546,990 307,258 (307,891)
As at 31.12.19
Foreign exchange derivatives 4,999,865 56,576 (57,021)
Interest rate derivatives 35,098,216 142,325 (135,759)
Credit derivatives 825,516 8,215 (8,086)
Equity and stock index and commodity derivatives 1,187,513 21,947 (27,751)
Derivative assets/(liabilities) held for trading 42,111,110 229,063 (228,617)
Derivatives in hedge accounting relationships
Derivatives designated as cash flow hedges 67,773 7 (1)
Derivatives designated as fair value hedges 112,457 136 (586)
Derivatives designated as hedges of net investments 1,145 30 -
Derivative assets/(liabilities) designated in hedge accounting relationships 181,375 173 (587)
Total recognised derivative assets/(liabilities) 42,292,485 229,236 (229,204)
The IFRS netting posted against derivative assets was £67bn including £8bn of cash collateral netted (December 2019: £37bn
including £4bn cash collateral netted) and £67bn for liabilities including £11bn of cash collateral netted (December 2019: £37bn
including £5bn of cash collateral netted). Derivative asset exposures would be £283bn (December 2019: £209bn) lower than
reported under IFRS if netting were permitted for assets and liabilities with the same counterparty or for which the Group holds
cash collateral of £46bn (December 2019: £33bn). Similarly, derivative liabilities would be £286bn (December 2019: £212bn) lower
reflecting counterparty netting and cash collateral placed of £49bn (December 2019: £36bn). In addition, non-cash collateral of
£5bn (December 2019: £6bn) was held in respect of derivative assets and £4bn (December 2019: £3bn) was placed in respect of
derivative liabilities. Collateral amounts are limited to net on balance sheet exposure so as to not include over-collateralisation.

-- 71 of 120 --

Financial Statement Notes
69
11. Fair value of financial instruments
This section should be read in conjunction with Note 17, Fair value of financial instruments of the Barclays PLC Annual Report 2019
and Note 1, Basis of preparation on page 62, which provides more detail about accounting policies adopted, valuation
methodologies used in calculating fair value and the valuation control framework which governs oversight of valuations. There
have been no changes in the accounting policies adopted or the valuation methodologies used.
Valuation
The following table shows the Group’s assets and liabilities that are held at fair value disaggregated by valuation technique (fair
value hierarchy) and balance sheet classification:
Valuation technique using
Quoted market
prices
Observable
inputs
Significant
unobservable
inputs
(Level 1) (Level 2) (Level 3) Total
As at 30.06.20 £m £m £m £m
Trading portfolio assets 49,460 57,524 3,078 110,062
Financial assets at fair value through the income statement 1,877 148,046 9,052 158,975
Derivative financial instruments 8,761 290,749 7,748 307,258
Financial assets at fair value through other comprehensive income 20,657 58,760 347 79,764
Investment property - - 10 10
Total assets 80,755 555,079 20,235 656,069
Trading portfolio liabilities (32,411) (19,195) - (51,606)
Financial liabilities designated at fair value (123) (220,968) (369) (221,460)
Derivative financial instruments (8,445) (290,514) (8,932) (307,891)
Total liabilities (40,979) (530,677) (9,301) (580,957)
As at 31.12.19
Trading portfolio assets 60,352 51,579 2,264 114,195
Financial assets at fair value through the income statement 10,445 114,141 8,500 133,086
Derivative financial instruments 5,439 220,642 3,155 229,236
Financial assets at fair value through other comprehensive income 18,755 46,566 429 65,750
Investment property - - 13 13
Total assets 94,991 432,928 14,361 542,280
Trading portfolio liabilities (20,977) (15,939) - (36,916)
Financial liabilities designated at fair value (82) (203,882) (362) (204,326)
Derivative financial instruments (5,305) (219,910) (3,989) (229,204)
Total liabilities (26,364) (439,731) (4,351) (470,446)

-- 72 of 120 --

Financial Statement Notes
70
The following table shows the Group’s Level 3 assets and liabilities that are held at fair value disaggregated by product type:
As at 30.06.20 As at 31.12.19
Assets Liabilities Assets Liabilities
£m £m £m £m
Interest rate derivatives 4,153 (3,772) 605 (812)
Foreign exchange derivatives 655 (588) 291 (298)
Credit derivatives 193 (456) 539 (342)
Equity derivatives 2,730 (4,099) 1,711 (2,528)
Commodity derivatives 17 (17) 9 (9)
Corporate debt 516 - 521 -
Reverse repurchase and repurchase agreements - (175) - (167)
Non-asset backed loans 8,271 - 6,811 -
Asset backed securities 740 - 756 -
Equity cash products 1,146 - 1,228 -
Private equity investments 880 (15) 899 (19)
Other1 934 (179) 991 (176)
Total 20,235 (9,301) 14,361 (4,351)
1 Other includes commercial real estate loans, funds and fund-linked products, asset backed loans, issued debt, commercial paper, government sponsored debt and
investment property.
Assets and liabilities reclassified between Level 1 and Level 2
During the period, there were no material transfers between Level 1 and Level 2 (period ended December 2019: no material
transfers between Level 1 and Level 2).
Level 3 movement analysis
The following table summarises the movements in the balances of Level 3 assets and liabilities during the period. The table shows
gains and losses and includes amounts for all financial assets and liabilities that are held at fair value transferred to and from Level
3 during the period. Transfers have been reflected as if they had taken place at the beginning of the year.
Asset and liability moves between Level 2 and Level 3 are primarily due to i) an increase or decrease in observable market activity
related to an input or ii) a change in the significance of the unobservable input, with assets and liabilities classified as Level 3 if an
unobservable input is deemed significant.

-- 73 of 120 --

Financial Statement Notes
71
Level 3 movement analysis
As at
01.01.20 Purchases Sales Issues
Settle-
ments
Total gains and losses
in the period
recognised in the
income statement Total gains
or losses
recognised
in OCI
Transfers
As at
30.06.20
Trading
income
Other
income In Out
£m £m £m £m £m £m £m £m £m £m £m
Corporate debt 120 25 - - - (26) - - 4 (17) 106
Non-asset backed loans 974 1,926 (740) - (4) (111) - - 97 (320) 1,822
Asset backed securities 656 249 (224) - (76) (12) - - 41 (11) 623
Equity cash products 392 2 (4) - - (67) - - 28 (4) 347
Other 122 48 - - - 2 - - 8 - 180
Trading portfolio assets 2,264 2,250 (968) - (80) (214) - - 178 (352) 3,078
Non-asset backed loans 5,494 1,050 (270) - (410) 381 - - - (58) 6,187
Equity cash products 835 14 - - - (22) (28) - - - 799
Private equity investments 900 19 (6) - (2) 2 (44) - 23 (12) 880
Other 1,271 1,870 (2,017) - (18) (8) 64 - 24 - 1,186
Financial assets at fair value
through the income statement 8,500 2,953 (2,293) - (430) 353 (8) - 47 (70) 9,052
Non-asset backed loans 343 79 - - (157) - - (3) - - 262
Asset backed securities 86 - (1) - - 1 - (1) - - 85
Assets at fair value through
other comprehensive income 429 79 (1) - (157) 1 - (4) - - 347
Investment property 13 - (1) - - - (2) - 2 (2) 10
Trading portfolio liabilities - - - - - - - - - - -
Issued debt (146) - - (3) - - - - (22) 14 (157)
Other (216) - 1 - - (10) 2 - - 11 (212)
Financial liabilities designated
at fair value (362) - 1 (3) - (10) 2 - (22) 25 (369)
Interest rate derivatives (206) 18 - - 10 268 1 - 300 (10) 381
Foreign exchange derivatives (7) - - - (12) 89 - - 5 (8) 67
Credit derivatives 198 (258) 11 - (376) 151 1 - 2 8 (263)
Equity derivatives (819) (448) (1) - 17 (90) - - (5) (23) (1,369)
Commodity derivatives - - - - - - - - - - -
Net derivative financial
instruments1 (834) (688) 10 - (361) 418 2 - 302 (33) (1,184)
Total 10,010 4,594 (3,252) (3) (1,028) 548 (6) (4) 507 (432) 10,934
1 Derivative financial instruments are represented on a net basis. On a gross basis, derivative financial assets were £7,748m and derivative financial liabilities were
£8,932m.

-- 74 of 120 --

Financial Statement Notes
72
Level 3 movement analysis
As at
01.01.19 Purchases Sales Issues
Settle-
ments
Total gains and
losses in the period
recognised in the
income statement Transfers
As at
30.06.19
Trading
income
Other
income In Out
£m £m £m £m £m £m £m £m £m £m
Government and government
sponsored debt 14 2 - - - - - - (14) 2
Corporate debt 388 70 (24) - (31) 14 - 32 (74) 375
Non-asset backed loans 2,263 1,235 (1,260) - (19) 12 - 19 (90) 2,160
Asset backed securities 664 81 (127) - - 5 - 16 (29) 610
Equity cash products 136 48 (13) - - (2) - 116 (20) 265
Other 148 - - - (1) (10) - - (1) 136
Trading portfolio assets 3,613 1,436 (1,424) - (51) 19 - 183 (228) 3,548
Non-asset backed loans 5,688 2 - - (295) 248 - - (9) 5,634
Equity cash products 559 9 - - (10) 4 178 - - 740
Private equity investments 1,071 21 (73) - (1) - 43 - (148) 913
Other 2,064 2,334 (2,619) - (2) 17 9 24 (840) 987
Financial assets at fair value
through the income statement 9,382 2,366 (2,692) - (308) 269 230 24 (997) 8,274
Non-asset backed loans 353 48 - - (55) - - - (218) 128
Asset backed securities - 40 - - - - - - - 40
Equity cash products 2 - - - - - - - - 2
Financial assets at fair value
through other comprehensive
income
355 88 - - (55) - - - (218) 170
Investment property 9 - - - - - (1) - - 8
Trading portfolio liabilities (3) - - - - 2 - (5) - (6)
Certificates of deposit, commercial
paper and other money market
instruments
(10) - - - 1 - (1) (11) - (21)
Issued debt (251) - - (16) 1 5 - (3) 1 (263)
Other (19) - - - - - (1) - - (20)
Financial liabilities designated at
fair value (280) - - (16) 2 5 (2) (14) 1 (304)
Interest rate derivatives 22 (3) - - 76 116 - (107) 145 249
Foreign exchange derivatives 7 - - - (12) (41) - (51) 17 (80)
Credit derivatives 1,050 (63) 4 - (3) 86 - 2 3 1,079
Equity derivatives (607) (122) (5) - 23 89 - (16) 292 (346)
Net derivative financial
instruments1 472 (188) (1) - 84 250 - (172) 457 902
Total 13,548 3,702 (4,117) (16) (328) 545 227 16 (985) 12,592
1 Derivative financial instruments are represented on a net basis. On a gross basis, derivative financial assets were £5,701m and derivative financial liabilities were
£4,799m.

-- 75 of 120 --

Financial Statement Notes
73
Unrealised gains and losses on Level 3 financial assets and liabilities
The following table discloses the unrealised gains and losses recognised in the period arising on Level 3 financial assets and
liabilities held at the period end.
Half year ended 30.06.20 Half year ended 30.06.19
Income statement Other
compre-
hensive
income Total
Income statement Other
compre-
hensive
income Total
Trading
income
Other
income
Trading
income
Other
income
£m £m £m £m £m £m £m £m
Trading portfolio assets (177) - - (177) 21 - - 21
Financial assets at fair value through the
income statement 397 (53) - 344 253 205 - 458
Financial assets at fair value through
other comprehensive income - - (2) (2) - - - -
Investment properties - (2) - (2) - (1) - (1)
Trading portfolio liabilities - - - - 2 - - 2
Financial liabilities designated at fair
value (16) (1) - (17) 6 - - 6
Net derivative financial instruments 248 - - 248 212 - - 212
Total 452 (56) (2) 394 494 204 - 698
Valuation techniques and sensitivity analysis
Sensitivity analysis is performed on products with significant unobservable inputs (Level 3) to generate a range of reasonably
possible alternative valuations. The sensitivity methodologies applied take account of the nature of valuation techniques used, as
well as the availability and reliability of observable proxy and historical data and the impact of using alternative models.
Current year valuation and sensitivity methodologies are consistent with those described within Note 17, Fair value of financial
instruments in the Barclays PLC Annual Report 2019.
Sensitivity analysis of valuations using unobservable inputs
As at 30.06.20 As at 31.12.19
Favourable changes Unfavourable changes Favourable changes Unfavourable changes
Income
statement Equity
Income
statement Equity
Income
statement Equity
Income
statement Equity
£m £m £m £m £m £m £m £m
Interest rate derivatives 138 - (255) - 44 - (127) -
Foreign exchange derivatives 7 - (11) - 5 - (7) -
Credit derivatives 127 - (109) - 73 - (47) -
Equity derivatives 151 - (158) - 114 - (119) -
Commodity derivatives - - - - - - - -
Corporate debt 23 - (23) - 11 - (16) -
Non-asset backed loans 253 4 (558) (4) 214 8 (492) (8)
Equity cash products 164 - (206) - 123 - (175) -
Private equity investments 236 - (269) - 205 - (235) -
Other1 2 - (2) - 1 - (1) -
Total 1,101 4 (1,591) (4) 790 8 (1,219) (8)
1 Other includes commercial real estate loans, funds and fund-linked products, asset backed loans, issued debt, commercial paper, government sponsored debt and
investment property.
The effect of stressing unobservable inputs to a range of reasonably possible alternatives, alongside considering the impact of using
alternative models, would be to increase fair values by up to £1,105m (December 2019: £798m) or to decrease fair values by up to
£1,595m (December 2019: £1,227m) with substantially all the potential effect impacting profit and loss rather than reserves.

-- 76 of 120 --

Financial Statement Notes
74
Significant unobservable inputs
The valuation techniques and significant unobservable inputs for assets and liabilities recognised at fair value and classified as Level
3 are consistent with Note 17, Fair value of financial instruments in the Barclays PLC Annual Report 2019. The description of the
significant unobservable inputs and the sensitivity of fair value measurement of the instruments categorised as Level 3 assets or
liabilities to increases in significant unobservable inputs is also found in Note 17, Fair value of financial instruments of the Barclays
PLC Annual Report 2019.
Fair value adjustments
Key balance sheet valuation adjustments are quantified below:
As at As at
30.06.20 31.12.19
£m £m
Exit price adjustments derived from market bid-offer spreads (575) (429)
Uncollateralised derivative funding (181) (57)
Derivative credit valuation adjustments (378) (135)
Derivative debit valuation adjustments 149 155
 Exit price adjustments derived from market bid-offer spreads increased by £146m to £575m as a result of movements in market
bid offer spreads
 Uncollateralised derivative funding increased by £124m to £181m as a result of widening input funding spreads and an update
to methodology
 Derivative credit valuation adjustments increased by £243m to £378m as a result of widening input counterparty credit spreads
 Derivative debit valuation adjustments decreased by £6m to £149m as a result of widening input Barclays Bank PLC credit
spreads and an update to methodology
Portfolio exemption
The Group uses the portfolio exemption in IFRS 13, Fair Value Measurement to measure the fair value of groups of financial assets
and liabilities. Instruments are measured using the price that would be received to sell a net long position (i.e. an asset) for a
particular risk exposure or to transfer a net short position (i.e. a liability) for a particular risk exposure in an orderly transaction
between market participants at the balance sheet date under current market conditions. Accordingly, the Group measures the fair
value of the group of financial assets and liabilities consistently with how market participants would price the net risk exposure at
the measurement date.
Unrecognised gains as a result of the use of valuation models using unobservable inputs
The amount that has yet to be recognised in income that relates to the difference between the transaction price (the fair value at
initial recognition) and the amount that would have arisen had valuation models using unobservable inputs been used on initial
recognition, less amounts subsequently recognised, is £114m (December 2019: £113m) for financial instruments measured at fair
value and £254m (December 2019: £255m) for financial instruments carried at amortised cost. There are additions of £12m
(December 2019: £41m) and amortisation and releases of £11m (December 2019: £69m) for financial instruments measured at fair
value and additions of £6m (December 2019: £7m) and amortisation and releases of £7m (December 2019: £14m) for financial
instruments carried at amortised cost.
Third party credit enhancements
Structured and brokered certificates of deposit issued by the Group are insured up to $250,000 per depositor by the Federal Deposit
Insurance Corporation (FDIC) in the United States. The FDIC is funded by premiums that Barclays and other banks pay for deposit
insurance coverage. The carrying value of these issued certificates of deposit that are designated under the IFRS 9 fair value option
includes this third party credit enhancement. The on balance sheet value of these brokered certificates of deposit amounted to
£3,162m (December 2019: £3,218m).

-- 77 of 120 --

Financial Statement Notes
75
Comparison of carrying amounts and fair values for assets and liabilities not held at fair value
Valuation methodologies employed in calculating the fair value of financial assets and liabilities measured at amortised cost are
consistent with the Barclays PLC Annual Report 2019 disclosure.
The following table summarises the fair value of financial assets and liabilities measured at amortised cost on the Group’s balance
sheet.
As at 30.06.20 As at 31.12.19
Carrying
amount Fair value
Carrying
amount Fair value
Financial assets £m £m £m £m
Loans and advances at amortised cost 354,912 353,369 339,115 337,510
Reverse repurchase agreements and other similar secured lending 22,224 22,224 3,379 3,379
Financial liabilities
Deposits at amortised cost (466,913) (466,986) (415,787) (415,807)
Repurchase agreements and other similar secured borrowing (19,144) (19,144) (14,517) (14,517)
Debt securities in issue (103,970) (104,576) (76,369) (78,512)
Subordinated liabilities (19,886) (21,422) (18,156) (18,863)
12. Loans and advances and deposits at amortised cost
As at As at
30.06.20 31.12.19
£m £m
Loans and advances at amortised cost to banks 10,013 9,624
Loans and advances at amortised cost to customers 320,582 311,739
Debt securities at amortised cost 24,317 17,752
Total loans and advances at amortised cost 354,912 339,115
Deposits at amortised cost from banks 17,390 15,402
Deposits at amortised cost from customers 449,523 400,385
Total deposits at amortised cost 466,913 415,787
13. Subordinated liabilities Half year
ended Year ended
30.06.20 31.12.19
£m £m
Opening balance as at 1 January 18,156 20,559
Issuances 580 1,352
Redemptions (296) (3,248)
Other 1,446 (507)
Closing balance 19,886 18,156
Issuances of £580m comprises £500m 3.75% Fixed Rate Resetting Subordinated Callable Notes issued externally by Barclays PLC
and £80m USD Floating Rate Notes issued externally by a Barclays subsidiary.
Redemptions of £296m comprises £266m USD Floating Rate Notes and £30m USD Fixed Rate Notes issued externally by Barclays
subsidiaries.
Other movements predominantly include foreign exchange movements and fair value hedge adjustments.

-- 78 of 120 --

Financial Statement Notes
76
14. Provisions
As at As at
30.06.20 31.12.19
£m £m
PPI redress 774 1,155
Other customer redress 372 420
Legal, competition and regulatory matters 269 376
Redundancy and restructuring 104 143
Undrawn contractually committed facilities and guarantees 741 322
Onerous contracts 23 42
Sundry provisions 329 306
Total 2,612 2,764
PPI redress
As at 30 June 2020, Barclays had recognised cumulative provisions totalling £11bn (December 2019: £11bn). Utilisation of the
cumulative provisions to date is £10.2bn (December 2019: £9.8bn), leaving a residual provision of £0.8bn (December 2019: £1.2bn).
This represents Barclays best estimate as at 30 June 2020 based on the information available.
The current provision reflects the estimated cost of PPI redress attributable to claims and information requests from customers,
Claims Management Companies and the Official Receiver in relation to bankrupt individuals.
Q3 2019 saw an exceptional level of claims and information requests received in advance of the complaint deadline of 29 August
2019. All the items outstanding at Q3 2019, greater than two million in total, have now been processed into Barclays’ systems. 70%
of these have been resolved including invalid items.
It is possible that the eventual cumulative provision will differ from the current estimate. The table below shows the predicted level
of valid claims and the impact of a 1% increase or decrease in the percentage of valid volumes on the outstanding claims at 30 June
2020:
Validity assumptions1
Total volumes
assumed valid2
Sensitivity on the
remaining volumes
% £m
Claims received 21% 1% = £3m
Information requests received 7% 1% = £2m
Final agreement has yet to be reached in relation to claims received from the Official Receiver, however we do not expect any
further exposure from these claims to be material in the context of the total provision.
1 Total valid claims and information requests received, excluding those for which no PPI policy exists, claims from the Official Receiver in relation to bankrupt
individuals and responses to proactive mailing. The sensitivity has been calculated to show the impact a 1% increase or decrease in the volume of unresolved valid
claims would have on the provision level.
2 Based on the observed data from September 2019 to June 2020.

-- 79 of 120 --

Financial Statement Notes
77
15. Retirement benefits
As at 30 June 2020, the Group’s IAS 19 pension surplus across all schemes was £2.5bn (December 2019: £1.8bn). The UK
Retirement Fund (UKRF), which is the Group’s main scheme, had an IAS 19 pension surplus of £2.8bn (December 2019: £2.1bn). The
movement for the UKRF was driven by higher than assumed asset returns and lower than expected long-term price inflation,
partially offset by a decrease in the discount rate.
UKRF funding valuations
The last triennial actuarial valuation of the UKRF had an effective date of 30 September 2019 and was completed in February 2020.
This valuation showed a funding deficit of £2.3bn and a funding level of 94.0%. A revised deficit recovery plan was agreed with
deficit reduction contributions required from Barclays Bank PLC of £500m in 2019, £500m in 2020, £700m in 2021, £294m in 2022
and £286m in 2023. The deficit reduction contributions are in addition to the regular contributions to meet the Group’s share of
the cost of benefits accruing over each year.
On 12 June 2020, Barclays Bank PLC paid the £500m deficit reduction contribution agreed for 2020 and at the same time the UKRF
subscribed for non-transferrable listed senior fixed rate notes for £750m, backed by UK gilts (the Senior Notes). These Senior Notes
entitle the UKRF to semi-annual coupon payments for five years, and full repayment in cash in three equal tranches in 2023, 2024,
and at final maturity in 2025. The Senior Notes were issued by Heron Issuer Number 2 Limited (Heron 2), an entity that is
consolidated within the Group under IFRS 10. As a result of the investment in Senior Notes, the regulatory capital impact of the
£500m deficit reduction contribution paid on 12 June 2020 takes effect in 2023, 2024 and 2025 on maturity of the notes. The
£250m additional investment by the UKRF in the Senior Notes has a positive capital impact in 2020 which is reduced equally in
2023, 2024 and 2025 on the maturity of the notes. Heron 2 acquired a total of £750m of gilts from Barclays Bank PLC for cash to
support payments on the Senior Notes.
The next triennial actuarial valuation of the UKRF is due to be completed in 2023 with an effective date of 30 September 2022.
16. Called up share capital
Called up share capital comprised 17,345m (December 2019: 17,322m) ordinary shares of 25p each. The increase was due to the
issuance of shares under employee share schemes.
Ordinary share
capital Share premium
Total share
capital and
share premium
Half year ended 30.06.20 £m £m £m
Opening balance as at 1 January 4,331 263 4,594
Movement 5 21 26
Closing balance 4,336 284 4,620

-- 80 of 120 --

Financial Statement Notes
78
17. Other equity instruments Half year
ended Year ended
30.06.20 31.12.19
£m £m
Opening balance as at 1 January 10,871 9,632
Issuances - 3,500
Redemptions - (2,262)
Other - 1
Closing balance 10,871 10,871
Other equity instruments of £10,871m (December 2019: £10,871m) include AT1 securities issued by Barclays PLC. There have been
no issuances or redemptions in the period.
The AT1 securities are perpetual securities with no fixed maturity and are structured to qualify as AT1 instruments under prevailing
capital rules applicable as at the relevant issue date. AT1 securities are undated and are redeemable, at the option of Barclays PLC,
in whole at the initial call date, or on any fifth anniversary after the initial call date. In addition, the AT1 securities are redeemable,
at the option of Barclays PLC, in whole in the event of certain changes in the tax or regulatory treatment of the securities. Any
redemptions require the prior consent of the PRA.
All Barclays PLC AT1 securities will be converted into ordinary shares of Barclays PLC, at a pre-determined price, should the fully
loaded CET1 ratio of the Group fall below 7%.

-- 81 of 120 --

Financial Statement Notes
79
18. Other reserves As at As at
30.06.20 31.12.19
£m £m
Currency translation reserve 4,564 3,344
Fair value through other comprehensive income reserve (565) (187)
Cash flow hedging reserve 1,914 1,002
Own credit reserve 123 (373)
Other reserves and treasury shares 960 974
Total 6,996 4,760
Currency translation reserve
The currency translation reserve represents the cumulative gains and losses on the retranslation of the Group’s net investment in
foreign operations, net of the effects of hedging.
As at 30 June 2020, there was a credit balance of £4,564m (December 2019: £3,344m credit) in the currency translation reserve.
The £1,220m credit movement principally reflects the strengthening of period end USD exchange rate against GBP.
Fair value through other comprehensive income reserve
The fair value through other comprehensive income reserve represents the unrealised change in the fair value through other
comprehensive income investments since initial recognition.
As at 30 June 2020, there was a debit balance of £565m (December 2019: £187m debit) in the fair value through other
comprehensive income reserve. The loss of £378m is principally driven by a loss of £515m due to a decrease in the Absa Group
Limited share price and £150m of net gains transferred to the income statement. This is partially offset by a gain of £307m from the
increase in fair value of bonds due to decreasing bond yields.
Cash flow hedging reserve
The cash flow hedging reserve represents the cumulative gains and losses on effective cash flow hedging instruments that will be
recycled to the income statement when the hedged transactions affect profit or loss.
As at 30 June 2020, there was a credit balance of £1,914m (December 2019: £1,002m credit) in the cash flow hedging reserve. The
increase of £912m principally reflects a £1,458m increase in the fair value of interest rate swaps held for hedging purposes as major
interest rate forward curves decreased. This is partially offset by £197m of gains transferred to the income statement and a tax
charge of £358m.
Own credit reserve
The own credit reserve reflects the cumulative own credit gains and losses on financial liabilities at fair value. Amounts in the own
credit reserve are not recycled to profit or loss in future periods.
As at 30 June 2020, there was a credit balance of £123m (December 2019: £373m debit) in the own credit reserve. The movement
of £496m principally reflects a £845m gain from the widening of Barclays’ funding spreads. This is partially offset by other activity
of £209m and a tax charge of £144m.
Other reserves and treasury shares
Other reserves relate to redeemed ordinary and preference shares issued by the Group. Treasury shares relate to Barclays PLC
shares held principally in relation to the Group’s various share schemes.
As at 30 June 2020, there was a credit balance of £960m (December 2019: £974m credit) in other reserves and treasury shares. The
decrease of £14m is due to an increase in treasury shares held in relation to employee share schemes.

-- 82 of 120 --

Financial Statement Notes
80
19. Contingent liabilities and commitments
As at As at
30.06.20 31.12.19
Contingent liabilities £m £m
Guarantees and letters of credit pledged as collateral security 16,225 17,606
Performance guarantees, acceptances and endorsements 6,739 6,921
Total 22,964 24,527
Commitments
Documentary credits and other short-term trade related transactions 1,162 1,291
Standby facilities, credit lines and other commitments 332,969 333,164
Total 334,131 334,455
In addition to the above, Note 20, Legal, competition and regulatory matters details out further contingent liabilities where it is not
practicable to disclose an estimate of the potential financial effect on Barclays.
20. Legal, competition and regulatory matters
Members of the Group face legal, competition and regulatory challenges, many of which are beyond our control. The extent of the
impact of these matters cannot always be predicted but may materially impact our operations, financial results, condition and
prospects. Matters arising from a set of similar circumstances can give rise to either a contingent liability or a provision, or both,
depending on the relevant facts and circumstances.
The recognition of provisions in relation to such matters involves critical accounting estimates and judgments in accordance with
the relevant accounting policies as described in Note 14, Provisions. We have not disclosed an estimate of the potential financial
impact or effect on the Group of contingent liabilities where it is not currently practicable to do so. Various matters detailed in this
note seek damages of an unspecified amount. While certain matters specify the damages claimed, such claimed amounts do not
necessarily reflect the Group’s potential financial exposure in respect of those matters.
Matters are ordered under headings corresponding to the financial statements in which they are disclosed.
1. Barclays PLC and Barclays Bank PLC
Investigations into certain advisory services agreements and other matters and civil action
FCA proceedings
In 2008, Barclays Bank PLC and Qatar Holdings LLC entered into two advisory service agreements (the Agreements). The Financial
Conduct Authority (FCA) conducted an investigation into whether the Agreements may have related to Barclays PLC’s capital
raisings in June and November 2008 (the Capital Raisings) and therefore should have been disclosed in the announcements or
public documents relating to the Capital Raisings. In 2013, the FCA issued warning notices (the Notices) finding that Barclays PLC
and Barclays Bank PLC acted recklessly and in breach of certain disclosure-related listing rules, and that Barclays PLC was also in
breach of Listing Principle 3. The financial penalty provided in the Notices is £50m. Barclays PLC and Barclays Bank PLC continue to
contest the findings. Following the conclusion of the Serious Fraud Office (SFO) proceedings against certain former Barclays
executives resulting in their acquittals, the FCA proceedings, which were stayed, have resumed. All charges brought by the SFO
against Barclays PLC and Barclays Bank PLC in relation to the Agreements were dismissed in 2018.
Civil action
PCP Capital Partners LLP and PCP International Finance Limited (PCP) are seeking damages of approximately £1.6bn from Barclays
Bank PLC for fraudulent misrepresentation and deceit, arising from alleged statements made by Barclays Bank PLC to PCP in
relation to the terms on which securities were to be issued to potential investors, allegedly including PCP, in the November 2008
capital raising. Barclays Bank PLC is defending the claim and trial commenced in June 2020.
Investigations into LIBOR and other benchmarks and related civil actions
Regulators and law enforcement agencies, including certain competition authorities, from a number of governments have
conducted investigations relating to Barclays Bank PLC’s involvement in allegedly manipulating certain financial benchmarks, such
as LIBOR. The SFO has closed its investigation with no action to be taken against the Group. Various individuals and corporates in a
range of jurisdictions have threatened or brought civil actions against the Group and other banks in relation to the alleged
manipulation of LIBOR and/or other benchmarks. Certain actions remain pending.

-- 83 of 120 --

Financial Statement Notes
81
USD LIBOR civil actions
The majority of the USD LIBOR cases, which have been filed in various US jurisdictions, have been consolidated for pre-trial
purposes in the US District Court in the Southern District of New York (SDNY). The complaints are substantially similar and allege,
among other things, that Barclays PLC, Barclays Bank PLC, Barclays Capital Inc. (BCI) and other financial institutions individually and
collectively violated provisions of the US Sherman Antitrust Act (Antitrust Act), the US Commodity Exchange Act (CEA), the US
Racketeer Influenced and Corrupt Organizations Act (RICO), the Securities Exchange Act of 1934 and various state laws by
manipulating USD LIBOR rates.
Putative class actions and individual actions seek unspecified damages with the exception of three lawsuits, in which the plaintiffs
are seeking a combined total of approximately $900m in actual damages and additional punitive damages against all defendants,
including Barclays Bank PLC. Some of the lawsuits also seek trebling of damages under the Antitrust Act and RICO. Barclays has
previously settled certain claims. Two of the class action settlements where Barclays has paid $20m and $7.1m, respectively,
remain subject to final court approval and/or the right of class members to opt out of the settlement to file their own claims.
Sterling LIBOR civil actions
In 2016, two putative class actions filed in the SDNY against Barclays Bank PLC, BCI and other Sterling LIBOR panel banks alleging,
among other things, that the defendants manipulated the Sterling LIBOR rate in violation of the Antitrust Act, CEA and RICO, were
consolidated. The defendants’ motion to dismiss the claims was granted in December 2018. The plaintiffs have appealed the
dismissal.
Japanese Yen LIBOR civil actions
In 2012, a putative class action was filed in the SDNY against Barclays Bank PLC and other Japanese Yen LIBOR panel banks by a lead
plaintiff involved in exchange-traded derivatives and members of the Japanese Bankers Association’s Euroyen Tokyo Interbank
Offered Rate (Euroyen TIBOR) panel. The complaint alleges, among other things, manipulation of the Euroyen TIBOR and Yen LIBOR
rates and breaches of the CEA and the Antitrust Act. In 2014, the court dismissed the plaintiff’s antitrust claims in full, but the
plaintiff’s CEA claims remain pending.
In 2015, a second putative class action, making similar allegations to the above class action, was filed in the SDNY against Barclays
PLC, Barclays Bank PLC and BCI. In 2017, this action was dismissed in full and the plaintiffs appealed the dismissal. The appellate
court reversed the dismissal and the matter has been remanded to the lower court.
SIBOR/SOR civil action
In 2016, a putative class action was filed in the SDNY against Barclays PLC, Barclays Bank PLC, BCI and other defendants, alleging
manipulation of the Singapore Interbank Offered Rate (SIBOR) and Singapore Swap Offer Rate (SOR). In October 2018, the court
dismissed all claims against Barclays PLC, Barclays Bank PLC and BCI. The plaintiffs have appealed the dismissal.
ICE LIBOR civil actions
In 2019, several putative class actions have been filed in the SDNY against Barclays PLC, Barclays Bank PLC, BCI, other financial
institution defendants and Intercontinental Exchange Inc. and certain of its affiliates (ICE), asserting antitrust claims that
defendants manipulated USD LIBOR through defendants’ submissions to ICE. These actions have been consolidated. The
defendants’ motion to dismiss was granted in March 2020. The plaintiffs have appealed the dismissal.
Non-US benchmarks civil actions
Legal proceedings (which include the claims referred to below in ‘Local authority civil actions concerning LIBOR’) have been brought
or threatened against Barclays Bank PLC (and, in certain cases, Barclays Bank UK PLC) in the UK in connection with alleged
manipulation of LIBOR, EURIBOR and other benchmarks. Proceedings have also been brought in a number of other jurisdictions in
Europe and Israel. Additional proceedings in other jurisdictions may be brought in the future.
Foreign Exchange investigations and related civil actions
In 2015, the Group reached settlements totalling approximately $2.38bn with various US federal and state authorities and the FCA
in relation to investigations into certain sales and trading practices in the Foreign Exchange market. Under the related plea
agreement with the US Department of Justice (DoJ), which received final court approval in January 2017, the Group agreed to a
term of probation of three years, which expired in January 2020. The Group also continues to provide relevant information to
certain authorities.
The European Commission is one of a number of authorities still conducting an investigation into certain trading practices in
Foreign Exchange markets. The European Commission announced two settlements in May 2019 and the Group paid penalties
totalling approximately €210m. In June 2019, the Swiss Competition Commission announced two settlements and the Group paid
penalties totalling approximately CHF 27m. The financial impact of the ongoing matters is not expected to be material to the
Group’s operating results, cash flows or financial position.

-- 84 of 120 --

Financial Statement Notes
82
A number of individuals and corporates in a range of jurisdictions have also threatened or brought civil actions against the Group
and other banks in relation to alleged manipulation of Foreign Exchange markets, and may do so in the future. Certain actions
remain pending.
FX opt out civil action
In 2018, Barclays Bank PLC and BCI settled a consolidated action filed in the SDNY, alleging manipulation of Foreign Exchange
markets (Consolidated FX Action), for a total amount of $384m. Also in 2018, a group of plaintiffs who opted out of the
Consolidated FX Action filed a complaint in the SDNY against Barclays PLC, Barclays Bank PLC, BCI and other defendants. Some of
the plaintiff’s claims were dismissed in May 2020.
Retail basis civil action
In 2015, a putative class action was filed against several international banks, including Barclays PLC and BCI, on behalf of a
proposed class of individuals who exchanged currencies on a retail basis at bank branches (Retail Basis Claims). The SDNY has ruled
that the Retail Basis Claims are not covered by the settlement agreement in the Consolidated FX Action. The Court subsequently
dismissed all Retail Basis Claims against the Group and all other defendants. The plaintiffs have filed an amended complaint.
State law FX civil action
In 2017, the SDNY dismissed consolidated putative class actions brought under federal and various state laws on behalf of proposed
classes of (i) stockholders of Exchange Traded Funds and others who purportedly were indirect investors in FX instruments, and (ii)
investors who traded FX instruments through FX dealers or brokers not alleged to have manipulated Foreign Exchange Rates.
Barclays Bank PLC and BCI have settled the claim, which is subject to court approval.
Non-US FX civil actions
In addition to the actions described above, legal proceedings have been brought or are threatened against Barclays PLC, Barclays
Bank PLC, BCI and Barclays Execution Services Limited (BX) in connection with alleged manipulation of Foreign Exchange in the UK,
a number of other jurisdictions in Europe, Israel and Australia and additional proceedings may be brought in the future.
Metals investigations and related civil actions
Barclays Bank PLC previously provided information to the DoJ, the US Commodity Futures Trading Commission and other
authorities in connection with investigations into metals and metals-based financial instruments.
A number of US civil complaints, each on behalf of a proposed class of plaintiffs, have been consolidated and transferred to the
SDNY. The complaints allege that Barclays Bank PLC and other members of The London Gold Market Fixing Ltd. manipulated the
prices of gold and gold derivative contracts in violation of US antitrust and other federal laws. This consolidated putative class
action remains pending. A separate US civil complaint by a proposed class of plaintiffs against a number of banks, including Barclays
Bank PLC, BCI and BX, alleging manipulation of the price of silver in violation of the CEA, the Antitrust Act and state antitrust and
consumer protection laws, has been dismissed as against the Barclays entities. The plaintiffs have the option to seek the court’s
permission to appeal.
Civil actions have also been filed in Canadian courts against Barclays PLC, Barclays Bank PLC, Barclays Capital Canada Inc. and BCI on
behalf of proposed classes of plaintiffs alleging manipulation of gold and silver prices.
US residential mortgage related civil actions
There are various pending civil actions relating to US Residential Mortgage-Backed Securities (RMBS), including four actions arising
from unresolved repurchase requests submitted by Trustees for certain RMBS, alleging breaches of various loan-level
representations and warranties (R&Ws) made by Barclays Bank PLC and/or a subsidiary acquired in 2007 (the Acquired Subsidiary).
The unresolved repurchase requests received as at 31 December 2019 had an original unpaid principal balance of approximately
$2.1bn. The Trustees have also alleged that the relevant R&Ws may have been breached with respect to a greater (but unspecified)
amount of loans than previously stated in the unresolved repurchase requests.
These repurchase actions are ongoing. In one repurchase action, the New York Court of Appeals held that claims related to certain
R&Ws are time-barred. Barclays Bank PLC has reached a settlement to resolve two of the repurchase actions, which is subject to
final court approval. The financial impact of the settlement is not expected to be material to the Group’s operating results, cash
flows or financial position. The remaining two repurchase actions are pending.
Government and agency securities civil actions and related matters
Certain governmental authorities are conducting investigations into activities relating to the trading of certain government and
agency securities in various markets. The Group provided information in cooperation with such investigations. Civil actions have
also been filed on the basis of similar allegations, as described below.

-- 85 of 120 --

Financial Statement Notes
83
Treasury auction securities civil actions
Consolidated putative class action complaints filed in US federal court against Barclays Bank PLC, BCI and other financial institutions
under the Antitrust Act and state common law allege that the defendants (i) conspired to manipulate the US Treasury securities
market and/or (ii) conspired to prevent the creation of certain platforms by boycotting or threatening to boycott such trading
platforms. The defendants have filed a motion to dismiss.
In addition, certain plaintiffs have filed a related, direct action against BCI and certain other financial institutions, alleging that
defendants conspired to fix and manipulate the US Treasury securities market in violation of the Antitrust Act, the CEA and state
common law.
Supranational, Sovereign and Agency bonds civil actions
Civil antitrust actions have been filed in the SDNY and Federal Court of Canada in Toronto against Barclays Bank PLC, BCI, BX,
Barclays Capital Securities Limited and, with respect to the civil action filed in Canada only, Barclays Capital Canada, Inc. and other
financial institutions alleging that the defendants conspired to fix prices and restrain competition in the market for US dollar-
denominated Supranational, Sovereign and Agency bonds.
In one of the actions filed in the SDNY, the court granted the defendants’ motion to dismiss the plaintiffs’ complaint, which the
plaintiffs have appealed. The plaintiffs have voluntarily dismissed the other SDNY action.
Variable Rate Demand Obligations civil actions
Civil actions have been filed against Barclays Bank PLC and BCI and other financial institutions alleging the defendants conspired or
colluded to artificially inflate interest rates set for Variable Rate Demand Obligations (VRDOs). VRDOs are municipal bonds with
interest rates that reset on a periodic basis, most commonly weekly. Two actions in state court have been filed by private plaintiffs
on behalf of the states of Illinois and California. Two putative class action complaints, which have been consolidated, have been
filed in the SDNY.
Government bond civil actions
In a putative class action filed in the SDNY in 2019, plaintiffs alleged that BCI and certain other bond dealers conspired to fix the
prices of US government sponsored entity bonds in violation of US antitrust law. BCI agreed to a settlement of $87m, which
received final court approval in June 2020. Separately, various entities in Louisiana, including the Louisiana Attorney General and
the City of Baton Rouge, have filed complaints against Barclays Bank PLC and other financial institutions making similar allegations
as the class action plaintiffs.
In 2018, a separate putative class action against various financial institutions including Barclays PLC, Barclays Bank PLC, BCI,
Barclays Bank Mexico, S.A., and certain other subsidiaries of the Group was consolidated in the SDNY. The plaintiffs asserted
antitrust and state law claims arising out of an alleged conspiracy to fix the prices of Mexican Government bonds. Barclays PLC has
settled the claim for $5.7m, which is subject to court approval.
BDC Finance L.L.C.
In 2008, BDC Finance L.L.C. (BDC) filed a complaint in the NY Supreme Court, demanding damages of $298m, alleging that Barclays
Bank PLC had breached a contract in connection with a portfolio of total return swaps governed by an ISDA Master Agreement
(collectively, the Agreement). Following a trial on certain liability issues, the court ruled in December 2018 that Barclays Bank PLC
was not a defaulting party, which was affirmed on appeal. Barclays Bank PLC’s counterclaim against BDC remains pending.
In 2011, BDC’s investment advisor, BDCM Fund Adviser, L.L.C. and its parent company, Black Diamond Capital Holdings, L.L.C. also
sued Barclays Bank PLC and BCI in Connecticut State Court for unspecified damages allegedly resulting from Barclays Bank PLC’s
conduct relating to the Agreement, asserting claims for violation of the Connecticut Unfair Trade Practices Act and tortious
interference with business and prospective business relations. This case is currently stayed.
Civil actions in respect of the US Anti-Terrorism Act
There are a number of civil actions, on behalf of more than 4,000 plaintiffs, filed in US federal courts in the US District Court in the
Eastern District of New York (EDNY) and SDNY against Barclays Bank PLC and a number of other banks. The complaints generally
allege that Barclays Bank PLC and those banks engaged in a conspiracy to facilitate US dollar-denominated transactions for the
Government of Iran and various Iranian banks, which in turn funded acts of terrorism that injured or killed plaintiffs or plaintiffs’
family members. The plaintiffs seek to recover damages for pain, suffering and mental anguish under the provisions of the US Anti-
Terrorism Act, which allow for the trebling of any proven damages.
The court granted the defendants’ motion to dismiss three actions in the EDNY. Plaintiffs have appealed in one action. The court
also granted the defendants’ motion to dismiss another action in the SDNY. The remaining actions are stayed pending decisions in
these cases.

-- 86 of 120 --

Financial Statement Notes
84
Interest rate swap and credit default swap US civil actions
Barclays PLC, Barclays Bank PLC and BCI, together with other financial institutions that act as market makers for interest rate swaps
(IRS) are named as defendants in several antitrust class actions which were consolidated in the SDNY in 2016. The complaints allege
the defendants conspired to prevent the development of exchanges for IRS and demand unspecified money damages.
In 2018, trueEX LLC filed an antitrust class action in the SDNY against a number of financial institutions including Barclays PLC,
Barclays Bank PLC and BCI based on similar allegations with respect to trueEX LLC’s development of an IRS platform. In 2017, Tera
Group Inc. filed a separate civil antitrust action in the SDNY claiming that certain conduct alleged in the IRS cases also caused the
plaintiff to suffer harm with respect to the Credit Default Swaps market. In November 2018 and July 2019, respectively, the court
dismissed certain claims in both cases for unjust enrichment and tortious interference but denied motions to dismiss the federal
and state antitrust claims, which remain pending.
Odd-lot corporate bonds antitrust class action
In 2020, BCI, together with other financial institutions, were named as defendants in a putative class action. The complaint alleges a
conspiracy to boycott developing electronic trading platforms for odd-lots and price fixing. Plaintiffs demand unspecified money
damages.
2. Barclays PLC, Barclays Bank PLC and Barclays Bank UK PLC
Investigation into collections and recoveries relating to unsecured lending
Since February 2018, the FCA has been investigating whether the Group implemented effective systems and controls with respect
to collections and recoveries and whether it paid due consideration to the interests of customers in default and arrears. The FCA
investigation is at an advanced stage.
HM Revenue & Customs (HMRC) assessments concerning UK Value Added Tax
In 2018, HMRC issued notices that have the effect of removing certain overseas subsidiaries that have operations in the UK from
Barclays’ UK VAT group, in which group supplies between members are generally free from VAT. The notices have retrospective
effect and correspond to assessments of £181m (inclusive of interest), of which Barclays would expect to attribute an amount of
approximately £128m to Barclays Bank UK PLC and £53m to Barclays Bank PLC. HMRC’s decision has been appealed to the First Tier
Tribunal (Tax Chamber).
Local authority civil actions concerning LIBOR
Following settlement by Barclays Bank PLC of various governmental investigations concerning certain benchmark interest rate
submissions referred to above in ‘Investigations into LIBOR and other benchmarks and related civil actions’, in the UK, certain local
authorities have brought claims against Barclays Bank PLC (and, in certain cases, Barclays Bank UK PLC) asserting that they entered
into loans in reliance on misrepresentations made by Barclays Bank PLC in respect of its conduct in relation to LIBOR. Barclays has
applied to strike out the claims.
General
The Group is engaged in various other legal, competition and regulatory matters in the UK, the US and a number of other overseas
jurisdictions. It is subject to legal proceedings brought by and against the Group which arise in the ordinary course of business from
time to time, including (but not limited to) disputes in relation to contracts, securities, debt collection, consumer credit, fraud,
trusts, client assets, competition, data management and protection, money laundering, financial crime, employment,
environmental and other statutory and common law issues.
The Group is also subject to enquiries and examinations, requests for information, audits, investigations and legal and other
proceedings by regulators, governmental and other public bodies in connection with (but not limited to) consumer protection
measures, compliance with legislation and regulation, wholesale trading activity and other areas of banking and business activities
in which the Group is or has been engaged. The Group is cooperating with the relevant authorities and keeping all relevant
agencies briefed as appropriate in relation to these matters and others described in this note on an ongoing basis.
At the present time, Barclays PLC does not expect the ultimate resolution of any of these other matters to have a material adverse
effect on the Group’s financial position. However, in light of the uncertainties involved in such matters and the matters specifically
described in this note, there can be no assurance that the outcome of a particular matter or matters (including formerly active
matters or those matters arising after the date of this note) will not be material to Barclays PLC’s results, operations or cash flow
for a particular period, depending on, among other things, the amount of the loss resulting from the matter(s) and the amount of
profit otherwise reported for the reporting period.

-- 87 of 120 --

Financial Statement Notes
85
21. Related party transactions
Related party transactions in the half year ended 30 June 2020 were similar in nature to those disclosed in the Barclays PLC Annual
Report 2019. No related party transactions that have taken place in the half year ended 30 June 2020 have materially affected the
financial position or the performance of the Group during this period.

-- 88 of 120 --

Financial Statement Notes
86
22. Barclays PLC parent company balance sheet
As at As at
30.06.20 31.12.19
Assets £m £m
Investment in subsidiaries 61,488 59,546
Loans and advances to subsidiaries 28,254 28,850
Financial assets at fair value through the income statement 16,246 10,348
Derivative financial instruments 116 58
Other assets 37 2
Total assets 106,141 98,804
Liabilities
Deposits at amortised cost 534 500
Debt securities in issue 31,417 30,564
Subordinated liabilities 8,669 7,656
Financial liabilities designated at fair value 8,206 3,498
Other liabilities 112 119
Total liabilities 48,938 42,337
Equity
Called up share capital 4,336 4,331
Share premium account 284 263
Other equity instruments 10,865 10,865
Other reserves 394 394
Retained earnings 41,324 40,614
Total equity 57,203 56,467
Total liabilities and equity 106,141 98,804
Investment in subsidiaries
The investment in subsidiaries of £61,488m (December 2019: £59,546m) predominantly relates to investments in Barclays Bank PLC
and Barclays Bank UK PLC, as well as holdings of their AT1 securities of £10,843m (December 2019: £10,843m). The increase of
£1,942m during the period was predominantly driven by capital contributions into Barclays Bank PLC totalling £1,500m and
Barclays Bank UK PLC totalling £220m. Barclays PLC considers the carrying value of its investment in subsidiaries to be fully
recoverable.
Financial assets and liabilities designated at fair value
Financial liabilities designated at fair value of £8,206m (December 2019: £3,498m) comprises issuances during the period of $300m
Zero Coupon Callable Notes, $1,750m Fixed-to-Floating Rate Senior Notes, $1,000m Fixed Rate Resetting Senior Callable Notes and
€2,000m Reset Notes. The proceeds raised through these transactions were used to invest in subsidiaries of Barclays PLC which are
included within the financial assets designated at fair value through the income statement balance of £16,246m (December 2019:
£10,348m).
Subordinated liabilities
During H120, Barclays PLC issued £500m of Fixed Rate Resetting Subordinated Callable Notes, which is included within the
subordinated liabilities balance of £8,669m (December 2019: £7,656m).
Other equity instruments
Other equity instruments comprises AT1 securities issued by Barclays PLC. There have been no new issuances or redemptions
during the period.
Management of internal investments, loans and advances
Barclays PLC retains the discretion to manage the nature of its internal investments in subsidiaries according to their regulatory and
business needs. Barclays PLC may invest capital and funding into Barclays Bank PLC, Barclays Bank UK PLC and other Group
subsidiaries such as Barclays Execution Services Limited and the US Intermediate Holding Company (IHC).

-- 89 of 120 --

Appendix: Non-IFRS Performance Measures
87
The Group’s management believes that the non-IFRS performance measures included in this document provide valuable
information to the readers of the financial statements as they enable the reader to identify a more consistent basis for comparing
the businesses’ performance between financial periods, and provide more detail concerning the elements of performance which
the managers of these businesses are most directly able to influence or are relevant for an assessment of the Group. They also
reflect an important aspect of the way in which operating targets are defined and performance is monitored by management.
However, any non-IFRS performance measures in this document are not a substitute for IFRS measures and readers should
consider the IFRS measures as well.
Non-IFRS performance measures glossary
Measure Definition
Loan: deposit ratio Loans and advances at amortised cost divided by deposits at amortised cost. The components of the
calculation have been included on page 44.
Period end allocated
tangible equity
Allocated tangible equity is calculated as 13.0% (2019: 13.0%) of RWAs for each business, adjusted
for capital deductions, excluding goodwill and intangible assets, reflecting the assumptions the Group
uses for capital planning purposes. Head Office allocated tangible equity represents the difference
between the Group’s tangible shareholders’ equity and the amounts allocated to businesses.
Average tangible
shareholders’ equity
Calculated as the average of the previous month’s period end tangible equity and the current
month’s period end tangible equity. The average tangible shareholders’ equity for the period is the
average of the monthly averages within that period.
Average allocated
tangible equity
Calculated as the average of the previous month’s period end allocated tangible equity and the
current month’s period end allocated tangible equity. The average allocated tangible equity for the
period is the average of the monthly averages within that period.
Return on average
tangible shareholders’
equity
Annualised profit after tax attributable to ordinary equity holders of the parent, as a proportion of
average shareholders’ equity excluding non-controlling interests and other equity instruments
adjusted for the deduction of intangible assets and goodwill. The components of the calculation have
been included on page 88.
Return on average
allocated tangible equity
Annualised profit after tax attributable to ordinary equity holders of the parent, as a proportion of
average allocated tangible equity. The components of the calculation have been included on page 88.
Cost: income ratio Total operating expenses divided by total income.
Loan loss rate Quoted in basis points and represents total annualised impairment charges divided by gross loans
and advances held at amortised cost at the balance sheet date. The components of the calculation
have been included on page 27.
Net interest margin Annualised net interest income divided by the sum of average customer assets. The components of
the calculation have been included on page 24.
Tangible net asset value
per share
Calculated by dividing shareholders’ equity, excluding non-controlling interests and other equity
instruments, less goodwill and intangible assets, by the number of issued ordinary shares. The
components of the calculation have been included on page 96.
Performance measures
excluding litigation and
conduct
Calculated by excluding litigation and conduct charges from performance measures. The components
of the calculations have been included on pages 89 to 96.
Pre-provision profits Calculated by excluding credit impairment charges from profit before tax. The components of the
calculation have been included on pages 89 to 91.
Pre-provision profits
excluding litigation and
conduct
Calculated by excluding credit impairment charges, and litigation and conduct charges from profit
before tax. The components of the calculation have been included on pages 89 to 91.

-- 90 of 120 --

Appendix: Non-IFRS Performance Measures
88
Returns
Return on average tangible equity is calculated as profit after tax attributable to ordinary equity holders of the parent as a
proportion of average tangible equity, excluding non-controlling and other equity interests for businesses. Allocated tangible equity
has been calculated as 13.0% (2019: 13.0%) of RWAs for each business, adjusted for capital deductions, excluding goodwill and
intangible assets, reflecting the assumptions the Group uses for capital planning purposes. Head Office average allocated tangible
equity represents the difference between the Group’s average tangible shareholders’ equity and the amounts allocated to
businesses.
Profit/(loss)
attributable to
ordinary equity
holders of the
parent
Average
tangible equity
Return on
average
tangible equity
Half year ended 30.06.20 £m £bn %
Barclays UK 52 10.2 1.0
Corporate and Investment Bank 1,514 27.7 11.0
Consumer, Cards and Payments (517) 4.7 (21.9)
Barclays International 997 32.4 6.2
Head Office (354) 6.0 n/m
Barclays Group 695 48.6 2.9
Half year ended 30.06.19
Barclays UK 750 10.3 14.5
Corporate and Investment Bank 1,178 25.5 9.3
Consumer, Cards and Payments 442 5.3 16.6
Barclays International 1,620 30.8 10.5
Head Office (298) 4.6 n/m
Barclays Group 2,072 45.7 9.1

-- 91 of 120 --

Appendix: Non-IFRS Performance Measures
89
Performance measures excluding litigation and conduct
Half year ended 30.06.20
Barclays UK
Corporate and
Investment
Bank
Consumer,
Cards and
Payments
Barclays
International Head Office
Barclays
Group
Cost: income ratio £m £m £m £m £m £m
Total operating expenses (2,052) (3,373) (1,043) (4,416) (125) (6,593)
Impact of litigation and conduct 11 3 8 11 8 30
Operating expenses (2,041) (3,370) (1,035) (4,405) (117) (6,563)
Total income 3,171 6,933 1,721 8,654 (204) 11,621
Cost: income ratio excluding litigation and
conduct 64% 49% 60% 51% n/m 56%
Profit before tax
Profit/(loss) before tax 68 2,243 (614) 1,629 (425) 1,272
Impact of litigation and conduct 11 3 8 11 8 30
Profit/(loss) before tax excluding litigation and
conduct 79 2,246 (606) 1,640 (417) 1,302
Profit attributable to ordinary equity holders of
the parent
Attributable profit/(loss) 52 1,514 (517) 997 (354) 695
Post-tax impact of litigation and conduct 8 2 6 8 (1) 15
Profit/(loss) attributable to ordinary equity
holders of the parent excluding litigation and
conduct
60 1,516 (511) 1,005 (355) 710
Return on average tangible shareholders'
equity £bn £bn £bn £bn £bn £bn
Average shareholders' equity 13.8 27.7 5.4 33.1 9.9 56.8
Average goodwill and intangibles (3.6) - (0.7) (0.7) (3.9) (8.2)
Average tangible shareholders' equity 10.2 27.7 4.7 32.4 6.0 48.6
Return on average tangible shareholders'
equity excluding litigation and conduct 1.2% 11.0% (21.7%) 6.2% n/m 2.9%
Basic earnings per ordinary share
Basic weighted average number of shares (m) 17,294
Basic earnings per ordinary share excluding
litigation and conduct 4.1p
Pre-provision profits
Profit before tax excluding credit impairment
charges and litigation and conduct £m
Profit before tax 1,272
Impact of credit impairment charges 3,738
Profit before tax excluding credit impairment
charges 5,010
Impact of litigation and conduct 30
Profit before tax excluding credit impairment
charges and litigation and conduct 5,040

-- 92 of 120 --

Appendix: Non-IFRS Performance Measures
90
Half year 30.06.19
Barclays UK
Corporate and
Investment
Bank
Consumer,
Cards and
Payments
Barclays
International Head Office
Barclays
Group
Cost: income ratio £m £m £m £m £m £m
Total operating expenses (2,065) (3,505) (1,166) (4,671) (136) (6,872)
Impact of litigation and conduct 44 26 4 30 40 114
Operating expenses (2,021) (3,479) (1,162) (4,641) (96) (6,758)
Total income 3,548 5,300 2,173 7,473 (231) 10,790
Cost: income ratio excluding litigation and
conduct 57% 66% 53% 62% n/m 63%
Profit before tax
Profit/(loss) before tax 1,062 1,714 627 2,341 (389) 3,014
Impact of litigation and conduct 44 26 4 30 40 114
Profit/(loss) before tax excluding litigation and
conduct 1,106 1,740 631 2,371 (349) 3,128
Profit attributable to ordinary equity holders of
the parent
Attributable profit/(loss) 750 1,178 442 1,620 (298) 2,072
Post-tax impact of litigation and conduct 32 21 3 24 30 86
Profit/(loss) attributable to ordinary equity
holders of the parent excluding litigation and
conduct
782 1,199 445 1,644 (268) 2,158
Return on average tangible shareholders'
equity £bn £bn £bn £bn £bn £bn
Average shareholders' equity 13.9 25.5 6.4 31.9 7.9 53.7
Average goodwill and intangibles (3.6) - (1.1) (1.1) (3.3) (8.0)
Average tangible shareholders' equity 10.3 25.5 5.3 30.8 4.6 45.7
Return on average tangible shareholders'
equity excluding litigation and conduct 15.1% 9.4% 16.7% 10.7% n/m 9.4%
Basic earnings per ordinary share
Basic weighted average number of shares (m) 17,178
Basic earnings per ordinary share excluding
litigation and conduct 12.6p
Pre-provision profits
Profit before tax excluding credit impairment
charges and litigation and conduct £m
Profit before tax 3,014
Impact of credit impairment charges 928
Profit before tax excluding credit impairment
charges 3,942
Impact of litigation and conduct 114
Profit before tax excluding credit impairment
charges and litigation and conduct 4,056

-- 93 of 120 --

Appendix: Non-IFRS Performance Measures
91
Barclays Group
Q220 Q120 Q419 Q319 Q219 Q119 Q418 Q318
Cost: income ratio £m £m £m £m £m £m £m £m
Total operating expenses (3,330) (3,263) (3,701) (4,861) (3,554) (3,318) (4,093) (3,434)
Impact of litigation and conduct 20 10 167 1,568 53 61 60 105
Operating expenses (3,310) (3,253) (3,534) (3,293) (3,501) (3,257) (4,033) (3,329)
Total income 5,338 6,283 5,301 5,541 5,538 5,252 5,073 5,129
Cost: income ratio excluding litigation and
conduct 62% 52% 67% 59% 63% 62% 79% 65%
Profit before tax
Profit before tax 359 913 1,097 246 1,531 1,483 374 1,461
Impact of litigation and conduct 20 10 167 1,568 53 61 60 105
Profit before tax excluding litigation and
conduct 379 923 1,264 1,814 1,584 1,544 434 1,566
Profit attributable to ordinary equity holders
of the parent
Attributable profit/(loss) 90 605 681 (292) 1,034 1,038 (14) 1,050
Post-tax impact of litigation and conduct 16 (1) 122 1,525 40 46 62 85
Profit attributable to ordinary equity holders
of the parent excluding litigation and conduct 106 604 803 1,233 1,074 1,084 48 1,135
Return on average tangible shareholders'
equity £bn £bn £bn £bn £bn £bn £bn £bn
Average shareholders' equity 58.4 55.2 54.5 56.4 54.0 53.2 52.2 52.5
Average goodwill and intangibles (8.2) (8.2) (8.1) (8.0) (7.8) (8.0) (7.9) (7.9)
Average tangible shareholders' equity 50.2 47.0 46.4 48.4 46.2 45.2 44.3 44.6
Return on average tangible shareholders'
equity excluding litigation and conduct 0.8% 5.1% 6.9% 10.2% 9.3% 9.6% 0.4% 10.2%
Basic earnings per ordinary share
Basic weighted average number of shares (m) 17,294 17,278 17,200 17,192 17,178 17,111 17,075 17,074
Basic earnings per ordinary share excluding
litigation and conduct 0.6p 3.5p 4.7p 7.2p 6.3p 6.3p 0.3p 6.6p
Pre-provision profits
Profit before tax excluding credit impairment
charges and litigation and conduct Q220 Q120 Q419 Q319 Q219 Q119 Q418 Q318
£m £m £m £m £m £m £m £m
Profit before tax 359 913 1,097 246 1,531 1,483 374 1,461
Impact of credit impairment charges 1,623 2,115 523 461 480 448 643 254
Profit before tax excluding credit impairment
charges 1,982 3,028 1,620 707 2,011 1,931 1,017 1,715
Impact of litigation and conduct 20 10 167 1,568 53 61 60 105
Profit before tax excluding credit impairment
charges and litigation and conduct 2,002 3,038 1,787 2,275 2,064 1,992 1,077 1,820

-- 94 of 120 --

Appendix: Non-IFRS Performance Measures
92
Barclays UK
Q220 Q120 Q419 Q319 Q219 Q119 Q418 Q318
Cost: income ratio £m £m £m £m £m £m £m £m
Total operating expenses (1,024) (1,028) (1,122) (2,432) (1,063) (1,002) (1,175) (1,042)
Impact of litigation and conduct 6 5 58 1,480 41 3 15 54
Operating expenses (1,018) (1,023) (1,064) (952) (1,022) (999) (1,160) (988)
Total income 1,467 1,704 1,959 1,846 1,771 1,777 1,863 1,896
Cost: income ratio excluding litigation and
conduct 69% 60% 54% 52% 58% 56% 62% 52%
Profit before tax
(Loss)/profit before tax (127) 195 647 (687) 477 585 390 740
Impact of litigation and conduct 6 5 58 1,480 41 3 15 54
(Loss)/profit before tax excluding litigation and
conduct (121) 200 705 793 518 588 405 794
Profit attributable to ordinary equity holders
of the parent
Attributable (loss)/profit (123) 175 438 (907) 328 422 241 510
Post-tax impact of litigation and conduct 5 3 43 1,457 30 2 12 48
(Loss)/profit attributable to ordinary equity
holders of the parent excluding litigation and
conduct
(118) 178 481 550 358 424 253 558
Return on average allocated tangible equity £bn £bn £bn £bn £bn £bn £bn £bn
Average allocated equity 13.9 13.7 13.8 13.9 13.8 13.9 13.6 13.7
Average goodwill and intangibles (3.6) (3.6) (3.5) (3.5) (3.5) (3.5) (3.5) (3.6)
Average allocated tangible equity 10.3 10.1 10.3 10.4 10.3 10.4 10.1 10.1
Return on average allocated tangible equity
excluding litigation and conduct (4.6%) 7.0% 18.7% 21.2% 13.9% 16.4% 10.1% 22.0%

-- 95 of 120 --

Appendix: Non-IFRS Performance Measures
93
Barclays International
Q220 Q120 Q419 Q319 Q219 Q119 Q418 Q318
Cost: income ratio £m £m £m £m £m £m £m £m
Total operating expenses (2,197) (2,219) (2,500) (2,282) (2,446) (2,225) (2,684) (2,309)
Impact of litigation and conduct 11 - 86 - 11 19 33 32
Operating expenses (2,186) (2,219) (2,414) (2,282) (2,435) (2,206) (2,651) (2,277)
Total income 4,010 4,644 3,452 3,750 3,903 3,570 3,221 3,290
Cost: income ratio excluding litigation and
conduct 55% 48% 70% 61% 62% 62% 82% 69%
Profit before tax
Profit before tax 807 822 640 1,137 1,223 1,118 215 850
Impact of litigation and conduct 11 - 86 - 11 19 33 32
Profit before tax excluding litigation and conduct 818 822 726 1,137 1,234 1,137 248 882
Profit attributable to ordinary equity holders of
the parent
Attributable profit/(loss) 468 529 397 799 832 788 (21) 687
Post-tax impact of litigation and conduct 8 - 64 2 8 16 34 26
Profit attributable to ordinary equity holders of
the parent excluding litigation and conduct 476 529 461 801 840 804 13 713
Return on average allocated tangible equity £bn £bn £bn £bn £bn £bn £bn £bn
Average allocated equity 34.2 31.9 31.9 33.3 32.1 31.6 32.4 32.5
Average goodwill and intangibles (0.7) (0.7) (1.0) (1.1) (1.0) (1.1) (1.1) (1.3)
Average allocated tangible equity 33.5 31.2 30.9 32.2 31.1 30.5 31.3 31.1
Return on average allocated tangible equity
excluding litigation and conduct 5.7% 6.8% 6.0% 10.0% 10.8% 10.6% 0.2% 9.2%

-- 96 of 120 --

Appendix: Non-IFRS Performance Measures
94
Corporate and Investment Bank
Q220 Q120 Q419 Q319 Q219 Q119 Q418 Q318
Cost: income ratio £m £m £m £m £m £m £m £m
Total operating expenses (1,683) (1,690) (1,926) (1,716) (1,867) (1,638) (2,046) (1,744)
Impact of litigation and conduct 3 - 79 4 7 19 23 32
Operating expenses (1,680) (1,690) (1,847) (1,712) (1,860) (1,619) (2,023) (1,712)
Total income 3,316 3,617 2,314 2,617 2,795 2,505 2,151 2,235
Cost: income ratio excluding litigation and
conduct 51% 47% 80% 65% 67% 65% 94% 77%
Profit before tax
Profit before tax 1,040 1,203 359 882 887 827 85 498
Impact of litigation and conduct 3 - 79 4 7 19 23 32
Profit before tax excluding litigation and conduct 1,043 1,203 438 886 894 846 108 530
Profit attributable to ordinary equity holders of
the parent
Attributable profit/(loss) 694 820 193 609 596 582 (84) 431
Post-tax impact of litigation and conduct 2 - 58 5 5 16 27 25
Profit/(loss) attributable to ordinary equity
holders of the parent excluding litigation and
conduct
696 820 251 614 601 598 (57) 456
Return on average allocated tangible equity £bn £bn £bn £bn £bn £bn £bn £bn
Average allocated equity 29.1 26.2 25.9 26.9 25.8 25.2 26.0 26.2
Average goodwill and intangibles (0.1) - (0.1) - - (0.1) - (0.2)
Average allocated tangible equity 29.0 26.2 25.8 26.9 25.8 25.1 26.0 25.9
Return on average allocated tangible equity
excluding litigation and conduct 9.6% 12.5% 3.9% 9.2% 9.3% 9.5% (0.9%) 7.0%

-- 97 of 120 --

Appendix: Non-IFRS Performance Measures
95
Consumer, Cards and Payments
Q220 Q120 Q419 Q319 Q219 Q119 Q418 Q318
Cost: income ratio £m £m £m £m £m £m £m £m
Total operating expenses (514) (529) (574) (566) (579) (587) (638) (565)
Impact of litigation and conduct 8 - 7 (4) 4 - 10 -
Operating expenses (506) (529) (567) (570) (575) (587) (628) (565)
Total income 694 1,027 1,138 1,133 1,108 1,065 1,070 1,055
Cost: income ratio excluding litigation and
conduct 73% 52% 50% 50% 52% 55% 59% 54%
Profit before tax
(Loss)/profit before tax (233) (381) 281 255 336 291 130 352
Impact of litigation and conduct 8 - 7 (4) 4 - 10 -
(Loss)/profit before tax excluding litigation and
conduct (225) (381) 288 251 340 291 140 352
Profit attributable to ordinary equity holders of
the parent
Attributable (loss)/profit (226) (291) 204 190 236 206 63 256
Post-tax impact of litigation and conduct 6 - 6 (3) 3 - 7 1
(Loss)/profit attributable to ordinary equity
holders of the parent excluding litigation and
conduct
(220) (291) 210 187 239 206 70 257
Return on average allocated tangible equity £bn £bn £bn £bn £bn £bn £bn £bn
Average allocated equity 5.1 5.7 6.0 6.4 6.3 6.4 6.4 6.3
Average goodwill and intangibles (0.6) (0.7) (0.9) (1.1) (1.0) (1.0) (1.1) (1.1)
Average allocated tangible equity 4.5 5.0 5.1 5.3 5.3 5.4 5.3 5.2
Return on average allocated tangible equity
excluding litigation and conduct (19.6%) (23.5%) 16.3% 14.0% 18.0% 15.4% 5.4% 19.9%

-- 98 of 120 --

Appendix: Non-IFRS Performance Measures
96
Head Office
Q220 Q120 Q419 Q319 Q219 Q119 Q418 Q318
Profit before tax £m £m £m £m £m £m £m £m
Loss before tax (321) (104) (190) (204) (169) (220) (231) (129)
Impact of litigation and conduct 3 5 23 88 1 39 12 19
Loss before tax excluding litigation and conduct (318) (99) (167) (116) (168) (181) (219) (110)
Profit attributable to ordinary equity holders of
the parent
Attributable loss (255) (99) (154) (184) (126) (172) (234) (147)
Post-tax impact of litigation and conduct 3 (4) 15 66 2 28 16 11
Attributable loss excluding litigation and conduct (252) (103) (139) (118) (124) (144) (218) (136)
Tangible net asset value per share As at As at As at
30.06.20 31.12.19 31.06.19
£m £m £m
Total equity excluding non-controlling interests 68,304 64,429 67,576
Other equity instruments (10,871) (10,871) (12,123)
Shareholders' equity attributable to ordinary shareholders of the parent 57,433 53,558 55,453
Goodwill and intangibles (8,163) (8,119) (7,993)
Tangible shareholders' equity attributable to ordinary shareholders of the parent 49,270 45,439 47,460
m m m
Shares in issue 17,345 17,322 17,245
p p p
Net asset value per share 331 309 322
Tangible net asset value per share 284 262 275

-- 99 of 120 --

Appendix: Non-IFRS Performance Measures
97
Profit/(loss) attributable to ordinary
equity holders of the parent
H120 H119 Q220 Q120 Q419 Q319 Q219 Q119 Q418 Q318
£m £m £m £m £m £m £m £m £m £m
Barclays UK 52 750 (123) 175 438 (907) 328 422 241 510
Corporate and Investment Bank 1,514 1,178 694 820 193 609 596 582 (84) 431
Consumer, Cards and Payments (517) 442 (226) (291) 204 190 236 206 63 256
Barclays International 997 1,620 468 529 397 799 832 788 (21) 687
Head Office (354) (298) (255) (99) (154) (184) (126) (172) (234) (147)
Barclays Group 695 2,072 90 605 681 (292) 1,034 1,038 (14) 1,050
Average equity
H120 H119 Q220 Q120 Q419 Q319 Q219 Q119 Q418 Q318
£bn £bn £bn £bn £bn £bn £bn £bn £bn £bn
Barclays UK 13.8 13.9 13.9 13.7 13.8 13.9 13.8 13.9 13.6 13.7
Corporate and Investment Bank 27.7 25.5 29.1 26.2 25.9 26.9 25.8 25.2 26.0 26.2
Consumer, Cards and Payments 5.4 6.4 5.1 5.7 6.0 6.4 6.3 6.4 6.4 6.3
Barclays International 33.1 31.9 34.2 31.9 31.9 33.3 32.1 31.6 32.4 32.5
Head Office 9.9 7.9 10.3 9.6 8.8 9.2 8.1 7.7 6.2 6.4
Barclays Group 56.8 53.7 58.4 55.2 54.5 56.4 54.0 53.2 52.2 52.5
Return on average equity
H120 H119 Q220 Q120 Q419 Q319 Q219 Q119 Q418 Q318
% % % % % % % % % %
Barclays UK 0.8% 10.8% (3.6%) 5.1% 12.7% (26.1%) 9.5% 12.2% 7.1% 14.9%
Corporate and Investment Bank 10.9% 9.2% 9.5% 12.5% 3.0% 9.1% 9.2% 9.3% (1.3%) 6.6%
Consumer, Cards and Payments (19.2%) 13.8% (17.7%) (20.7%) 13.6% 11.8% 14.9% 12.8% 3.9% 16.3%
Barclays International 6.0% 10.2% 5.5% 6.6% 5.0% 9.6% 10.3% 10.0% (0.3%) 8.5%
Head Office n/m n/m n/m n/m n/m n/m n/m n/m n/m n/m
Barclays Group 2.5% 7.7% 0.6% 4.4% 5.0% (2.1%) 7.6% 7.8% (0.1%) 8.0%

-- 100 of 120 --

Shareholder Information
98
Results timetable1 Date
Q320 Results Announcement 23 October 2020
% Change3
Exchange rates2 30.06.20 31.12.19 30.06.19 31.12.19 30.06.19
Period end - USD/GBP 1.24 1.33 1.27 (7%) (2%)
6 month average - USD/GBP 1.26 1.26 1.29 - (2%)
3 month average - USD/GBP 1.24 1.29 1.29 (4%) (4%)
Period end - EUR/GBP 1.10 1.18 1.12 (7%) (2%)
6 month average - USD/GBP 1.14 1.14 1.15 - (1%)
3 month average - EUR/GBP 1.13 1.16 1.14 (3%) (1%)
Share price data
Barclays PLC (p) 114.42 179.64 149.80
Barclays PLC number of shares (m) 17,345 17,322 17,245
For further information please contact
Investor relations Media relations
Chris Manners +44 (0) 20 7773 2136 Tom Hoskin +44 (0) 20 7116 4755
More information on Barclays can be found on our website: home.barclays.
Registered office
1 Churchill Place, London, E14 5HP, United Kingdom. Tel: +44 (0) 20 7116 1000. Company number: 48839.
Registrar
Equiniti, Aspect House, Spencer Road, Lancing, West Sussex, BN99 6DA, United Kingdom.
Tel: 0371 384 20554 from the UK or +44 121 415 7004 from overseas.
American Depositary Receipts (ADRs)
J.P.Morgan Chase Bank, N.A
StockTransfer@equiniti.com
Tel: +1 800 990 1135 (toll free in US and Canada), +1 651 453 2128 (outside the US and Canada) or +1 866 700 1652 (for the hearing
impaired).
J.P.Morgan Chase Bank N.A., Shareowner Services, PO Box 64504, St Paul, MN 55164-0504, USA.
Delivery of ADR certificates and overnight mail
J.P.Morgan Chase Bank N.A., Shareowner Services, 1110 Centre Pointe Curve, Suite 101, Mendota Heights, MN 55120, USA.
1 Note that these dates are provisional and subject to change.
2 The average rates shown above are derived from daily spot rates during the year.
3 The change is the impact to GBP reported information.
4 Lines open 8.30am to 5.30pm (UK time), Monday to Friday, excluding UK public holidays in England and Wales.

-- 101 of 120 --

Glossary of Terms
99
‘A-IRB’ / ‘Advanced-Internal Ratings Based’ See ‘Internal Ratings Based (IRB)’.
‘Acceptances and endorsements’ An acceptance is an undertaking by a bank to pay a bill of exchange drawn on a customer. The
Barclays Group expects most acceptances to be presented, but reimbursement by the customer is normally immediate.
Endorsements are residual liabilities of the Barclays Group in respect of bills of exchange which have been paid and subsequently
rediscounted.
‘Additional Tier 1 (AT1) capital’ AT1 capital largely comprises eligible non-common equity capital securities and any related share
premium.
‘Additional Tier 1 (AT1) securities’ Non-common equity securities that are eligible as AT1 capital.
‘Advanced Measurement Approach (AMA)’ Under the AMA, banks are allowed to develop their own empirical model to quantify
required capital for operational risk. Banks can only use this approach subject to approval from their local regulators.
‘Agencies’ Bonds issued by state and / or government agencies or government-sponsored entities.
‘Agency Mortgage-Backed Securities’ Mortgage-Backed Securities issued by government-sponsored entities.
‘All price risk (APR)’ An estimate of all the material market risks, including rating migration and default for the correlation trading
portfolio.
‘American Depository Receipts (ADR)’ A negotiable certificate that represents the ownership of shares in a non-US company (for
example Barclays) trading in US financial markets.
‘Americas’ Geographic segment comprising the US, Canada and countries where Barclays operates within Latin America.
‘Annual Earnings at Risk (AEaR)’ A measure of the potential change in Net Interest Income (NII) due to an interest rate movement
over a one-year period.
‘Annualised cumulative weighted average lifetime PD’ The probability of default over the remaining life of the asset, expressed as
an annual rate, reflecting a range of possible economic scenarios.
‘Application scorecards’ Algorithm based decision tools used to aid business decisions and manage credit risk based on available
customer data at the point of application for a product.
‘Arrears’ Customers are said to be in arrears when they are behind in fulfilling their obligations with the result that an outstanding
loan is unpaid or overdue. Such customers are also said to be in a state of delinquency. When a customer is in arrears, their entire
outstanding balance is said to be delinquent, meaning that delinquent balances are the total outstanding loans on which payments
are overdue.
‘Asia’ Geographic segment comprising countries where Barclays operates within Asia and the Middle East.
‘Asset Backed Commercial Paper’ Typically short-term notes secured on specified assets issued by consolidated special purpose
entities for funding purposes.
‘Asset Backed Securities (ABS)’ Securities that represent an interest in an underlying pool of referenced assets. The referenced pool
can comprise any assets which attract a set of associated cash flows but are commonly pools of residential or commercial
mortgages and, in the case of Collateralised Debt Obligations (CDOs), the referenced pool may be ABS or other classes of assets.
‘Attributable profit’ Profit after tax that is attributable to ordinary equity holders of Barclays adjusted for the after tax amounts of
capital securities classified as equity.
‘Average allocated tangible equity’ Calculated as the average of the previous month’s period end allocated tangible equity and the
current month’s period end allocated tangible equity. The average allocated tangible equity for the period is the average of the
monthly averages within that period.
‘Average tangible shareholders’ equity’ Calculated as the average of the previous month’s period end tangible equity and the
current month’s period end tangible equity. The average tangible shareholders’ equity for the period is the average of the monthly
averages within that period.
‘Average UK leverage ratio’ As per the PRA rulebook, is calculated as the average capital measure based on the last day of each
month in the quarter divided by the average exposure measure for the quarter, where the average exposure is based on each day
in the quarter.
‘Back testing’ Includes a number of techniques that assess the continued statistical validity of a model by simulating how the model
would have predicted recent experience.
‘Barclays Africa’ or ‘Absa’ Barclays Africa Group Limited (now Absa Group Limited), which was previously a subsidiary of the
Barclays Group. Following a sell down of shares resulting in a loss of control, the Barclays Group’s shareholding in Absa Group
Limited is now classified as a financial asset at fair value through other comprehensive income.
‘Balance weighted Loan to Value (LTV) ratio’ In the context of the credit risk disclosures on secured home loans, a means of
calculating marked to market LTVs derived by calculating individual LTVs at account level and weighting it by the balances to arrive

-- 102 of 120 --

Glossary of Terms
100
at the average position. Balance weighted loan to value is calculated using the following formula: LTV = ((loan balance 1 x MTM
LTV% for loan 1) + (loan balance 2 x MTM LTV% for loan 2) + ...) / total outstandings in portfolio.
‘Barclaycard’ An international consumer payments business serving the needs of businesses and consumers through credit cards,
consumer lending, merchant acquiring, commercial cards and point of sale finance. Barclaycard has scaled operations in the UK, US,
Germany and Scandinavia.
‘Barclaycard Consumer UK’ The UK Barclaycard business.
‘Barclays’ or ’Barclays Group’ Barclays PLC, together with its subsidiaries.
‘Barclays Bank Group’ Barclays Bank PLC, together with its subsidiaries.
‘Barclays Bank UK Group’ Barclays Bank UK PLC, together with its subsidiaries.
‘Barclays Operating businesses’ The core Barclays businesses operated by Barclays UK (which include the UK Personal banking; UK
business banking and the Barclaycard consumer UK businesses) and Barclays International (the large UK Corporate business; the
international Corporate and Private Bank businesses; the Investment Bank; the international Barclaycard business; and payments).
‘Barclays Execution Services’ or ‘BX’ or ‘BSerL’ or ‘Group Service Company’ Barclays Execution Services Limited, the Group services
company set up to provide services to Barclays UK and Barclays International to deliver operational continuity.
‘Barclays International’ The segment of Barclays held by Barclays Bank PLC. The division includes the large UK Corporate business;
the international Corporate and Private Bank businesses; the Investment Bank; the international Barclaycard business; and
payments.
‘Barclays UK’ The segment of Barclays held by Barclays Bank UK PLC. The division includes the UK Personal banking; UK business
banking and the Barclaycard consumer UK businesses.
‘Basel 3’ The third of the Basel Accords, setting minimum requirements and standards that apply to internationally active banks.
Basel 3 is a set of measures developed by the Basel Committee on Banking Supervision aiming to strengthen the regulation,
supervision and risk management of banks.
‘Basel Committee of Banking Supervision (BCBS or The Basel Committee)’ A forum for regular cooperation on banking supervisory
matters which develops global supervisory standards for the banking industry. Its 45 members are officials from central banks or
prudential supervisors from 28 jurisdictions.
‘Basic Indicator Approach (BIA)’ Under the BIA, banks are required to hold regulatory capital for operational risk equal to 15% of the
annual average, calculated over a rolling three-year period, of the relevant income indicator for the bank as whole.
‘Basis point(s)’ / ‘bp(s)’ One hundredth of a per cent (0.01%); 100 basis points is 1%. The measure is used in quoting movements in
interest rates, yields on securities and for other purposes.
‘Basis risk’ Index/Tenor risk, that arises when floating rate products are linked to different interest rate indices, which are
imperfectly correlated, especially under stressed market conditions.
‘Behavioural scorecards’ Algorithm based decision tools used to aid business decisions and manage credit risk based on existing
customer data derived from account usage.
‘Book quality’ In the context of the Capital Risk section, changes in RWAs caused by factors such as underlying customer behaviour
or demographics leading to changes in risk profile.
‘Book size’ In the context of the Capital Risk section, changes in RWAs driven by business activity, including net originations or
repayments.
‘Bounce Back Loan Scheme (BBLS)’ A government (British Business Bank) backed loan scheme which allows small and medium-sized
businesses to borrow between £2,000 and £50,000. The UK government guarantees 100% of the loan and pays the first 12 months
of interest on behalf of the borrowers, subject to terms and conditions.
‘Business Banking’ Offers specialist advice, products and services to small and medium enterprises in the UK.
‘Business Lending’ Business Lending in Barclays UK that primarily relates to small and medium enterprises typically with a turnover
up to £16m.
‘Business scenario stresses’ Multi asset scenario analysis of extreme, but plausible events that may impact the market risk
exposures of the Investment Bank.
‘Buy to let mortgage’ A mortgage where the intention of the customer (investor) was to let the property at origination.
‘Capital Conservation Buffer (CCB)’ A capital buffer of 2.5% of a bank’s total exposures that needs to be met with an additional
amount of Common Equity Tier 1 capital above the 4.5% minimum requirement for Common Equity Tier 1 set out in CRR. Its
objective is to conserve a bank’s capital by ensuring that banks build up surplus capital outside periods of stress which can be
drawn down if losses are incurred.

-- 103 of 120 --

Glossary of Terms
101
‘Capital ratios’ Key financial ratios measuring the Bank's capital adequacy or financial strength expressed as a percentage of RWAs.
‘Capital Requirements Directive (CRD)’ Directive 2013/36/EU, a component of the CRD IV package which accompanies the Capital
Requirements Regulation and sets out macroprudential standards including the countercyclical capital buffer and capital buffers for
systemically important institutions. Directive (EU) 2019/878, published as part of the EU Risk Reduction Measure package amends
CRD. These amendments enter into force from 27 June 2019, with EU member states required to adopt the measures within the
Directive by 28 December 2020.
‘Capital Requirements Regulation (CRR)’ Regulation (EU) No 575/2013, a component of the CRD IV package which accompanies the
Capital Requirements Directive and sets out detailed rules for capital eligibility, the calculation of RWAs, the measurement of
leverage, the management of large exposures and minimum standards for liquidity. Between 27 June 2019 and 28 June 2023, this
regulation will be amended in line with the requirements of amending Regulation (EU) 2019/876 (CRR II).
‘Capital Requirements Regulation II (CRR II)’ Regulation (EU) 2019/876, amending Regulation (EU) No 575/2013 (CRR). This is a
component of the EU Risk Reduction Measure package. The requirements set out in CRR II will be introduced between 27 June
2019 and 28 June 2023.
‘Capital requirements on the underlying exposures (KIRB)’ An approach available to banks when calculating RWAs for securitisation
exposures. This is based upon the RWA amounts that would be calculated under the IRB approach for the underlying pool of
securitised exposures in the program, had such exposures not been securitised.
‘Capital resources’ Common Equity Tier 1, Additional Tier 1 and Tier 2 capital that are eligible to satisfy capital requirements under
CRD. Referred to as ‘own funds’ within EU regulatory texts.
‘Capital risk’ The risk that the Barclays Group has an insufficient level or composition of capital to support its normal business
activities and to meet its regulatory capital requirements under normal operating environments or stressed conditions (both actual
and as defined for internal planning or regulatory testing purposes). This includes the risk from the Barclays Group’s pension plans.
‘Central Counterparty’ / ‘Central Clearing Counterparties (CCPs)’ A clearing house mediating between the buyer and the seller in a
financial transaction, such as a derivative contract or repurchase agreement (repo). Where a central counterparty is used, a single
bi-lateral contract between the buyer and seller is replaced with two contracts, one between the buyer and the CCP and one
between the CCP and the seller. The use of CCPs allows for greater oversight and improved credit risk mitigation in over-the-
counter (OTC) markets.
‘Charge-off’ In the retail segment this refers to the point in time when collections activity changes from the collection of arrears to
the recovery of the full balance. This is normally when six payments are in arrears.
‘Client Assets’ Assets managed or administered by Barclays Group on behalf of clients including assets under management (AUM),
custody assets, assets under administration and client deposits.
‘CLOs and Other insured assets’ Highly rated CLO positions wrapped by monolines, non-CLOs wrapped by monolines and other
assets wrapped with Credit Support Annex (CSA) protection.
‘Collateralised Debt Obligation (CDO)’ Securities issued by a third party which reference Asset Backed Securities (ABSs) (defined
above) and/or certain other related assets purchased by the issuer. CDOs may feature exposure to sub-prime mortgage assets
through the underlying assets.
‘Collateralised Loan Obligation (CLO)’ A security backed by the repayments from a pool of commercial loans. The payments may be
made to different classes of owners (in tranches).
‘Collateralised Mortgage Obligation (CMO)’ A type of security backed by mortgages. A special purpose entity receives income from
the mortgages and passes them on to investors of the security.
‘Combined Buffer Requirement’ In the context of the CRD capital obligations, the combined requirements of the Capital
Conservation Buffer, the GSII Buffer, the OSII buffer, the Systemic Risk buffer and an institution specific counter-cyclical buffer.
‘Commercial paper (CP)’ Short-term notes issued by entities, including banks, for funding purposes.
‘Commercial real estate (CRE)’ Commercial real estate includes office buildings, industrial property, medical centres, hotels, retail
stores, shopping centres, farm land, multifamily housing buildings, warehouses, garages, and industrial properties and other similar
properties. Commercial real estate loans are loans backed by a package of commercial real estate. Note: for the purposes of the
Credit Risk section, the UK CRE portfolio includes property investment, development, trading and housebuilders but excludes social
housing contractors.
‘Commissions and other incentives’ Includes commission-based arrangements, guaranteed incentives and Long Term Incentive Plan
awards.
‘Committee of Sponsoring Organisations of the Treadway Commission Framework (COSO)’ A joint initiative of five private sector
organisations dedicated to the development of frameworks and providing guidance on enterprise risk management, internal
control and fraud deterrence.

-- 104 of 120 --

Glossary of Terms
102
‘Commodity derivatives’ Exchange traded and over-the-counter (OTC) derivatives based on an underlying commodity (e.g. metals,
precious metals, oil and oil related, power and natural gas).
‘Commodity risk’ Measures the impact of changes in commodity prices and volatilities, including the basis between related
commodities (e.g. Brent vs. WTI crude prices).
‘Common Equity Tier 1 (CET1) capital’ The highest quality form of regulatory capital under CRR that comprises common shares
issued and related share premium, retained earnings and other reserves, less specified regulatory adjustments.
‘Common Equity Tier 1 (CET1) ratio’ A measure of Common Equity Tier 1 capital expressed as a percentage of RWAs.
‘Compensation: income ratio’ The ratio of compensation expense over total income. Compensation represents total staff costs less
non-compensation items consisting of outsourcing, staff training, redundancy costs and retirement costs.
‘Comprehensive Capital Analysis and Review (CCAR)’ An annual exercise, required by and evaluated by the Federal Reserve,
through which the largest bank holding companies operating in the US assess whether they have sufficient capital to continue
operations through periods of economic and financial stress and have robust capital-planning processes that account for their
unique risks.
‘Comprehensive Risk Measure (CRM)’ An estimate of all the material market risks, including rating migration and default for the
correlation trading portfolio. Also referred to as All Price Risk (APR) and Comprehensive Risk Capital Charge (CRCC).
‘Conduct risk’ The risk of detriment to customers, clients, market integrity, competition or Barclays from the inappropriate supply
of financial services, including instances of wilful or negligent misconduct.
‘Constant Currency Basis’ Excluding the impact of foreign currency conversion to GBP when comparing financial results in two
different financial periods.
‘Consumer, Cards and Payments’ Barclays US Consumer Bank, Barclaycard Germany, Barclays Partner Finance, Barclaycard
Commercial Payments, Barclaycard Payment Solutions (including merchant acquiring) and the international Wealth business.
‘Contingent capital notes (CCNs)’ Interest bearing debt securities issued by Barclays Group or its subsidiaries that are either
permanently written off or converted into an equity instrument from the issuer's perspective in the event of the Common Equity
Tier 1 (CET1) ratio of the relevant Barclays Group entity falling below a specific level, or at the direction of regulators.
‘Conversion Trigger’ Used in the context of Contingent Capital Notes and AT1 securities. A capital adequacy trigger event occurs
when the CET1 ratio of the bank falls below a certain level (the trigger) as defined in the Terms & Conditions of the instruments
issued. See ‘Contingent capital notes’.
‘Coronavirus Business Interruption Loan Scheme (CBILS)’ A loan scheme by the British Business Bank (BBB) to support UK based
small and medium-sized businesses (turnover of up to £45 million) adversely impacted by COVID-19, . The CBILS scheme provides
loans up to £5 million which are backed by an 80% government (BBB) guarantee. The UK government will pay interest and fees for
the first 12 months on behalf of the borrowers, subject to terms and conditions.
Coronavirus Large Business Interruption Loan Scheme (CLBILS)’ A loan scheme by the British Business Bank (BBB) to support UK
based medium-sized businesses (turnover above £45 million, but with no access to CCFF) adversely impacted by COVID-19, The
CBILS scheme provides loans up to £50 million which are backed by an 80% government (BBB) guarantee. ‘Corporate and
Investment Bank (CIB)’ Barclays Corporate and Investment Bank businesses which form part of Barclays International.
‘Correlation risk’ Refers to the change in marked to market value of a security when the correlation between the underlying assets
changes over time.
‘Cost: income ratio’ Total operating expenses divided by total income.
‘Cost of Equity’ The rate of return targeted by the equity holders of a company.
‘Cost: income jaws’ Relationship of the percentage change movement in operating expenses relative to total income.
‘Countercyclical Capital Buffer (CCyB)’ An additional buffer introduced as part of the CRD IV package that requires banks to have an
additional cushion of CET 1 capital with which to absorb potential losses, enhancing their resilience and contributing to a stable
financial system.
‘Countercyclical leverage ratio buffer (CCLB)’ A macroprudential buffer that has applied to specific PRA regulated institutions since
2018 and is calculated at 35% of any risk weighted countercyclical capital buffer set by the Financial Policy Committee (FPC). The
CCLB applies in addition to the minimum of 3.25% and any G-SII additional Leverage Ratio Buffer that applies.
‘Counterparty credit risk’ The risk related to a counterparty defaulting before the final settlement of a transaction’s cash flows. In
the context of RWAs, a component of RWAs that represents the risk of loss in derivatives, repurchase agreements and similar
transactions resulting from the default of the counterparty.
‘Coverage ratio’ This represents the percentage of impairment allowance reserve against the gross exposure.

-- 105 of 120 --

Glossary of Terms
103
‘Covered bonds’ Debt securities backed by a portfolio of mortgages that are segregated from the issuer’s other assets solely for the
benefit of the holders of the covered bonds.
‘Covid Corporate Finance Facility (CCFF)’: Bank of England (BOE) scheme to support liquidity among larger investment grade firms
which make a material UK contribution, helping to bridge coronavirus disruption to their cash flows. The Bank of England provides
liquidity by purchasing short-term debt in the form of commercial paper from corporates. Barclays acts as dealer.
‘CRD IV’ The Fourth Capital Requirements Directive, an EU Directive and an accompanying Regulation (CRR) that together prescribe
EU capital adequacy and liquidity requirements and implements Basel 3 in the European Union.
‘CRD V’ The Fifth Capital Requirements Directive, comprising an EU amending Directive and an accompanying amending Regulation
(CRR II) that together prescribe EU capital adequacy and liquidity requirements and implements enhanced Basel 3 proposals in the
European Union.
‘Credit conversion factor (CCF)’ Factor used to estimate the risk from off-balance sheet commitments for the purpose of calculating
the total Exposure at Default (EAD) used to calculate RWAs.
‘Credit default swaps (CDS)’ A contract under which the protection seller receives premiums or interest-related payments in return
for contracting to make payments to the protection buyer in the event of a defined credit event. Credit events normally include
bankruptcy, payment default on a reference asset or assets, or downgrades by a rating agency.
‘Credit derivatives (CDs)’ An arrangement whereby the credit risk of an asset (the reference asset) is transferred from the buyer to
the seller of the protection.
‘Credit impairment charges’ Also known as ‘credit impairment’. Impairment charges on loans and advances to customers and banks
and impairment charges on fair value through other comprehensive income assets and reverse repurchase agreements.
‘Credit market exposures’ Assets and other instruments relating to commercial real estate and leveraged finance businesses that
have been significantly impacted by the deterioration in the global credit markets. The exposures include positions subject to fair
value movements in the Income Statement, positions that are classified as loans and advances and available for sale and other
assets.
‘Credit quality step’ In the context of the Standardised Approach to calculating credit risk RWAs, a “credit quality assessment scale”
maps the credit assessments of a recognised credit rating agency or export credit agency to credit quality steps that determine the
risk weight to be applied to an exposure.
‘Credit Rating’ An evaluation of the creditworthiness of an entity seeking to enter into a credit agreement.
‘Credit risk’ The risk of loss to Barclays from the failure of clients, customers or counterparties, including sovereigns, to fully honour
their obligations to Barclays, including the whole and timely payment of principal, interest, collateral and other receivables. In the
context of RWAs, it is the component of RWAs that represents the risk of loss in loans and advances and similar transactions
resulting from the default of the counterparty.
‘Credit risk mitigation’ A range of techniques and strategies to actively mitigate credit risks to which the bank is exposed. These can
be broadly divided into three types; collateral, netting and set-off, and risk transfer.
‘Credit spread’ The premium over the benchmark or risk-free rate required by the market to accept a lower credit quality.
‘Credit Valuation Adjustment (CVA)’ The difference between the risk-free value of a portfolio of trades and the market value which
takes into account the counterparty’s risk of default. The CVA therefore represents an estimate of the adjustment to fair value that
a market participant would make to incorporate the credit risk of the counterparty due to any failure to perform on contractual
agreements.
‘CRR leverage exposure’ Is calculated in accordance with article 429 as per the CRR.
‘CRR leverage ratio’ Is calculated using the CRR definition of Tier 1 capital for the numerator and the CRR definition of leverage
exposure as the denominator.
‘Customer assets’ Represents loans and advances to customers. Average balances are calculated as the sum of all daily balances for
the year to date divided by number of days in the year to date.
‘Customer deposits’ In the context of the Liquidity Risk section, money deposited by all individuals and companies that are not
credit institutions. Such funds are recorded as liabilities in the Barclays Group’s balance sheet under deposits at amortised cost.
‘Customer liabilities’ See ‘Customer deposits’.
‘Daily Value at Risk (DVaR)’ An estimate of the potential loss which might arise from market movements under normal market
conditions, if the current positions were to be held unchanged for one business day, measured to a specified confidence level.
‘DBRS’ A credit rating agency.
‘Debit Valuation Adjustment (DVA)’ The opposite of Credit Valuation Adjustment (CVA). It is the difference between the risk-free
value of a portfolio of trades and the market value which takes into account the Barclays Group’s risk of default. The DVA,

-- 106 of 120 --

Glossary of Terms
104
therefore, represents an estimate of the adjustment to fair value that a market participant would make to incorporate the credit
risk of the Barclays Group due to any failure to perform on contractual obligations. The DVA decreases the value of a liability to
take into account a reduction in the remaining balance that would be settled should the Barclays Group default or not perform any
contractual obligations.
‘Debt buybacks’ Purchases of the Barclays Group’s issued debt securities, including equity accounted instruments, leading to their
de-recognition from the balance sheet.
‘Debt securities in issue’ Transferable securities evidencing indebtedness of the Barclays Group. These are liabilities of the Barclays
Group and include certificates of deposit and commercial paper.
‘Default grades’ Barclays Group classify ranges of default probabilities into a set of 21 intervals called default grades, in order to
distinguish differences in the probability of default risk.
‘Default fund contributions’ The amount of contribution made by members of a central counterparty (CCP). All members are
required to contribute to this fund in advance of using a CCP. The default fund can be used by the CCP to cover losses incurred by
the CCP where losses are greater than the margins provided by that member.
‘Derivatives netting’ Adjustments applied across asset and liability mark-to-market derivative positions pursuant to legally
enforceable bilateral netting agreements and eligible cash collateral received in derivative transactions that meet the requirements
of BCBS 270.
‘Diversification effect’ Reflects the fact the risk of a diversified portfolio is smaller than the sum of the risks of its constituent parts.
It is measured as the sum of the individual asset class DVaR estimates less the total DVaR.
‘Dodd-Frank Act (DFA)’ The US Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010.
‘Economic Value of Equity (EVE)’ A measure of the potential change in value of expected future cash flows due to an adverse
interest rate movement, based on existing balance sheet run-off profile.
'Effective Expected Positive Exposure (EEPE)' The weighted average over time of effective expected exposure. The weights are the
proportion that an individual exposure represents of the entire exposure horizon time interval.
‘Eligible liabilities’ Liabilities and capital instruments that are eligible to meet MREL that do not already qualify as own funds.
‘Encumbrance’ The use of assets to secure liabilities, such as by way of a lien or charge.
‘Enterprise Risk Management Framework (ERMF)’ Barclays Group risk management responsibilities are laid out in the Enterprise
Risk Management Framework, which describes how Barclays identifies and manages risk. The framework identifies the principal
risks faced by the Barclays Group; sets out risk appetite requirements; sets out roles and responsibilities for risk management; and
sets out risk committee structure.
‘Equities’ Trading businesses encompassing Cash Equities, Equity Derivatives & Equity Financing
‘Equity and stock index derivatives’ Derivatives whose value is derived from equity securities. This category includes equity and
stock index swaps and options (including warrants, which are equity options listed on an exchange). The Barclays Group also enters
into fund-linked derivatives, being swaps and options whose underlyings include mutual funds, hedge funds, indices and multi-
asset portfolios. An equity swap is an agreement between two parties to exchange periodic payments, based upon a notional
principal amount, with one side paying fixed or floating interest and the other side paying based on the actual return of the stock or
stock index. An equity option provides the buyer with the right, but not the obligation, either to purchase or sell a specified stock,
basket of stocks or stock index at a specified price or level on or before a specified date.
‘Equity risk’ In the context of trading book capital requirements, the risk of change in market value of an equity investment.
‘Equity structural hedge’ An interest rate hedge in place to reduce earnings volatility of the overnight / short term equity
investment and to smoothen the income over a medium/long term.
‘EU Risk Reduction Measure package’ A collection of amending Regulations and Directives that update core EU regulatory texts and
which came into force on 27 June 2019.
‘Euro Interbank Offered Rate (EURIBOR)’ A benchmark interest rate at which banks can borrow funds from other banks in the
European interbank market.
‘Europe’ Geographic segment comprising countries in which Barclays operates within the EU (excluding UK), Northern Continental
and Eastern Europe.
‘European Banking Authority (EBA)’ The European Banking Authority (EBA) is an independent EU Authority which works to ensure
effective and consistent prudential regulation and supervision across the European banking sector. Its overall objectives are to
maintain financial stability in the EU and to safeguard the integrity, efficiency and orderly functioning of the banking sector.

-- 107 of 120 --

Glossary of Terms
105
‘European Securities and Markets Authority (ESMA)’ An independent European Supervisory Authority with the remit of enhancing
the protection of investors and reinforcing stable and well-functioning financial markets in the European Union.
‘Eurozone’ Represents the 19 European Union countries that have adopted the euro as their common currency. The 19 countries
are Austria, Belgium, Cyprus, Estonia, Finland, France, Germany, Greece, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta,
Netherlands, Portugal, Slovakia, Slovenia and Spain.
‘Expected Credit Losses (ECL)’ A present value measure of the credit losses expected to result from default events that may occur
during a specified period of time. ECLs must reflect the present value of cash shortfalls, and must reflect the unbiased and
probability weighted assessment of a range of outcomes.
‘Expected Losses’ A regulatory measure of anticipated losses for exposures captured under an internals ratings based credit risk
approach for capital adequacy calculations. It is measured as the Barclays Group's modelled view of anticipated losses based on
Probability of Default (PD), Loss Given Default (LGD) and Exposure at Default (EAD), with a one-year time horizon.
’Expert lender models’ Models of risk measures that are used for parts of the portfolio where the risk drivers are specific to a
particular counterparty, but where there is insufficient data to support the construction of a statistical model. These models utilise
the knowledge of credit experts that have in depth experience of the specific customer type being modelled.
‘Exposure’ Generally refers to positions or actions taken by the bank, or consequences thereof, that may put a certain amount of a
bank’s resources at risk.
‘Exposure at Default (EAD)’ The estimation of the extent to which Barclays Group may be exposed to a customer or counterparty in
the event of, and at the time of, that counterparty’s default. At default, the customer may not have drawn the loan fully or may
already have repaid some of the principal, so that exposure may be less than the approved loan limit.
‘External Credit Assessment Institutions (ECAI)’ Institutions whose credit assessments may be used by credit institutions for the
determination of risk weight exposures according to CRR.
‘Federal Reserve Board (FRB)’ Is the governing board of the Federal Reserve System of the US, in charge of making the
country's monetary policy.
'FICC' Represents Macro (including rates and currency), Credit and Securitised products.
'Financial Policy Committee (FPC)' The Bank of England’s Financial Policy Committee (FPC) identifies, monitors and takes action to
remove or reduce systemic risks with a view to protecting and enhancing the resilience of the UK financial system. The FPC also has
a secondary objective to support the economic policy of the UK Government.
‘F-IRB’/ 'Foundation-Internal Ratings Based’ See ‘Internal Ratings Based (IRB)’.
‘Financial Conduct Authority (FCA)’ The statutory body responsible for conduct of business regulation and supervision of UK
authorised firms. The FCA also has responsibility for the prudential regulation of firms that do not fall within the PRA’s scope.
‘Financial Services Compensation Scheme (FSCS)’ The UK’s fund for compensation of authorised financial services firms that are
unable to pay claims.
‘Financial collateral comprehensive method (FCCM)’ A counterparty credit risk exposure calculation approach which applies
volatility adjustments to the market value of exposure and collateral when calculating RWA values.
‘Financial Stability Board (FSB)’ An international body that monitors and makes recommendations about the global financial
system. It promotes international financial stability by coordinating national financial authorities and international standard-setting
bodies as they work toward developing strong regulatory, supervisory and other financial sector policies. It fosters a level playing
field by encouraging coherent implementation of these policies across sectors and jurisdictions.
‘Fitch’ A credit rating agency.
‘Forbearance Programmes’ Forbearance programmes to assist customers in financial difficulty through agreements to accept less
than contractual amounts due where financial distress would otherwise prevent satisfactory repayment within the original terms
and conditions of the contract. These agreements may be initiated by the customer, Barclays or a third party and include approved
debt counselling plans, minimum due reductions, interest rate concessions and switches from capital and interest repayments to
interest-only payments.
‘Foreclosures in Progress’ The process by which the bank initiates legal action against a customer with the intention of terminating
a loan agreement whereby the bank may repossess the property subject to local law and recover amounts it is owed.
‘Foreign exchange derivatives’ The Barclays Group’s principal exchange rate-related contracts are forward foreign exchange
contracts, currency swaps and currency options. Forward foreign exchange contracts are agreements to buy or sell a specified
quantity of foreign currency, usually on a specified future date at an agreed rate. Currency swaps generally involves the exchange,
or notional exchange, of equivalent amounts of two currencies and a commitment to exchange interest periodically until the
principal amounts are re-exchanged on a future date. Currency options provide the buyer with the right, but not the obligation,
either to purchase or sell a fixed amount of a currency at a specified exchange rate on or before a future date. As compensation for
assuming the option risk, the option writer generally receives a premium at the start of the option period.

-- 108 of 120 --

Glossary of Terms
106
‘Foreign exchange risk’ In the context of DVaR, the impact of changes in foreign exchange rates and volatilities.
‘Full time equivalent’ Full time equivalent units are the on-job hours paid for employee services divided by the number of ordinary-
time hours normally paid for a full-time staff member when on the job (or contract employees where applicable).
‘Fully loaded’ When a measure is presented or described as being on a fully loaded basis, it is calculated without applying the
transitional provisions set out in Part Ten of CRR.
‘Funded credit protection’ Is a technique of credit risk mitigation where the reduction of the credit risk on the exposure of an
institution derives from the right of that institution, in the event of the default of the counterparty or on the occurrence of other
specified credit events relating to the counterparty, to liquidate, or to obtain transfer or appropriation of, or to retain certain assets
or amounts, or to reduce the amount of the exposure to, or to replace it with, the amount of the difference between the amount of
the exposure and the amount of a claim on the institution.
‘Gains on acquisitions’ The amount by which the acquirer’s interest in the net fair value of the identifiable assets, liabilities and
contingent liabilities, recognised in a business combination, exceeds the cost of the combination.
‘General Data Protection Regulation (GDPR)’ GDPR (Regulation (EU) 2016/679) is a regulation by which the European Parliament,
the Council of the European Union and the European Commission intend to strengthen and unify data protection for all individuals
within the European Union.
‘General market risk’ The risk of a price change in a financial instrument due to a change in level of interest rates or owing to a
broad equity market movement unrelated to any specific attributes of individual securities.
‘Global-Systemically Important Banks (G-SIBs or G-SIIs)’ Global financial institutions whose size, complexity and systemic
interconnectedness, mean that their distress or failure would cause significant disruption to the wider financial system and
economic activity. The Financial Stability Board and the Basel Committee on Banking Supervision publish a list of globally
systemically important banks.
‘G-SII additional leverage ratio buffer (G-SII ALRB)’ A macroprudential buffer that applies to globally systemically important banks
(G-SIBs) and other major domestic UK banks and building societies, including banks that are subject to ring-fencing requirements.
The G-SII ALRB will be calibrated as 35% (on a phased basis) of the combined systemic risk buffers that applies to the bank.
‘GSII Buffer’ Common Equity Tier 1 capital required to be held under CRD to ensure that G-SIBs build up surplus capital to
compensate for the systemic risk that such institutions represent to the financial system.
’Grandfathering’ In the context of capital resources, the phasing in of the application of instrument eligibility rules which allows CRR
and CRR II non-compliant capital instruments to be included in regulatory capital subject to certain thresholds which decrease over
the transitional period.
‘Gross charge-off rates’ Represents the balances charged-off to recoveries in the reporting period, expressed as a percentage of
average outstanding balances excluding balances in recoveries. Charge-off to recoveries generally occurs when the collections focus
switches from the collection of arrears to the recovery of the entire outstanding balance, and represents a fundamental change in
the relationship between the bank and the customer. This is a measure of the proportion of customers that have gone into default
during the period.
‘Gross write-off rates’ Expressed as a percentage and represents balances written off in the reporting period divided by gross loans
and advances held at amortised cost at the balance sheet date.
‘Gross new lending’ New lending advanced to customers during the period.
‘Guarantee’ Unless otherwise described, an undertaking by a third party to pay a creditor should a debtor fail to do so. It is a form
of credit substitution.
‘Head Office’ A division comprising Brand and Marketing, Finance, Head Office, Human Resources, Internal Audit, Legal,
Compliance, Risk, Treasury and Tax and other operations.
‘High-Net-Worth’ Businesses within Barclays UK and Barclays International that provide banking and other services to high net
worth customers.
‘High Risk’ In retail banking, ‘High Risk’ is defined as the subset of up-to-date customers who, either through an event or observed
behaviour exhibit potential financial difficulty. Where appropriate, these customers are proactively contacted to assess whether
assistance is required.
‘Home loan’ A loan to purchase a residential property. The property is then used as collateral to guarantee repayment of the loan.
The borrower gives the lender a lien against the property and the lender can foreclose on the property if the borrower does not
repay the loan per the agreed terms. Also known as a residential mortgage.
‘IHC’ or ‘US IHC’ Barclays US LLC, the intermediate holding company established by Barclays in July 2016, which holds most of
Barclays’ subsidiaries and assets in the US.

-- 109 of 120 --

Glossary of Terms
107
‘IMA’ / 'Internal Model Approach’ In the context of RWAs, RWAs for which the exposure amount has been derived via the use of a
PRA approved internal market risk model.
‘IMM’ / 'Internal Model Method’ In the context of RWAs, RWAs for which the exposure amount has been derived via the use of a
PRA approved internal counterparty credit risk model.
‘Identified Impairment (II)’ Specific impairment allowances for financial assets, individually estimated.
‘IFRS 9 transitional arrangements’ Following the application of IFRS 9 as of 1 January 2018, Article 473a of CRR permits institutions
to phase-in the impact on capital and leverage ratios of the impairment requirements under the new accounting standard.
‘Impairment Allowances’ A provision held on the balance sheet as a result of the raising of a charge against profit for expected
losses in the lending book. An impairment allowance may either be identified or unidentified and individual or collective.
‘Income’ Total income, unless otherwise specified.
‘Incremental Risk Charge (IRC)’ An estimate of the incremental risk arising from rating migrations and defaults for traded debt
instruments beyond what is already captured in specific market risk VaR for the non-correlation trading portfolio.
‘Independent Validation Unit (IVU)’ The function within the bank responsible for independent review, challenge and approval of all
models.
‘Individual liquidity guidance (ILG)’ Guidance given to a bank about the amount, quality and funding profile of liquidity resources
that the PRA has asked the bank to maintain.
‘Inflation risk’ In the context of DVaR, the impact of changes in inflation rates and volatilities on cash instruments and derivatives.
‘Insurance Risk’ The risk of the Barclays Group’s aggregate insurance premiums received from policyholders under a portfolio of
insurance contracts being inadequate to cover the claims arising from those policies.
‘Interchange’ Income paid to a credit card issuer for the clearing and settlement of a sale or cash advance transaction.
‘Interest-only home loans’ Under the terms of these loans, the customer makes payments of interest only for the entire term of the
mortgage, although customers may make early repayments of the principal within the terms of their agreement. The customer is
responsible for repaying the entire outstanding principal on maturity, which may require the sale of the mortgaged property.
‘Interest rate derivatives’ Derivatives linked to interest rates. This category includes interest rate swaps, collars, floors options and
swaptions. An interest rate swap is an agreement between two parties to exchange fixed rate and floating rate interest by means of
periodic payments based upon a notional principal amount and the interest rates defined in the contract. Certain agreements
combine interest rate and foreign currency swap transactions, which may or may not include the exchange of principal amounts. A
basis swap is a form of interest rate swap, in which both parties exchange interest payments based on floating rates, where the
floating rates are based upon different underlying reference indices. In a forward rate agreement, two parties agree a future
settlement of the difference between an agreed rate and a future interest rate, applied to a notional principal amount. The
settlement, which generally occurs at the start of the contract period, is the discounted present value of the payment that would
otherwise be made at the end of that period.
‘Interest rate risk’ The risk of interest rate volatility adversely impacting the Barclays Group’s net interest margin. In the context of
the calculation of market risk DVaR, measures the impact of changes in interest (swap) rates and volatilities on cash instruments
and derivatives.
‘Interest rate risk in the banking book (IRRBB)’ The risk that the Barclays Group is exposed to capital or income volatility because of
a mismatch between the interest rate exposures of its (non-traded) assets and liabilities.
‘Internal Assessment Approach (IAA)’ One of three types of calculation that a bank with permission to use the Internal Ratings
Based (IRB) approach may apply to securitisation exposures. It consists of mapping a bank's internal rating methodology for credit
exposures to those of an External Credit Assessment Institution (ECAI) to determine the appropriate risk weight based on the
ratings based approach. Its applicability is limited to ABCP programmes related to liquidity facilities and credit enhancement.
‘Internal Capital Adequacy Assessment Process (ICAAP)’ Companies are required to perform a formal Internal Capital Adequacy
Assessment Process (ICAAP) as part of the Pillar 2 requirements (BIPRU) and to provide this document to the PRA on a yearly basis.
The ICAAP document summarises the Barclays Group’s risk management framework, including approach to managing all risks (i.e.
Pillar 1 and non-Pillar 1 risks); and, the Barclays Group’s risk appetite, economic capital and stress testing frameworks.
‘Internal Ratings Based (IRB)’ An approach under the CRR framework that relies on the bank’s internal models to derive the risk
weights. The IRB approach is divided into two alternative applications, Advanced and Foundation:
– Advanced IRB (A-IRB): the bank uses its own estimates of probability of default (PD), loss given default (LGD) and credit
conversion factor to model a given risk exposure.
– Foundation IRB: the bank applies its own PD as for Advanced, but it uses standard parameters for the LGD and the credit
conversion factor. The Foundation IRB approach is specifically designed for wholesale credit exposures. Hence retail,
equity, securitisation positions and non-credit obligations asset exposures are treated under standardised or A-IRB.

-- 110 of 120 --

Glossary of Terms
108
‘Investment Bank’ The Barclays Group’s investment bank which consists of origination led and returns focused markets and banking
business which forms part of the Corporate and Investment Bank segment of Barclays International.
‘Investment Banking Fees’ In the context of Investment Bank Analysis of Total Income, fees generated from origination activity
businesses – including financial advisory, debt and equity underwriting.
‘Investment grade’ A debt security, treasury bill or similar instrument with a credit rating of AAA to BBB as measured by external
credit rating agencies.
‘ISDA Master Agreement’ The most commonly used master contract for OTC derivative transactions internationally. It is part of a
framework of documents, designed to enable OTC derivatives to be documented fully and flexibly. The framework consists of a
master agreement, a schedule, confirmations, definition booklets, and a credit support annex. The ISDA master agreement is
published by the International Swaps and Derivatives Association (ISDA).
‘Key Risk Scenarios (KRS)’ Key Risk Scenarios are a summary of the extreme potential risk exposure for each Key Risk in each
business and function, including an assessment of the potential frequency of risk events, the average size of losses and three
extreme scenarios. The Key Risk Scenario assessments are a key input to the Advanced Measurement Approach calculation of
regulatory and economic capital requirements.
‘Large exposure’ A large exposure is defined as the total exposure of a bank to a counterparty or group of connected clients,
whether in the banking book or trading book or both, which in aggregate equals or exceeds 10% of the bank's eligible capital.
‘Legal risk’ The risk of loss or imposition of penalties, damages or fines from the failure of the Barclays Group to meet its legal
obligations including regulatory or contractual requirements.
‘Lending’ In the context of Investment Bank Analysis of Total Income, lending income includes net interest income, gains or losses
on loan sale activity, and risk management activity relating to the loan portfolio.
‘Letters of credit’ A letter typically used for the purposes of international trade guaranteeing that a debtor’s payment to a creditor
will be made on time and in full. In the event that the debtor is unable to make payment, the bank will be required to cover the full
or remaining amount of the purchase.
‘Level 1 assets’ High quality liquid assets under the Basel Committee’s Liquidity Coverage Ratio (LCR), including cash, central bank
reserves and higher quality government securities.
‘Level 2 assets’ Under the Basel Committee’s Liquidity Coverage Ratio high quality liquid assets (HQLA) are comprised of Level 1 and
Level 2 assets, with the latter comprised of Level 2A and Level 2B assets. Level 2A assets include, for example, lower quality
government securities, covered bonds and corporate debt securities. Level 2B assets include, for example, lower rated corporate
bonds, residential mortgage backed securities and equities that meet certain conditions.
‘Lifetime expected credit losses’ An assessment of expected losses associated with default events that may occur during the life of
an exposure, reflecting the present value of cash shortfalls over the remaining expected life of the asset.
‘Lifetime Probability’ The likelihood of accounts entering default during the expected remaining life of the asset.
‘Liquidity Coverage Ratio (LCR)’ The ratio of the stock of high quality liquid assets to expected net cash outflows over the next 30
days. High-quality liquid assets should be unencumbered, liquid in markets during a time of stress and, ideally, be central bank
eligible. These include, for example, cash and claims on central governments and central banks.
‘Liquidity Pool’ The Barclays Group liquidity pool comprises cash at central banks and highly liquid collateral specifically held by the
Barclays Group as a contingency to enable the bank to meet cash outflows in the event of stressed market conditions.
‘Liquidity Risk’ The risk that the Barclays Group is unable to meet its contractual or contingent obligations or that is does not have
the appropriate amount, tenor and composition of funding and liquidity to support its assets.
‘Liquidity risk appetite (LRA)’ The level of liquidity risk that the Barclays Group chooses to take in pursuit of its business objectives
and in meeting its regulatory obligations.
‘Liquidity Risk Management Framework (the Liquidity Framework)’ The Liquidity Risk Management Framework (the Liquidity
Framework), which is sanctioned by the Board Risk Committee (BRC) and which incorporates liquidity policies, systems and controls
that the Barclays Group has implemented to manage liquidity risk within tolerances approved by the Board and regulatory
agencies.
‘Litigation and conduct charges’ or ‘Litigation and conduct’ Litigation and conduct charges include regulatory fines, litigation
settlements and conduct related customer redress.
‘Loan loss rate’ Quoted in basis points and represents total annualised impairment charges divided by gross loans and advances
held at amortised cost at the balance sheet date.
‘Loan to deposit ratio’ Loans and advances at amortised costs divided by deposits at amortised cost.

-- 111 of 120 --

Glossary of Terms
109
‘Loan to value (LTV) ratio’ Expresses the amount borrowed against an asset (i.e. a mortgage) as a percentage of the appraised value
of the asset. The ratios are used in determining the appropriate level of risk for the loan and are generally reported as an average
for new mortgages or an entire portfolio. Also see ‘Marked to market (MTM) LTV ratio.’
‘London Interbank Offered Rate (LIBOR)’ A benchmark interest rate at which banks can borrow funds from other banks in the
London interbank market.
‘Loss Given Default (LGD)’ The percentage of Exposure at Default (EAD) (defined above) that will not be recovered following
default. LGD comprises the actual loss (the part that is not expected to be recovered), together with the economic costs associated
with the recovery process.
‘Management VaR’ A measure of the potential loss of value arising from unfavourable market movements at a specific confidence
level, if current positions were to be held unchanged for predefined period. Corporate and Investment Bank uses Management VaR
with a two-year equally weighted historical period, at a 95% confidence level, with a one day holding period.
‘Mandatory break clause’ In the context of counterparty credit risk, a contract clause that means a trade will be ended on a
particular date.
‘Marked to market approach’ A counterparty credit risk exposure calculation approach which uses the current mark to market
value of derivative positions as well as a potential future exposure add-on to calculate an exposure to which a risk weight can be
applied. This is also known as the Current Exposure Method.
‘Marked to market (MTM) LTV ratio’ The loan amount as a percentage of the current value of the asset used to secure the loan.
Also see ‘Balance weighted Loan to Value (LTV) ratio’ and ‘Valuation weighted Loan to Value (LTV) ratio.’
‘Market risk’ The risk of loss arising from potential adverse changes in the value of the Barclays Group’s assets and liabilities from
fluctuation in market variables including, but not limited to, interest rates, foreign exchange, equity prices, commodity prices,
credit spreads, implied volatilities and asset correlations.
‘Master netting agreements’ An agreement that provides for a single net settlement of all financial instruments and collateral
covered by the agreement in the event of the counterparty’s default or bankruptcy or insolvency, resulting in a reduced exposure.
‘Master trust securitisation programmes’ A securitisation structure where a trust is set up for the purpose of acquiring a pool of
receivables. The trust issues multiple series of securities backed by these receivables.
‘Material Risk Takers (MRTs)’ Categories of staff whose professional activities have or are deemed to have a material impact on
Barclays’ risk profile, as determined in accordance with the European Banking Authority regulatory technical standard on the
identification of such staff.
‘Maximum Distributable Amount (MDA)’ The MDA is a factor representing the available distributable profit whilst remaining in
excess of its combined buffer requirement. CRD IV places restrictions on a bank’s dividend decisions depending on its proximity to
meeting the buffer.
‘Medium-Term Notes’ Corporate notes (or debt securities) continuously offered by a company to investors through a dealer.
Investors can choose from differing maturities, ranging from nine months to 30 years. They can be issued on a fixed or floating
coupon basis or with an exotic coupon; with a fixed maturity date (non-callable) or with embedded call or put options or early
repayment triggers. MTNs are most generally issued as senior, unsecured debt.
‘Methodology and policy’ In the context of the Capital Risk section, the effect on RWAs of methodology changes driven by
regulatory policy changes.
‘MiFID II’ The Markets in Financial Instruments Directive 2004/39/EC (known as "MiFID" I) as subsequently amended to MiFID II is a
European Union law that provides harmonised regulation for investment services across the 31 member states of the European
Economic Area.
‘Minimum requirement for own funds and eligible liabilities (MREL)’ A European Union wide requirement under the Bank Recovery
and Resolution Directive for all European banks and investment banks to hold a minimum level of equity and/or loss absorbing
eligible liabilities to ensure the operation of the bail-in tool to absorb losses and recapitalise an institution in resolution. An
institution’s MREL requirement is set by its resolution authority. Amendments in the EU Risk Reduction Measure package are
designed to align MREL and TLAC for EU G-SIBs.
‘Model risk’ The risk of the potential adverse consequences from financial assessments or decisions based on incorrect or misused
model outputs and reports.
‘Model updates’ In the context of the Capital Risk section, changes in RWAs caused by model implementation, changes in model
scope or any changes required to address model malfunctions.
‘Model validation’ Process through which models are independently challenged, tested and verified to prove that they have been
built, implemented and used correctly, and that they continue to be fit-for-purpose.
‘Modelled—VaR’ In the context of RWAs, Market risk calculated using value at risk models laid down by the CRR and supervised by
the PRA.

-- 112 of 120 --

Glossary of Terms
110
‘Money market funds’ Investment funds typically invested in short-term debt securities.
‘Monoline derivatives’ Derivatives with a monoline insurer such as credit default swaps referencing the underlying exposures held.
‘Moody’s’ A credit rating agency.
‘Mortgage Servicing Rights (MSR)’ A contractual agreement in which the right to service an existing mortgage is sold by the original
lender to another party that specialises in the various functions involved with servicing mortgages.
‘Multilateral development banks’ Financial institutions created for the purposes of development, where membership transcends
national boundaries.
‘National discretion’ Discretions in CRD given to member states to allow the local regulator additional powers in the application of
certain CRD rules in its jurisdiction.
‘Net asset value per share’ Calculated by dividing shareholders’ equity, excluding non-controlling interests and other equity
instruments, by the number of issued ordinary shares.
‘Net interest income (NII)’ The difference between interest income on assets and interest expense on liabilities.
‘Net interest margin (NIM)’ Annualised net interest income divided by the sum of average customer assets.
‘Net investment income’ Changes in the fair value of financial instruments designated at fair value, dividend income and the net
result on disposal of available for sale assets.
‘Net Stable Funding Ratio (NSFR)’ The ratio of available stable funding to required stable funding over a one year time horizon,
assuming a stressed scenario. The ratio is required to be over 100%. Available stable funding would include such items as equity
capital, preferred stock with a maturity of over 1 year, or liabilities with a maturity of over 1 year. The required amount of stable
funding is calculated as the sum of the value of the assets held and funded by the institution, multiplied by a specific required
stable funding (RSF) factor assigned to each particular asset type, added to the amount of potential liquidity exposure multiplied by
its associated RSF factor.
‘Net trading income’ Gains and losses arising from trading positions which are held at fair value, in respect of both market-making
and customer business, together with interest, dividends and funding costs relating to trading activities.
‘Net write-off rate’ Expressed as a percentage and represents balances written off in the reporting period less any post write-off
recoveries divided by gross loans and advances held at amortised cost at the balance sheet date.
‘Net written credit protection’ In the context of leverage exposure, the net notional value of credit derivatives protection sold and
credit derivatives protection bought.
‘New bookings’ The total of the original balance on accounts opened in the reporting period, including any applicable fees and
charges included in the loan amount.
‘Non-asset backed debt instruments’ Debt instruments not backed by collateral, including government bonds; US agency bonds;
corporate bonds; commercial paper; certificates of deposit; convertible bonds; corporate bonds and issued notes.
‘Non-model method (NMM)’ In the context of RWAs, Counterparty credit risk, RWAs where the exposure amount has been derived
through the use of CRR norms, as opposed to an internal model.
‘Non-Traded Market Risk’ The risk that the current or future exposure in the banking book (i.e. non-traded book) will impact bank's
capital and/or earnings due to adverse movements in Interest or foreign exchange rates.
‘Non-Traded VaR’ Reflects the volatility in the value of the fair value through other comprehensive income (FVOCI) investments in
the liquidity pool which flow directly through capital via the FVOCI reserve. The underlying methodology to calculate non-traded
VaR is similar to Traded Management VaR, but the two measures are not directly comparable. The Non-Traded VaR represents the
volatility to capital driven by the FVOCI exposures. These exposures are in the banking book and do not meet the criteria for trading
book treatment.
‘Notch’ A single unit of measurement in a credit rating scale.
‘Notional amount’ The nominal or face amount of a financial instrument, such as a loan or a derivative, that is used to calculate
payments made on that instrument.
‘Open Banking’ The Payment Services Directive (PSD2) and the Open API standards and data sharing remedy imposed by the UK
Competition and Markets Authority following its Retail Banking Market Investigation Order.
‘Operating leverage’ Operating expenses compared to total income less credit impairment charges and other provisions.
‘Operational risk’ The risk of loss to the bank from inadequate or failed processes or systems, human factors or due to external
events (for example, fraud) where the root cause is not due to credit or market risks.

-- 113 of 120 --

Glossary of Terms
111
‘Operational Riskdata eXchange (ORX)’ The Operational Riskdata eXchange Association (ORX) is a not-for-profit industry association
dedicated to advancing the measurement and management of operational risk in the global financial services industry. Barclays is a
member of ORX.
‘Origination led’ Focus on high margin, low capital fee based activities and related hedging opportunities.
‘OSII’ Other systemically important institutions are institutions that are deemed to create risk to financial stability due to their
systemic importance.
‘Over-the-counter (OTC) derivatives’ Derivative contracts that are traded (and privately negotiated) directly between two parties.
They offer flexibility because, unlike standardised exchange-traded products, they can be tailored to fit specific needs.
‘Overall capital requirement’ The overall capital requirement is the sum of capital required to meet the total of a Pillar 1
requirement, a Pillar 2A requirement, a Global Systemically Important Institution (G-SII) buffer, a Capital Conservation Buffer (CCB)
and a Countercyclical Capital Buffer (CCyB).
‘Own credit’ The effect of changes in the Barclays Group’s own credit standing on the fair value of financial liabilities.
‘Owner occupied mortgage’ A mortgage where the intention of the customer was to occupy the property at origination.
‘Own funds’ The sum of Tier 1 and Tier 2 capital.
‘Past due items’ Refers to loans where the borrower has failed to make a payment when due under the terms of the loan contract.
‘Payment Protection Insurance (PPI) redress’ Provision for the settlement of PPI miss-selling claims and related claims management
costs.
‘Pension Risk’ The risk of the Barclays Group’s earnings and capital being adversely impacted by the Barclays Group’s defined
benefit obligations increasing or the value of the assets backing these defined benefit obligations decreasing due to changes in both
the level and volatility of prices.
‘Performance costs’ The accounting charge recognised in the period for performance awards. For deferred incentives and long-
term incentives, the accounting charge is spread over the relevant periods in which the employee delivers service.
‘Personal Banking’ Offers retail advice, products and services to community and premier customers in the UK.
‘Period end allocated tangible equity’ Allocated tangible equity is calculated as 13.0% (2018: 13.0%) of RWAs for each business,
adjusted for capital deductions, excluding goodwill and intangible assets, reflecting assumptions the Barclays Group uses for capital
planning purposes. Head Office allocated tangible equity represents the difference between the Barclays Group’s tangible
shareholders’ equity and the amounts allocated to businesses.
‘Pillar 1 requirements’ The minimum regulatory capital requirements to meet the sum of credit (including counterparty credit),
market and operational risk.
‘Pillar 2A requirements’ The additional regulatory capital requirement to meet risks not captured under Pillar 1 requirements. This
requirement is the outcome of the bank’s Internal Capital Adequacy Assessment Process (ICAAP) and the complementary
supervisory review and evaluation carried out by the PRA.
‘Post-model adjustment (PMA)’ In the context of Basel models, a PMA is a short term increase in regulatory capital applied at
portfolio level to account for model input data deficiencies, inadequate model performance or changes to regulatory definitions
(e.g. definition of default) to ensure the model output is accurate, complete and appropriate.
‘Potential Future Exposure (PFE) on Derivatives’ A regulatory calculation in respect of the Barclays Group’s potential future credit
exposure on both exchange traded and OTC derivative contracts, calculated by assigning a standardised percentage (based on the
underlying risk category and residual trade maturity) to the gross notional value of each contract.
‘PRA waivers’ PRA approvals that specifically give permission to the bank to either modify or waive existing rules. Waivers are
specific to an organisation and require applications being submitted to and approved by the PRA.
‘Primary securitisations’ The issuance of securities (bonds and commercial papers) for fund-raising.
‘Primary Stress Tests’ In the context of Traded Market Risk, Stress Testing provides an estimate of potentially significant future
losses that might arise from extreme market moves or scenarios. Primary Stress Tests apply stress moves to key liquid risk factors
for each of the major trading asset classes.
‘Prime Services’ Involves financing of fixed income and equity positions using Repo and stock lending facilities. The Prime Services
business also provides brokerage facilitation services for hedge fund clients offering execution and clearance facilities for a variety
of asset classes.
‘Principal’ In the context of a loan, the amount borrowed, or the part of the amount borrowed which remains unpaid (excluding
interest).
‘Principal Investments’ / ‘Private equity investments’ Investments in equity securities in operating companies not quoted on a
public exchange. Investment in private equity often involves the investment of capital in private companies or the acquisition of a

-- 114 of 120 --

Glossary of Terms
112
public company that results in the delisting of public equity. Capital for private equity investment is raised by retail or institutional
investors and used to fund investment strategies such as leveraged buyouts, venture capital, growth capital, distressed investments
and mezzanine capital.
‘Principal Risks’ The principal risks affecting the Barclays Group described in the risk review section of the Barclays PLC Annual
Report.
‘Pro-cyclicality’ Movements in financial variables (including capital requirements) following natural fluctuations in the economic
cycle, where the subsequent impact on lending or other market behaviours acts as an amplification of the economic cycle by the
financial sector.
‘Probability of Default (PD)’ The likelihood that a loan will not be repaid and will fall into default. PD may be calculated for each
client who has a loan (normally applicable to wholesale customers/clients) or for a portfolio of clients with similar attributes
(normally applicable to retail customers). To calculate PD, Barclays assesses the credit quality of borrowers and other
counterparties and assigns them an internal risk rating. Multiple rating methodologies may be used to inform the rating decision on
individual large credits, such as internal and external models, rating agency ratings, and for wholesale assets market information
such as credit spreads. For smaller credits, a single source may suffice such as the result from an internal rating model.
‘Product structural hedge’ An interest rate hedge in place to reduce earnings volatility on product balances with an instant access
(such as non-interest bearing current accounts and managed rate deposits) and to smoothen the income over a medium/long term.
‘Properties in Possession held as ’Loans and Advances to Customers’’ Properties in the UK and Italy where the customer continues
to retain legal title but where the bank has enforced the possession order as part of the foreclosure process to allow for the
disposal of the asset or the court has ordered the auction of the property.
‘Properties in Possession held as ‘Other Real Estate Owned’’ Properties in South Africa, where the bank has taken legal ownership
of the title as a result of purchase at an auction or similar and treated as ‘Other Real Estate Owned’ within other assets on the
bank’s balance sheet.
‘Proprietary trading’ When a bank, brokerage or other financial institution trades on its own account, at its own risk, rather than on
behalf of customers, so as to make a profit for itself.
‘Prudential Regulation Authority (PRA)’ The statutory body responsible for the prudential supervision of banks, building societies,
insurers and a small number of significant investment banks in the UK. The PRA is a subsidiary of the Bank of England.
‘Prudential valuation adjustment (PVA)’ A calculation which adjusts the accounting values of positions held on balance sheet at fair
value to comply with regulatory valuation standards, which place greater emphasis on the inherent uncertainty around the value at
which a trading book position could be exited.
‘Public benchmark’ Unsecured medium term notes issued in public syndicated transactions.
‘Qualifying central bank claims’ An amount calculated in line with the PRA policy statement allowing banks to exclude claims on the
central bank from the calculation of the leverage exposure measure, as long as these are matched by deposits denominated in the
same currency and of identical or longer maturity.
‘Qualifying Revolving Retail Exposure (QRRE)’ In the context of the IRB approach to credit risk RWA calculations, an exposure
meeting the criteria set out in BIPRU 4.6.42 R (2). It includes most types of credit card exposure.
‘Rates’ In the context of Investment Bank income analysis, trading revenue relating to government bonds and linear interest rate
derivatives.
‘Re-aging’ The returning of a delinquent account to up-to-date status without collecting the full arrears (principal, interest and
fees).
‘Real Estate Mortgage Investment Conduits (REMICs)’ An entity that holds a fixed pool of mortgages and that is separated into
multiple classes of interests for issuance to investors.
‘Recovery book’ Represents the total amount of exposure which has been transferred to recovery units who set and implement
strategies to recover the Group’s exposure.
‘Recovery book Impairment Coverage Ratio’ Impairment allowance held against recoveries balances expressed as a percentage of
balance in recoveries.
‘Recovery book proportion of outstanding balances’ Represents the amount of recoveries (gross month-end customer balances of
all accounts that have charged-off) as at the period end compared to total outstanding balances. The size of the recoveries book
would ultimately have an impact on the overall impairment requirement on the portfolio. Balances in recoveries will decrease if:
assets are written-off; amounts are collected; or assets are sold to a third party (i.e. debt sale).
‘Regulatory capital’ The amount of capital that a bank holds to satisfy regulatory requirements.
‘Renegotiated loans’ Loans are generally renegotiated either as part of an ongoing customer relationship or in response to an
adverse change in the circumstances of the borrower. In the latter case renegotiation can result in an extension of the due date of

-- 115 of 120 --

Glossary of Terms
113
payment or repayment plans under which the Barclays Group offers a concessionary rate of interest to genuinely distressed
borrowers. This will result in the asset continuing to be overdue and will be individually impaired where the renegotiated payments
of interest and principal will not recover the original carrying amount of the asset. In other cases, renegotiation will lead to a new
agreement, which is treated as a new loan.
‘Repurchase agreement (Repo)’ / ‘Reverse repurchase agreement (Reverse repo)’ Arrangements that allow counterparties to use
financial securities as collateral for an interest bearing cash loan. The borrower agrees to sell a security to the lender subject to a
commitment to repurchase the asset at a specified price on a given date. For the party selling the security (and agreeing to
repurchase it in the future) it is a Repurchase agreement or Repo; for the counterparty to the transaction (buying the security and
agreeing to sell in the future) it is a Reverse repurchase agreement or Reverse repo.
‘Reputation risk’ The risk that an action, transaction, investment or event will reduce trust in the Barclays Group’s integrity and
competence by clients, counterparties, investors, regulators, employees or the public.
‘Re-securitisations’ The repackaging of Securitised Products into securities. The resulting securities are therefore securitisation
positions where the underlying assets are also predominantly securitisation positions.
‘Reserve Capital Instruments (RCIs)’ Hybrid issued capital securities which may be debt or equity accounted, depending on the
terms.
‘Residential Mortgage-Backed Securities (RMBS)’ Securities that represent interests in a group of residential mortgages. Investors in
these securities have the right to cash received from future mortgage payments (interest and/or principal).
‘Residual maturity’ The remaining contractual term of a credit obligation associated with a credit exposure.
‘Restructured loans’ Comprises loans where, for economic or legal reasons related to the debtor’s financial difficulties, a concession
has been granted to the debtor that would not otherwise be considered. Where the concession results in the expected cash flows
discounted at the original effective interest rate being less than the loan’s carrying value, an impairment allowance will be raised.
‘Retail Loans’ Loans to individuals or small and medium sized enterprises rather than to financial institutions and larger businesses.
It includes both secured and unsecured loans such as mortgages and credit card balances, as well as loans to certain smaller
business customers, typically with exposures up to £3m or with a turnover up to £5m.
‘Return on average Risk Weighted Assets’ Statutory profit after tax as a proportion of average RWAs.
‘Return on average tangible shareholders’ equity’ (RoTE) Annualised profit after tax attributable to ordinary equity holders of the
parent, as a proportion of average shareholders’ equity excluding non-controlling interests and other equity instruments adjusted
for the deduction of intangible assets and goodwill.
‘Return on average allocated tangible equity’ Annualised profit after tax attributable to ordinary equity holders of the parent, as a
proportion of average allocated tangible equity.
‘Risk appetite’ The level of risk that Barclays is prepared to accept whilst pursuing its business strategy, recognising a range of
possible outcomes as business plans are implemented.
‘Risk weighted assets (RWAs)’ A measure of a bank’s assets adjusted for their associated risks. Risk weightings are established in
accordance with the Basel rules as implemented by CRR and local regulators.
‘Risks not in VaR (RNIVS)’ Refers to all the key market risks which are not captured or not well captured within the VaR model
framework.
‘Sarbanes-Oxley requirements’ The Sarbanes-Oxley Act 2002 (SOX), which was introduced by the US Government to safeguard
against corporate governance scandals such as Enron, WorldCom and Tyco. All US-listed companies must comply with SOX.
‘Second Lien’ Debt that is issued against the same collateral as higher lien debt but that is subordinate to it. In the case of default,
compensation for this debt will only be received after the first lien has been repaid and thus represents a riskier investment than
the first lien.
‘Secondary Stress Tests’ Secondary stress tests are used in measuring potential losses arising from illiquid market risks that cannot
be hedged or reduced within the time period covered in Primary Stress Tests.
‘Secured Overnight Financing Rate (SOFR)’ A broad measure of the cost of borrowing cash overnight collateralized by U.S. Treasury
securities in the repurchase agreement (repo) market.
‘Securities Financing Transactions (SFT)’ In the context of RWAs, any of the following transactions: a repurchase transaction, a
securities or commodities lending or borrowing transaction, or a margin lending transaction whereby cash collateral is received or
paid in respect of the transfer of a related asset.
‘Securities financing transactions adjustments’ In the context of leverage ratio, a regulatory add-on calculated as exposure less
collateral, taking into account master netting agreements.

-- 116 of 120 --

Glossary of Terms
114
‘Securities lending arrangements’ Arrangements whereby securities are legally transferred to a third party subject to an agreement
to return them at a future date. The counterparty generally provides collateral against non performance in the form of cash or
other assets.
‘Securitisation’ Typically, a process by which debt instruments such as mortgage loans or credit card balances are aggregated into a
pool, which is used to back new securities. A company sells assets to a special purpose vehicle (SPV) which then issues securities
backed by the assets. This allows the credit quality of the assets to be separated from the credit rating of the original borrower and
transfers risk to external investors.
‘Set-off clauses’ In the context of Counterparty credit risk, contract clauses that allow Barclays to set off amounts owed to us by a
counterparty against amounts owed by us to the counterparty.
‘Settlement balances’ Are receivables or payables recorded between the date (the trade date) a financial instrument (such as a
bond) is sold, purchased or otherwise closed out, and the date the asset is delivered by or to the entity (the settlement date) and
cash is received or paid.
‘Settlement risk’ The risk that settlement in a transfer system will not take place as expected, usually owing to a party defaulting on
one or more settlement obligations.
‘Significant Increase in Credit Risk (SICR)’ Barclays assesses when a significant increase in credit risk has occurred based on
quantitative and qualitative assessments.
‘Slotting’ Slotting is a Basel 2 approach that requires a standard set of rules to be used in the calculation of RWAs, based upon an
assessment of factors such as the financial strength of the counterparty. The requirements for the application of the Slotting
approach are detailed in BIPRU 4.5.
‘Sovereign exposure(s)’ Exposures to central governments, including holdings in government bonds and local government bonds.
‘Specific market risk’ A risk that is due to the individual nature of an asset and can potentially be diversified or the risk of a price
change in an investment due to factors related to the issuer or, in the case of a derivative, the issuer of the underlying investment.
‘Spread risk’ Measures the impact of changes to the swap spread, i.e. the difference between swap rates and government bond
yields.
‘SRB ALRB’ The systemic risk buffer (SRB) additional leverage ratio buffer (ALRB) is firm specific requirement set by the PRA using its
powers under section 55M of the Financial Services and Markets Act (2000). Barclays is required to hold an amount of CET1 capital
that is equal to or greater than its ALRB.
‘Stage 1’ This represents financial instruments where the credit risk of the financial instrument has not increased significantly since
initial recognition. Stage 1 financial instruments are required to recognise a 12 month expected credit loss allowance.
‘Stage 2’ This represents financial instruments where the credit risk of the financial instrument has increased significantly since
initial recognition. Stage 2 financial instruments are required to recognise a lifetime expected credit loss allowance.
‘Stage 3’ This represents financial instruments where the financial instrument is considered impaired. Stage 3 financial instruments
are required to recognise a lifetime expected credit loss allowance.
‘Standard & Poor’s’ A credit rating agency.
‘Standby facilities, credit lines and other commitments’ Agreements to lend to a customer in the future, subject to certain
conditions. Such commitments are either made for a fixed period, or have no specific maturity but are cancellable by the lender
subject to notice requirements.
‘Statutory’ Line items of income, expense, profit or loss, assets, liabilities or equity stated in accordance with the requirements of
the UK Companies Act 2006 and the requirements of International Financial Reporting Standards (IFRS).
‘Statutory return on average shareholders’ equity’ Statutory profit after tax attributable to ordinary shareholders as a proportion of
average shareholders’ equity.
‘STD’ / ‘Standardised Approach’ A method of calculating RWAs that relies on a mandatory framework set by the regulator to derive
risk weights based on counterparty type and a credit rating provided by an External Credit Assessment Institute.
‘Sterling Over Night Index Average (SONIA)’ Reflects bank and building societies’ wholesale overnight funding rates in the sterling
unsecured market administrated and calculated by the Bank of England.
‘Stress Testing’ A process which involves identifying possible future adverse events or changes in economic conditions that could
have unfavourable effects on the Barclays Group (either financial or non-financial), assessing the Barclays Group’s ability to
withstand such changes, and identifying management actions to mitigate the impact.
‘Stressed Value at Risk (SVaR)’ An estimate of the potential loss arising from a 12-month period of significant financial stress
calibrated to 99% confidence level over a 10-day holding period.

-- 117 of 120 --

Glossary of Terms
115
‘Structured entity’ An entity in which voting or similar rights are not the dominant factor in deciding control. Structured entities are
generally created to achieve a narrow and well defined objective with restrictions around their ongoing activities.
‘Structural hedge’ / ‘hedging’ An interest rate hedge in place to reduce earnings volatility and to smoothen the income over a
medium/long term on positions that exist within the balance sheet and do not re-price in line with market rates. See also ‘Equity
structural hedge’ and ‘Product structural hedge’.
‘Structural model of default’ A model based on the assumption that an obligor will default when its assets are insufficient to cover
its liabilities.
‘Structured credit’ Includes legacy structured credit portfolio primarily comprising derivative exposure and financing exposure to
structured credit vehicles.
‘Structured finance/notes’ A structured note is an investment tool that pays a return linked to the value or level of a specified asset
or index and sometimes offers capital protection if the value declines. Structured notes can be linked to equities, interest rates,
funds, commodities and foreign currency.
‘Sub-prime’ Sub-prime is defined as loans to borrowers typically having weakened credit histories that include payment
delinquencies and potentially more severe problems such as court judgments and bankruptcies. They may also display reduced
repayment capacity as measured by credit scores, high debt-to-income ratios, or other criteria indicating heightened risk of default.
‘Subordinated liabilities’ Liabilities which, in the event of insolvency or liquidation of the issuer, are subordinated to the claims of
depositors and other creditors of the issuer.
‘Supranational bonds’ Bonds issued by an international organisation, where membership transcends national boundaries (e.g. the
European Union or World Trade Organisation).
‘Synthetic Securitisation Transactions’ Securitisation transactions effected through the use of derivatives.
‘Systemic Risk Buffer’ CET1 capital that may be required to be held as part of the Combined Buffer Requirement increasing the
capacity of UK banks to absorb stress and limiting the damage to the economy as a result of restricted lending.
‘Tangible net asset value (TNAV)’ Shareholders’ equity excluding non-controlling interests adjusted for the deduction of intangible
assets and goodwill.
‘Tangible net asset value per share’ Calculated by dividing shareholders’ equity, excluding non-controlling interests and other
equity instruments, less goodwill and intangible assets, by the number of issued ordinary shares.
‘Tangible shareholders’ equity’ Shareholders’ equity excluding non-controlling interests and other equity instruments adjusted for
the deduction of intangible assets and goodwill.
‘Term premium’ Additional interest required by investors to hold assets with a longer period to maturity.
‘The Fundamental Review of the Trading Book (FRTB)’ Is a comprehensive suite of capital rules developed by the Basel Committee
on Banking Supervision as part of Basel III applicable to banks’ wholesale trading activities.
‘The Standardised Approach (TSA)’ Under the TSA, banks are required to hold regulatory capital for operational risk equal to the
annual average, calculated over a rolling three-year period, of the relevant income indicator (across all business lines), multiplied by
a supervisory defined percentage factor by business lines.
‘The three lines of defence’ The three lines of defence operating model enables Barclays to separate risk management activities
between those client facing areas of the Barclays Group and associated support functions responsible for identifying risk, operating
within applicable limits and escalating risk events (first line); colleagues in Risk and Compliance who establish the limits, rules and
constraints under which the first line operates and monitors their performance against those limits and constraints (second line);
and, colleagues in Internal Audit who provide assurance to the Board and Executive Management over the effectiveness of
governance, risk management and control over risks (third line). The Legal function does not sit in any of the three lines, but
supports them all. The Legal function is, however, subject to oversight from Risk and Compliance with respect to operational and
conduct risks.
‘Tier 1 capital’ The sum of the Common Equity Tier 1 capital and Additional Tier 1 capital.
‘Tier 1 capital ratio’ The ratio which expresses Tier 1 capital as a percentage of RWAs under CRR.
‘Tier 2 (T2) capital’ A type of capital as defined in the CRR principally composed of capital instruments, subordinated loans and
share premium accounts where qualifying conditions have been met.
‘Tier 2 (T2) securities’ Securities that are treated as Tier 2 (T2) capital in the context of CRR.
‘Total capital ratio’ Total Regulatory capital as a percentage of RWAs.
‘Total Loss Absorbing Capacity (TLAC)’ A standard published by the FSB which is applicable to G-SIBs and requires a G-SIB to hold a
prescriptive minimum level of instruments and liabilities that should be readily available for bail-in within resolution to absorb
losses and recapitalise the institution.

-- 118 of 120 --

Glossary of Terms
116
‘Total outstanding balance’ In retail banking, total outstanding balance is defined as the gross month-end customer balances on all
accounts including accounts charged off to recoveries.
‘Total return swap’ An instrument whereby the seller of protection receives the full return of the asset, including both the income
and change in the capital value of the asset. The buyer of the protection in return receives a predetermined amount.
‘Total balances on forbearance programmes coverage ratio’ Impairment allowance held against Forbearance balances expressed as
a percentage of balance in forbearance.
‘Traded Market Risk’ The risk of a reduction to earnings or capital due to volatility of trading book positions.
‘Trading book’ All positions in financial instruments and commodities held by an institution either with trading intent, or in order to
hedge positions held with trading intent.
‘Traditional Securitisation Transactions’ Securitisation transactions in which an underlying pool of assets generates cash flows to
service payments to investors.
‘Transitional’ When a measure is presented or described as being on a transitional basis, it is calculated in accordance with the
transitional provisions set out in Part Ten of CRR.
‘Treasury and Capital Risk’ This comprises of Liquidity Risk, Capital Risk and Interest Rate Risk in the Banking Book.
‘Twelve month expected credit losses’ The portion of the lifetime ECL arising if default occurs within 12 months of the reporting
date (or shorter period if the expected life is less than 12 months), weighted by the probability of said default occurring.
‘Twelve month PD’ The likelihood of accounts entering default within 12 months of the reporting date.
‘Unencumbered’ Assets not used to secure liabilities or otherwise pledged.
‘United Kingdom (UK)’ Geographic segment where Barclays operates comprising the UK. Also see ‘Europe’.
‘UK Bank levy’ A levy that applies to UK banks, building societies and the UK operations of foreign banks. The levy is payable based
on a percentage of the chargeable equity and liabilities of the bank on its balance sheet date.
‘UK leverage exposure’ Is calculated as per the PRA rulebook, where the exposure calculation also includes the FPC’s
recommendation to allow banks to exclude claims on the central bank from the calculation of the leverage exposure measure, as
long as these are matched by deposits denominated in the same currency and of identical or longer maturity.
‘UK leverage ratio’ As per the PRA rulebook, means a bank’s tier 1 capital divided by its total exposure measure, with this ratio
expressed as a percentage.
‘Unfunded credit protection’ Is a technique of credit risk mitigation where the reduction of the credit risk on the exposure of an
institution derives from the obligation of a third party to pay an amount in the event of the default of the borrower or the
occurrence of other specified credit events.
‘US Partner Portfolio’ Co-branded credit card programs with companies across various sectors including travel, entertainment,
retail and financial sectors.
‘US Residential Mortgages’ Securities that represent interests in a group of US residential mortgages.
‘Valuation weighted Loan to Value (LTV) Ratio’ In the context of credit risk disclosures on secured home loans, a means of
calculating marked to market LTVs derived by comparing total outstanding balance and the value of total collateral we hold against
these balances. Valuation weighted loan to value is calculated using the following formula: LTV = total outstandings in
portfolio/total property values of total outstandings in portfolio.
‘Value at Risk (VaR)’ A measure of the potential loss of value arising from unfavourable market movements at a specific confidence
level and within a specific timeframe.
‘Weighted off balance sheet commitments’ Regulatory add-ons to the leverage exposure measure based on credit conversion
factors used in the Standardised Approach to credit risk.
‘Wholesale loans’ / ‘lending’ Lending to larger businesses, financial institutions and sovereign entities.
‘Write-off (gross)’ The point where it is determined that an asset is irrecoverable, or it is no longer considered economically viable
to try to recover the asset or it is deemed immaterial or full and final settlement is reached and the shortfall written off. In the
event of write-off, the customer balance is removed from the balance sheet and the impairment allowance held against the asset is
released. Net write-offs represent gross write-offs less post write-off recoveries.
‘Wrong-way risk’ Arises, in a trading exposure, when there is significant correlation between the underlying asset and the
counterparty, which in the event of default would lead to a significant mark to market loss. When assessing the credit exposure of a
wrong-way trade, analysts take into account the correlation between the counterparty and the underlying asset as part of the
sanctioning process.

-- 119 of 120 --

Exhibit 99.2 – Capitalisation and Indebtedness
117
The following table sets out the Group’s capitalisation, indebtedness and contingent liabilities on a consolidated basis, in
accordance with IFRS, as at 30 June 2020.
As at
30.06.20
m
Share Capital of Barclays PLC
Ordinary shares - issued and fully paid shares of £0.25 each 17,345
£m
Group equity
Called up share capital and share premium 4,620
Other equity instruments 10,871
Other reserves 6,996
Retained earnings 45,817
Total equity excluding non-controlling interests 68,304
Non-controlling interests 1,237
Total equity 69,541
Group indebtedness
Subordinated liabilities 19,886
Debt securities in issue 103,970
Total indebtedness 123,856
Total capitalisation and indebtedness 193,397
Group contingent liabilities and commitments
Guarantees and letters of credit pledged as collateral security 16,225
Performance guarantees, acceptances and endorsements 6,739
Total contingent liabilities 22,964
Documentary credits and other short-term trade related transactions 1,162
Standby facilities, credit lines and other commitments 332,969
Total commitments 334,131

-- 120 of 120 --